Tesis Doctorales

%7B%22status%22%3A%22success%22%2C%22updateneeded%22%3Afalse%2C%22instance%22%3Afalse%2C%22meta%22%3A%7B%22request_last%22%3A0%2C%22request_next%22%3A0%2C%22used_cache%22%3Atrue%7D%2C%22data%22%3A%5B%7B%22key%22%3A%22JVVRV55F%22%2C%22library%22%3A%7B%22id%22%3A6316110%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Recacha%20Villamor%22%2C%22parsedDate%22%3A%222019-03-20%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BRecacha%20Villamor%2C%20E.%20%282019%29.%20%26lt%3Bi%26gt%3BSupresion%20de%20la%20respuesta%20SOS%20como%20estrategia%20para%20la%20sensibilizaci%26%23xF3%3Bn%20de%20bacterias%20Gram-negativas%20resistentes%20a%20quinolonas.%26lt%3B%5C%2Fi%26gt%3B%20%26lt%3Ba%20class%3D%26%23039%3Bzp-ItemURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fhdl.handle.net%5C%2F11441%5C%2F84689%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fhdl.handle.net%5C%2F11441%5C%2F84689%26lt%3B%5C%2Fa%26gt%3B%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22thesis%22%2C%22title%22%3A%22Supresion%20de%20la%20respuesta%20SOS%20como%20estrategia%20para%20la%20sensibilizaci%5Cu00f3n%20de%20bacterias%20Gram-negativas%20resistentes%20a%20quinolonas.%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Esther%22%2C%22lastName%22%3A%22Recacha%20Villamor%22%7D%5D%2C%22abstractNote%22%3A%22%22%2C%22thesisType%22%3A%22%22%2C%22university%22%3A%22%22%2C%22date%22%3A%222019-03-20%22%2C%22language%22%3A%22spa%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fhdl.handle.net%5C%2F11441%5C%2F84689%22%2C%22collections%22%3A%5B%22VN54CXGB%22%5D%2C%22dateModified%22%3A%222025-11-25T09%3A55%3A37Z%22%7D%7D%2C%7B%22key%22%3A%22KDDK2VAX%22%2C%22library%22%3A%7B%22id%22%3A6316110%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Zakariya-Yousef%20Breval%22%2C%22parsedDate%22%3A%222017-12-14%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BZakariya-Yousef%20Breval%2C%20I.%20%282017%29.%20%26lt%3Bi%26gt%3BUtilidad%20del%201-3-beta-d-glucano%28BDG%29%20y%20los%20anticuerpos%20antimicelio%20%28CAGTA%29%2C%20en%20el%20diagn%26%23xF3%3Bstico%20de%20la%20candidiasis%20invasiva%20en%20pacientes%20cr%26%23xED%3Bticos%20no%20neutrop%26%23xE9%3Bnicos.%26lt%3B%5C%2Fi%26gt%3B%20%26lt%3Ba%20class%3D%26%23039%3Bzp-ItemURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fhdl.handle.net%5C%2F11441%5C%2F70701%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fhdl.handle.net%5C%2F11441%5C%2F70701%26lt%3B%5C%2Fa%26gt%3B%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22thesis%22%2C%22title%22%3A%22Utilidad%20del%201-3-beta-d-glucano%28BDG%29%20y%20los%20anticuerpos%20antimicelio%20%28CAGTA%29%2C%20en%20el%20diagn%5Cu00f3stico%20de%20la%20candidiasis%20invasiva%20en%20pacientes%20cr%5Cu00edticos%20no%20neutrop%5Cu00e9nicos.%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ismail%22%2C%22lastName%22%3A%22Zakariya-Yousef%20Breval%22%7D%5D%2C%22abstractNote%22%3A%22La%20alta%20morbilidad%20y%20mortalidad%20de%20las%20candidiasis%20invasivas%20implica%20la%20necesidad%20de%20un%20diagn%5Cu00f3stico%20r%5Cu00e1pido%20para%20instaurar%20un%20tratamiento%20antif%5Cu00fangico%20dirigido%20eficaz%20con%20rapidez.%20El%20m%5Cu00e9todo%20diagn%5Cu00f3stico%20de%20referencia%20es%20el%20hemocultivo%2C%20pero%20debido%20a%20su%20baja%20sensibilidad%20y%20lentitud%2C%20hace%20estrictamente%20necesario%20buscar%20alternativas%20diagn%5Cu00f3sticas.%20Entre%20los%20m%5Cu00e9todos%20diagn%5Cu00f3sticos%20alternativos%20se%20encuentran%20los%20biomarcadores%20anticuerpos%20antimicelio%20%28CAGTA%29%20y%201-3-Beta-D-Glucano%20%28BDG%29.%20El%20objetivo%20principal%20del%20estudio%20es%20analizar%20la%20utilidad%20y%20el%20rendimiento%20de%20los%20biomarcadores%2C%20CAGTA%20y%20BDG%2C%20tanto%20de%20forma%20individual%20como%20combinada%2C%20en%20el%20diagn%5Cu00f3stico%20de%20la%20CI%20en%20el%20paciente%20cr%5Cu00edtico%20no%20neutrop%5Cu00e9nico.%22%2C%22thesisType%22%3A%22%22%2C%22university%22%3A%22%22%2C%22date%22%3A%222017-12-14%22%2C%22language%22%3A%22spa%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fhdl.handle.net%5C%2F11441%5C%2F70701%22%2C%22collections%22%3A%5B%22VN54CXGB%22%5D%2C%22dateModified%22%3A%222025-11-24T12%3A13%3A38Z%22%7D%7D%2C%7B%22key%22%3A%22L5RY7TXN%22%2C%22library%22%3A%7B%22id%22%3A6316110%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Delgado%20Valverde%22%2C%22parsedDate%22%3A%222017-09-27%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BDelgado%20Valverde%2C%20M.%20M.%20%282017%29.%20%26lt%3Bi%26gt%3BImpacto%20de%20la%20concentraci%26%23xF3%3Bn%20m%26%23xED%3Bnima%20inhibitoria%20%28cmi%29%20y%20de%20los%20puntos%20de%20corte%20cl%26%23xED%3Bnicos%20%28clsi%20y%20eucast%29%20de%20las%20combinaciones%20betalact%26%23xE1%3Bmicos%20%5C%2F%20inhibidores%20de%20betalactamasas%20en%20el%20pron%26%23xF3%3Bstico%20de%20bacteriemias%20por%20enterobacteriaceae%26lt%3B%5C%2Fi%26gt%3B.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-ItemURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fhdl.handle.net%5C%2F11441%5C%2F73670%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fhdl.handle.net%5C%2F11441%5C%2F73670%26lt%3B%5C%2Fa%26gt%3B%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22thesis%22%2C%22title%22%3A%22Impacto%20de%20la%20concentraci%5Cu00f3n%20m%5Cu00ednima%20inhibitoria%20%28cmi%29%20y%20de%20los%20puntos%20de%20corte%20cl%5Cu00ednicos%20%28clsi%20y%20eucast%29%20de%20las%20combinaciones%20betalact%5Cu00e1micos%20%5C%2F%20inhibidores%20de%20betalactamasas%20en%20el%20pron%5Cu00f3stico%20de%20bacteriemias%20por%20enterobacteriaceae%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mar%5Cu00eda%20Mercedes%22%2C%22lastName%22%3A%22Delgado%20Valverde%22%7D%5D%2C%22abstractNote%22%3A%22Los%20puntos%20de%20corte%20cl%5Cu00ednicos%20se%20utilizan%20para%20predecir%20la%20eficacia%20terap%5Cu00e9utica%20de%20un%20antibi%5Cu00f3tico%20cuando%20se%20utiliza%20a%20la%20dosis%20est%5Cu00e1ndar%20para%20el%20tratamiento%20de%20una%20infecci%5Cu00f3n%20causada%20por%20el%20pat%5Cu00f3geno%20analizado.%20Por%20lo%20tanto%2C%20intentan%20distinguir%20entre%20los%20pacientes%20en%20los%20que%20es%20probable%20o%20improbable%2C%20respectivamente%2C%20una%20respuesta%20favorable%20al%20tratamiento.%20CLSI%20y%20EUCAST%20son%20los%20principales%20organismos%20internacionales%20que%20establecen%20puntos%20de%20corte%20cl%5Cu00ednicos%2C%20pero%20estos%20organismos%20difieren%20en%20los%20puntos%20de%20corte%20para%20ciertos%20antibi%5Cu00f3ticos.%20Amoxicilina-clavul%5Cu00e1nico%20%28AMC%29%20y%20piperacilina-tazobactam%20%28PTZ%29%20son%20betalact%5Cu00e1micos%20en%20asociaci%5Cu00f3n%20con%20inhibidores%20de%20betalactamasas%20con%20actividad%20frente%20a%20bacterias%20gramnegativas%20y%20grampositivas.%20El%20objetivo%20de%20este%20proyecto%20fue%2C%20en%20el%20caso%20de%20piperacilina-tazobactam%2C%20evaluar%20el%20impacto%20de%20la%20CMI%20de%20este%20antibi%5Cu00f3tico%20en%20el%20pron%5Cu00f3stico%20cl%5Cu00ednico%20de%20pacientes%20con%20bacteriemia%20por%20enterobacterias%20cuyos%20aislados%20eran%20totalmente%20sensibles%20a%20PTZ%20o%20en%20el%20l%5Cu00edmite%20de%20la%20sensibilidad%3B%20mientras%20que%20para%20AMC%2C%20el%20objetivo%20fue%20comparar%20los%20resultados%20de%20sensibilidad%20usando%20la%20metodolog%5Cu00eda%20CLSI%20y%20EUCAST%2C%20as%5Cu00ed%20como%20evaluar%20el%20impacto%20de%20la%20CMI%20determinada%20de%20acuerdo%20a%20cada%20recomendaci%5Cu00f3n%20en%20el%20pron%5Cu00f3stico%20de%20pacientes%20con%20bacteriemia%20causada%20por%20enterobacterias%20que%20han%20recibido%20AMC%20como%20tratamiento.%20Se%20llev%5Cu00f3%20a%20cabo%20un%20proyecto%20multic%5Cu00e9ntrico%20observacional%20de%20cohortes%20prospectivo%20en%20el%20que%20participaron%2013%20hospitales%20universitarios%20espa%5Cu00f1oles%20entre%20Enero%20de%202011%20y%20Diciembre%20de%202013.%20El%20pron%5Cu00f3stico%20se%20evalu%5Cu00f3%20como%20fracaso%20cl%5Cu00ednico%20al%20final%20del%20tratamiento%20con%20el%20antimicrobiano%20de%20inter%5Cu00e9s%2C%20fracaso%20cl%5Cu00ednico%20en%20el%20d%5Cu00eda%2021%20y%20mortalidad%20en%20el%20d%5Cu00eda%2030.%20La%20CMI%20de%20los%20aislados%20se%20determin%5Cu00f3%20mediante%20microdiluci%5Cu00f3n%20en%20caldo%20siguiendo%20las%20recomendaciones%20de%20CLSI%20y%20EUCAST%20cuando%20correspond%5Cu00eda.%20El%20an%5Cu00e1lisis%20de%20los%20resultados%20se%20realiz%5Cu00f3%20mediante%20an%5Cu00e1lisis%20univariante%2C%20CART%20y%20regresi%5Cu00f3n%20log%5Cu00edstica%20usando%20el%20programa%20SPSS%2018.0.%20En%20el%20grupo%20de%20PTZ%20se%20incluyeron%20275%3A%20248%20%2890%2C2%25%29%20in%20el%20grupo%20de%20CMI%20baja%20%28%5Cu22644%20mg%5C%2FL%29%20y%2027%20%289%2C8%25%29%20en%20el%20grupo%20de%20CMI%20l%5Cu00edmite%20%288-16%20mg%5C%2FL%29.%20La%20mortalidad%20cruda%20en%20el%20d%5Cu00eda%2030%20fue%20del%2010%2C5%25%20y%2011%2C1%25%20en%20el%20grupo%20de%20CMI%20baja%20y%20l%5Cu00edmite%2C%20respectivamente%20%28RR%3D1%2C06%3B%20IC%2095%25%200%2C34-%203%2C27%3B%20p%3D1%29.%20Los%20an%5Cu00e1lisis%20multivariante%20del%20fracaso%20en%20el%20d%5Cu00eda%2021%2C%20al%20final%20del%20tratamiento%20con%20PTZ%20y%20la%20mortalidad%20en%20el%20d%5Cu00eda%2030%20no%20mostraron%20tendencia%20de%20aumento%20de%20fracaso%20o%20mortalidad%20con%20CMI%20l%5Cu00edmite%20%28RR%3D0%2C96%2C%20IC%2095%25%200%2C18-4%2C88%2C%20p%3D0%2C06%3B%20RR%3D0%2C52%20IC%2095%25%200%2C11-2%2C39%2C%20p%3D0%2C09%3B%20RR%3D1%2C48%2C%20IC%2095%25%200%2C33-6%2C68%2C%20p%3D0%2C6%29.%20Se%20incluyeron%20264%20pacientes%20tratados%20con%20AMC%2C%2052%20aislados%20%2819%2C7%29%20fueron%20resistentes%20de%20acuerdo%20a%20CLSI%20y%20141%20%2853%2C4%25%29%20por%20EUCAST%2C%20lo%20que%20origin%5Cu00f3%20un%20%5Cu00edndice%20de%20concordancia%20de%20solo%200%2C24.%20Cuando%20la%20CMI%20se%20analiz%5Cu00f3%20como%20variable%20continua%2C%20solo%20la%20determinada%20seg%5Cu00fan%20EUCATS%20se%20asoci%5Cu00f3%20con%20el%20fracaso%20cl%5Cu00ednico.%20El%20an%5Cu00e1lisis%20CART%20sugiri%5Cu00f3%20como%20punto%20de%20corte%20de%20resistencia%20%26gt%3B8%5C%2F4%20mg%5C%2FL%20para%20CLSI%2C%20el%20cual%20predijo%20el%20fracaso%20al%20final%20del%20tratamiento%20con%20AMC%20en%20el%20an%5Cu00e1lisis%20ajustado%20%28OR%3D1.96%3B%20IC%2095%25%3A%200.98-3.90%29.%20Una%20CMIEUCAST%20%26gt%3B16%5C%2F2%20mg%5C%2FL%20se%20asoci%5Cu00f3%20de%20manera%20independientemente%20con%20el%20fracaso%20al%20final%20del%20tratamiento%20con%20AMC%20y%20en%20el%20d%5Cu00eda%2021%20%28OR%20%3D%202%2C10%3B%20IC%2095%25%3A%201%2C05-4%2C21%20y%203%2C01%3B%200%2C93-9%2C67%2C%20respectivamente%29.%20Valores%20de%20CMI-EUCAST%20%26gt%3B32%5C%2F2%20mg%5C%2FL%20s%5Cu00f3lo%20fueron%20predictivos%20de%20fracaso%20entre%20los%20pacientes%20con%20bacteriemia%20de%20origen%20urinario%20o%20biliar.%20En%20conclusi%5Cu00f3n%2C%20no%20encontramos%20que%20una%20CMI%20cercana%20al%20punto%20de%20corte%20de%20PTZ%20se%20asociar%5Cu00e1%20con%20mayores%20tasas%20de%20fracaso%20respecto%20a%20CMI%20m%5Cu00e1s%20bajas%20cuando%20los%20pacientes%20fueron%20tratados%20con%20este%20antibi%5Cu00f3tico%2C%20a%20las%20dosis%20utilizadas%20%28la%20m%5Cu00e1s%20habitual%2C%204%2C5%20g%20cada%208%20horas%2C%20administradas%20en%20bolo%20de%2030%20minutos%29.%20Existe%20un%20alto%20grado%20de%20discordancia%20en%20los%20valores%20de%20CMI%20de%20AMC%20para%20enterobacterias%20obtenidos%20usando%20las%20recomendaciones%20de%20CLSI%20y%20las%20de%20EUCAST%3B%20En%20general%2C%20nuestros%20resultados%20sugieren%20que%20la%20CMI%20determinada%20por%20EUCAST%20predice%20mejor%20el%20pron%5Cu00f3stico%20cl%5Cu00ednico%20del%20paciente%20con%20bacteriemia.%22%2C%22thesisType%22%3A%22%22%2C%22university%22%3A%22%22%2C%22date%22%3A%222017-09-27%22%2C%22language%22%3A%22spa%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fhdl.handle.net%5C%2F11441%5C%2F73670%22%2C%22collections%22%3A%5B%22VN54CXGB%22%5D%2C%22dateModified%22%3A%222025-11-24T12%3A11%3A46Z%22%7D%7D%2C%7B%22key%22%3A%22XS9EVHTT%22%2C%22library%22%3A%7B%22id%22%3A6316110%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Martos%20Gilabert%22%2C%22parsedDate%22%3A%222017-09-21%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BMartos%20Gilabert%2C%20A.%20I.%20%282017%29.%20%26lt%3Bi%26gt%3BEvaluaci%26%23xF3%3Bn%20de%20la%20T%26%23xE9%3Bcnica%20Molecular%20LightCycler%26%23xAE%3B%20SeptiFast%20utilizando%20una%20extracci%26%23xF3%3Bn%20automatizada%20de%20ADN%20para%20la%20detecci%26%23xF3%3Bn%20de%20bacteriemia%20y%20fungemia%20en%20pacientes%20cr%26%23xED%3Bticos%26lt%3B%5C%2Fi%26gt%3B.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-ItemURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fhdl.handle.net%5C%2F11441%5C%2F76273%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fhdl.handle.net%5C%2F11441%5C%2F76273%26lt%3B%5C%2Fa%26gt%3B%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22thesis%22%2C%22title%22%3A%22Evaluaci%5Cu00f3n%20de%20la%20T%5Cu00e9cnica%20Molecular%20LightCycler%5Cu00ae%20SeptiFast%20utilizando%20una%20extracci%5Cu00f3n%20automatizada%20de%20ADN%20para%20la%20detecci%5Cu00f3n%20de%20bacteriemia%20y%20fungemia%20en%20pacientes%20cr%5Cu00edticos%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Antonia%20Isabel%22%2C%22lastName%22%3A%22Martos%20Gilabert%22%7D%5D%2C%22abstractNote%22%3A%222.1.%20HIP%5Cu00d3TESIS%20El%20sistema%20MagNA%20Pure%20Compact%2C%20utiliza%20un%20kit%20para%20la%20extracci%5Cu00f3n%20automatizada%20de%20%5Cu00e1cidos%20nucleicos%20-desarrollado%20por%20Roche%20Diagnostics-%20que%20aplicado%20a%20las%20muestras%20con%20el%20protocolo%20de%20extracci%5Cu00f3n%20para%20ADN%20bacteriano%2C%20nos%20ofrece%20el%20elu%5Cu00eddo%20en%2030%20minutos.%20La%20extracci%5Cu00f3n%20autom%5Cu00e1tica%20mediante%20MagNA%20Pure%2C%20seguida%20de%20la%20detecci%5Cu00f3n%20mediante%20LightCycler%5Cu00ae%20SeptiFast%20Test%20MGRADE%20%28SeptiFast%29%20podr%5Cu00eda%20ser%20una%20herramienta%20r%5Cu00e1pida%20y%20segura%20en%20el%20abordaje%20de%20la%20sepsis%20en%20pacientes%20cr%5Cu00edticos%2C%20acortando%20el%20tiempo%20de%20respuesta%20y%20evitando%20contaminaciones.%202.2.%20OBJETIVOS%201.-%20Evaluar%20la%20eficacia%20de%20la%20extracci%5Cu00f3n%20automatizada%20de%20ADN%20bacteriano%20y%20f%5Cu00fangico%20frente%20a%20la%20extracci%5Cu00f3n%20manual.%202.-%20Aplicar%20esta%20extracci%5Cu00f3n%20automatizada%20en%20muestras%20de%20pacientes%20con%20alta%20sospecha%20de%20sepsis%2C%20para%20la%20detecci%5Cu00f3n%20de%20infecciones%20por%20bacterias%20y%5C%2Fu%20hongos.%203.-%20Determinar%20las%20ventajas%20que%20el%20uso%20de%20esta%20extracci%5Cu00f3n%2C%20junto%20con%20la%20detecci%5Cu00f3n%20mediante%20SeptiFast%20aportan%20al%20manejo%20del%20paciente%20cr%5Cu00edtico%20con%20sepsis.%22%2C%22thesisType%22%3A%22%22%2C%22university%22%3A%22%22%2C%22date%22%3A%222017-09-21%22%2C%22language%22%3A%22spa%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fhdl.handle.net%5C%2F11441%5C%2F76273%22%2C%22collections%22%3A%5B%22VN54CXGB%22%5D%2C%22dateModified%22%3A%222025-11-21T13%3A58%3A47Z%22%7D%7D%2C%7B%22key%22%3A%2285XGUFRC%22%2C%22library%22%3A%7B%22id%22%3A6316110%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Bellido%20Barquero%22%2C%22parsedDate%22%3A%222017-09-14%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BBellido%20Barquero%2C%20M.%20del%20M.%20%282017%29.%20%26lt%3Bi%26gt%3BPrevalencia%20de%20Escherichia%20Coli%20o25b%3A%20h4-st131%20productor%20o%20no%20de%20betalactamasa%20de%20espectro%20extendido%20%28BLEE%29%20en%20Sevilla%26lt%3B%5C%2Fi%26gt%3B.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-ItemURL%26%23039%3B%20href%3D%26%23039%3Bhttp%3A%5C%2F%5C%2Fhdl.handle.net%5C%2F11441%5C%2F64995%26%23039%3B%26gt%3Bhttp%3A%5C%2F%5C%2Fhdl.handle.net%5C%2F11441%5C%2F64995%26lt%3B%5C%2Fa%26gt%3B%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22thesis%22%2C%22title%22%3A%22Prevalencia%20de%20Escherichia%20Coli%20o25b%3A%20h4-st131%20productor%20o%20no%20de%20betalactamasa%20de%20espectro%20extendido%20%28BLEE%29%20en%20Sevilla%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mar%5Cu00eda%20del%20Mar%22%2C%22lastName%22%3A%22Bellido%20Barquero%22%7D%5D%2C%22abstractNote%22%3A%22Hasta%20finales%20de%20los%20a%5Cu00f1os%2090%20K.%20pneumoniae%20era%20la%20principal%20enterobacteria%20implicada%20en%20la%20producci%5Cu00f3n%20de%20estas%20enzimas%2C%20principalmente%20de%20los%20grupos%20TEM%20y%20SHV%20%281%29.%20Tambi%5Cu00e9n%20era%20la%20m%5Cu00e1s%20involucrada%20en%20brotes%20nosocomiales.%20Pero%20a%20finales%20de%20los%2090%20y%20principios%20del%20a%5Cu00f1o%202000%20se%20produjo%20un%20cambio%20epidemiol%5Cu00f3gico%20muy%20significativo.%20Emergi%5Cu00f3%20E.%20coli%20como%20principal%20especie%20productora%20de%20BLEE%2C%20lo%20cual%20estaba%20relacionado%20con%20el%20incremento%20de%20infecciones%20comunitarias%20por%20aislados%20de%20E.%20coli%20productores%20de%20BLEE%20del%20grupo%20CTX-M%20%282%29.%20En%20este%20contexto%20epidemiol%5Cu00f3gico%20se%20describe%20en%20el%20a%5Cu00f1o%202008%20la%20detecci%5Cu00f3n%20simult%5Cu00e1nea%20de%20un%20clon%20de%20E.%20coli%20en%20diferentes%20zonas%20geogr%5Cu00e1ficas%20del%20mundo%20que%20se%20caracteriza%20por%20pertenecer%20al%20serogrupo%20O25b%2C%20filogrupo%20B2%2C%20secuenciotipo%20ST131%20y%20ser%20resistente%20a%20betalact%5Cu00e1micos%20por%20producci%5Cu00f3n%20de%20CTX-M-15%20y%20a%20otros%20antimicrobianos%2C%20entre%20los%20que%20destaca%20el%20ciprofloxacino%20%28Chanoine%29.%20Posteriormente%20se%20han%20descrito%20aislados%20de%20este%20clon%20productores%20de%20otras%20BLEE%20diferentes%20a%20CTX-M-15%2C%20incluso%20aislados%20no%20productores%20de%20BLEE%20%283%29%2C%20y%20tambi%5Cu00e9n%20se%20han%20detectado%20casos%20de%20portadores%20sanos%20cuyos%20aislados%20eran%20sensibles%20al%20ciprofloxacino%20%284%29.%20Este%20clon%20presenta%20caracter%5Cu00edsticas%20microbiol%5Cu00f3gicas%20diferentes%20a%20los%20clones%20de%20E.%20coli%20mayoritarios%20hasta%20el%20momento%2C%20pero%20a%5Cu00fan%20se%20desconoce%20los%20mecanismos%20de%20transmisi%5Cu00f3n%20que%20contribuyen%20a%20su%20exitosa%20diseminaci%5Cu00f3n.%20Para%20poder%20dise%5Cu00f1ar%20medidas%20eficaces%20de%20control%20de%20esta%20expansi%5Cu00f3n%20es%20necesario%20conocer%20la%20prevalencia%20del%20clon%20que%20existe%20en%20nuestra%20%5Cu00e1rea%2C%20as%5Cu00ed%20como%20poder%20identificar%20sus%20v%5Cu00edas%20de%20transmisi%5Cu00f3n.%20Previo%20a%20este%20trabajo%20se%20ha%20descrito%20la%20relaci%5Cu00f3n%20de%20este%20clon%20con%20la%20diseminaci%5Cu00f3n%20de%20pl%5Cu00e1smidos%20que%20vehiculizan%20genes%20codificantes%20de%20CTX-M-15%2C%20por%20lo%20que%20comparamos%20los%20aislados%20ST131%20productores%20y%20no%20productores%20de%20BLEE%2C%20en%20cuanto%20a%20tipos%20de%20pl%5Cu00e1smidos%20y%20perfiles%20de%20sensibilidad.%20Por%20otra%20parte%2C%20se%20han%20encontrado%20aislados%20de%20este%20clon%20en%20muestras%20de%20animales%20de%20compa%5Cu00f1%5Cu00eda%2C%20por%20lo%20que%20quisimos%20averiguar%20si%20en%20nuestra%20%5Cu00e1rea%20el%20clon%20se%20transmit%5Cu00eda%20mediante%20el%20contacto%20de%20humanos%20con%20mascotas.%20Tambi%5Cu00e9n%20se%20ha%20relacionado%20la%20emergencia%20de%20este%20clon%20con%20a%5Cu00f1os%20recientes%2C%20por%20lo%20que%20estudiamos%20de%20manera%20retrospectiva%20cu%5Cu00e1ndo%20aparici%5Cu00f3n%20por%20primera%20vez%20en%20nuestra%20%5Cu00e1rea%20sanitaria.%20En%20nuestra%20%5Cu00e1rea%20la%20emergencia%20de%20este%20clon%20se%20ha%20producido%20de%20manera%20reciente%2C%20convirti%5Cu00e9ndose%20en%20el%20clon%20mayoritario%20de%20E.%20coli%20responsable%20de%20infecciones%20de%20car%5Cu00e1cter%20extraintestinal.%20La%20mayor%5Cu00eda%20de%20nuestros%20aislados%2C%20en%20contra%20de%20lo%20hallado%20en%20gran%20parte%20de%20estudios%2C%20no%20son%20productores%20de%20BLEE%2C%20aunque%20los%20que%20s%5Cu00ed%20lo%20son%2C%20producen%20CTX-M-15.%20Coincidiendo%20con%20otros%20trabajos%2C%20nuestros%20aislados%20son%20principalmente%20resistentes%20a%20ciprofloxacino.%20Tras%20estudiar%20la%20relaci%5Cu00f3n%20gen%5Cu00e9tica%2C%20hemos%20encontrado%20aislados%20productores%20y%20no%20productores%20de%20BLEE%20y%20tambi%5Cu00e9n%20resistentes%20y%20sensibles%20a%20FQ%20con%20el%20mismo%20pulsotipo%2C%20lo%20que%20sugiere%20que%20en%20nuestra%20%5Cu00e1rea%20la%20expansi%5Cu00f3n%20del%20clon%20fue%20previa%20a%20la%20adquisici%5Cu00f3n%20de%20resistencia.%20La%20transmisi%5Cu00f3n%20del%20clon%20debido%20al%20contacto%20con%20animales%20de%20compa%5Cu00f1%5Cu00eda%20es%20muy%20reducida%20en%20nuestra%20zona.%20En%20cuanto%20al%20papel%20que%20juegan%20los%20pl%5Cu00e1smidos%2C%20hemos%20observado%20tanto%20m%5Cu00faltiple%20adquisici%5Cu00f3n%20de%20pl%5Cu00e1smidos%20muy%20similares%20en%20un%20mismo%20pulsotipo%20como%20diseminaci%5Cu00f3n%20del%20mismo%20pl%5Cu00e1smido%20entre%20distintos%20pulsotipos.%20Este%20doble%20fen%5Cu00f3meno%20necesita%20de%20estudios%20de%20NGS%20para%20poder%20conocer%20las%20regiones%20implicadas%20en%20la%20diseminaci%5Cu00f3n%20del%20clon%2C%20as%5Cu00ed%20como%20una%20mejor%20caracterizaci%5Cu00f3n%20de%20todos%20los%20determinantes%20que%20vehiculizan%20estos%20pl%5Cu00e1smidos%20y%20establecer%20aquellos%20que%20juegan%20un%20papel%20en%20su%20estabilidad%20y%20fijaci%5Cu00f3n%20en%20las%20poblaciones%20de%20E.%20coli.%22%2C%22thesisType%22%3A%22%22%2C%22university%22%3A%22%22%2C%22date%22%3A%222017-09-14%22%2C%22language%22%3A%22spa%22%2C%22url%22%3A%22http%3A%5C%2F%5C%2Fhdl.handle.net%5C%2F11441%5C%2F64995%22%2C%22collections%22%3A%5B%22VN54CXGB%22%5D%2C%22dateModified%22%3A%222025-11-21T13%3A57%3A21Z%22%7D%7D%2C%7B%22key%22%3A%22YT4VQKWP%22%2C%22library%22%3A%7B%22id%22%3A6316110%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Jim%5Cu00e9nez%20R%5Cu00e1mila%22%2C%22parsedDate%22%3A%222017-07-06%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BJim%26%23xE9%3Bnez%20R%26%23xE1%3Bmila%2C%20C.%20%282017%29.%20%26lt%3Bi%26gt%3BColonizaci%26%23xF3%3Bn%20vagino-rectal%20y%20transmisi%26%23xF3%3Bn%20materno-neonatal%20de%20Enterobacteriaceae%20productores%20de%20betalactamasas%20de%20espectro%20extendido%26lt%3B%5C%2Fi%26gt%3B.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-ItemURL%26%23039%3B%20href%3D%26%23039%3Bhttp%3A%5C%2F%5C%2Fhdl.handle.net%5C%2F11441%5C%2F64007%26%23039%3B%26gt%3Bhttp%3A%5C%2F%5C%2Fhdl.handle.net%5C%2F11441%5C%2F64007%26lt%3B%5C%2Fa%26gt%3B%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22thesis%22%2C%22title%22%3A%22Colonizaci%5Cu00f3n%20vagino-rectal%20y%20transmisi%5Cu00f3n%20materno-neonatal%20de%20Enterobacteriaceae%20productores%20de%20betalactamasas%20de%20espectro%20extendido%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Carlos%22%2C%22lastName%22%3A%22Jim%5Cu00e9nez%20R%5Cu00e1mila%22%7D%5D%2C%22abstractNote%22%3A%22%22%2C%22thesisType%22%3A%22%22%2C%22university%22%3A%22%22%2C%22date%22%3A%222017-07-06%22%2C%22language%22%3A%22spa%22%2C%22url%22%3A%22http%3A%5C%2F%5C%2Fhdl.handle.net%5C%2F11441%5C%2F64007%22%2C%22collections%22%3A%5B%22VN54CXGB%22%5D%2C%22dateModified%22%3A%222025-11-21T13%3A55%3A40Z%22%7D%7D%2C%7B%22key%22%3A%22TRKHVG8M%22%2C%22library%22%3A%7B%22id%22%3A6316110%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Salamanca%20Rivera%22%2C%22parsedDate%22%3A%222017-06-28%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BSalamanca%20Rivera%2C%20E.%20%282017%29.%20%26lt%3Bi%26gt%3BBacteriemias%20por%20enterobacterias%20productoras%20de%20carbapenemasas%3A%20caracter%26%23xED%3Bsticas%20cl%26%23xED%3Bnicas%20y%20pron%26%23xF3%3Bsticas%20y%20evaluaci%26%23xF3%3Bn%20observacional%20de%20la%20eficacia%20de%20distintas%20alternativas%20terap%26%23xE9%3Buticas%26lt%3B%5C%2Fi%26gt%3B.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-ItemURL%26%23039%3B%20href%3D%26%23039%3Bhttp%3A%5C%2F%5C%2Fhdl.handle.net%5C%2F11441%5C%2F64022%26%23039%3B%26gt%3Bhttp%3A%5C%2F%5C%2Fhdl.handle.net%5C%2F11441%5C%2F64022%26lt%3B%5C%2Fa%26gt%3B%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22thesis%22%2C%22title%22%3A%22Bacteriemias%20por%20enterobacterias%20productoras%20de%20carbapenemasas%3A%20caracter%5Cu00edsticas%20cl%5Cu00ednicas%20y%20pron%5Cu00f3sticas%20y%20evaluaci%5Cu00f3n%20observacional%20de%20la%20eficacia%20de%20distintas%20alternativas%20terap%5Cu00e9uticas%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Elena%22%2C%22lastName%22%3A%22Salamanca%20Rivera%22%7D%5D%2C%22abstractNote%22%3A%22%22%2C%22thesisType%22%3A%22%22%2C%22university%22%3A%22%22%2C%22date%22%3A%222017-06-28%22%2C%22language%22%3A%22spa%22%2C%22url%22%3A%22http%3A%5C%2F%5C%2Fhdl.handle.net%5C%2F11441%5C%2F64022%22%2C%22collections%22%3A%5B%22VN54CXGB%22%5D%2C%22dateModified%22%3A%222025-11-19T13%3A25%3A41Z%22%7D%7D%2C%7B%22key%22%3A%22ZN57BIID%22%2C%22library%22%3A%7B%22id%22%3A6316110%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Granero%20Asencio%22%2C%22parsedDate%22%3A%222017-05-09%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BGranero%20Asencio%2C%20M.%20M.%20%282017%29.%20%26lt%3Bi%26gt%3BDeterminaci%26%23xF3%3Bn%20de%20la%20epidemiolog%26%23xED%3Ba%20infecciosa%20de%20una%20unidad%20neonatal%20de%20tercer%20nivel%20en%20un%20per%26%23xED%3Bodo%20de%2010%20a%26%23xF1%3Bos%26lt%3B%5C%2Fi%26gt%3B.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-ItemURL%26%23039%3B%20href%3D%26%23039%3Bhttp%3A%5C%2F%5C%2Fhdl.handle.net%5C%2F11441%5C%2F61115%26%23039%3B%26gt%3Bhttp%3A%5C%2F%5C%2Fhdl.handle.net%5C%2F11441%5C%2F61115%26lt%3B%5C%2Fa%26gt%3B%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22thesis%22%2C%22title%22%3A%22Determinaci%5Cu00f3n%20de%20la%20epidemiolog%5Cu00eda%20infecciosa%20de%20una%20unidad%20neonatal%20de%20tercer%20nivel%20en%20un%20per%5Cu00edodo%20de%2010%20a%5Cu00f1os%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mar%5Cu00eda%20Mercedes%22%2C%22lastName%22%3A%22Granero%20Asencio%22%7D%5D%2C%22abstractNote%22%3A%22%22%2C%22thesisType%22%3A%22%22%2C%22university%22%3A%22%22%2C%22date%22%3A%222017-05-09%22%2C%22language%22%3A%22spa%22%2C%22url%22%3A%22http%3A%5C%2F%5C%2Fhdl.handle.net%5C%2F11441%5C%2F61115%22%2C%22collections%22%3A%5B%22VN54CXGB%22%5D%2C%22dateModified%22%3A%222025-11-21T13%3A52%3A47Z%22%7D%7D%2C%7B%22key%22%3A%22YNGV7ATN%22%2C%22library%22%3A%7B%22id%22%3A6316110%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Borrego%20Dorado%22%2C%22parsedDate%22%3A%222016-01-29%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BBorrego%20Dorado%2C%20I.%20%282016%29.%20%26lt%3Bi%26gt%3BValor%20pron%26%23xF3%3Bstico%20del%20an%26%23xE1%3Blisis%20semicuantitativo%20del%20grado%20de%20fijaci%26%23xF3%3Bn%20de%20la%202.%5B.%5B18f%5Dfluoro-2-deoxi-d-glucosa%20mediante%20tomograf%26%23xED%3Ba%20por%20emisi%26%23xF3%3Bn%20de%20positrones%20en%20pacientes%20pedi%26%23xE1%3Btricos%20con%20linfoma%26lt%3B%5C%2Fi%26gt%3B.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-ItemURL%26%23039%3B%20href%3D%26%23039%3Bhttp%3A%5C%2F%5C%2Fhdl.handle.net%5C%2F11441%5C%2F34573%26%23039%3B%26gt%3Bhttp%3A%5C%2F%5C%2Fhdl.handle.net%5C%2F11441%5C%2F34573%26lt%3B%5C%2Fa%26gt%3B%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22thesis%22%2C%22title%22%3A%22Valor%20pron%5Cu00f3stico%20del%20an%5Cu00e1lisis%20semicuantitativo%20del%20grado%20de%20fijaci%5Cu00f3n%20de%20la%202.%5B.%5B18f%5Dfluoro-2-deoxi-d-glucosa%20mediante%20tomograf%5Cu00eda%20por%20emisi%5Cu00f3n%20de%20positrones%20en%20pacientes%20pedi%5Cu00e1tricos%20con%20linfoma%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Isabel%22%2C%22lastName%22%3A%22Borrego%20Dorado%22%7D%5D%2C%22abstractNote%22%3A%22El%20linfoma%20es%20una%20neoplasia%20relativamente%20frecuente%20en%20ni%5Cu00f1os%20y%20adolescentes%20j%5Cu00f3venes%20constituyendo%20del%2010%25%20al%2015%25%20de%20todas%20las%20neoplasias%20que%20aparecen%20durante%20la%20edad%20pedi%5Cu00e1trica1%2C%202.%20Su%20pron%5Cu00f3stico%20ha%20mejorado%20gracias%20al%20desarrollo%20de%20nuevos%20tratamientos%20en%20las%202%20%5Cu00faltimas%20d%5Cu00e9cadas3%2C%20presentando%20un%20amplio%20rango%20de%20supervivencia%20global%20a%20los%205%20a%5Cu00f1os%2C%20que%20var%5Cu00eda%20desde%20el%2075%25%20en%20los%20linfoma%20no%20hodgkin%20%28LNH%29%20hasta%20el%2090%25%20en%20la%20en%5Cu00acfermedad%20de%20Hodgkin%20%28EH%294-6.%20Por%20otra%20parte%2C%20la%20duraci%5Cu00f3n%20e%20intensidad%20del%20tratamiento%20a%20administrar%20en%20la%20EH%2C%20depende%20del%20grupo%20de%20riesgo%20en%20que%20se%20clasifique%20al%20paciente%2C%20des%5Cu00accribi%5Cu00e9ndose%20numerosos%20efectos%20tard%5Cu00edos%20secundarios%20a%20los%20tratamientos%20quimioter%5Cu00e1picos%20y%20radioter%5Cu00e1picos%20%28segundos%20tumores%20primarios%20de%20mama%20y%20pulm%5Cu00f3n%2C%20enfermedades%20car%5Cu00acdiovasculares%2C%20hipotiroidismo%2C%20infertilidad%2C%20secuelas%20en%20el%20aparato%20respiratorio%20y%20compli%5Cu00accaciones%20infecciosas%20en%20pacientes%20esplenectomizados%29%2C%20que%20incrementan%20la%20morbi-mor-talidad%20y%20disminuyen%20la%20calidad%20de%20vida%20de%20estos%20pacientes%20que%20sin%20embargo%20presentan%20una%20alta%20tasa%20de%20curaci%5Cu00f3n%20de%20su%20EH7-14.%20Tambi%5Cu00e9n%20en%20los%20LNH%20es%20fundamental%20constatar%20la%20respuesta%20de%20la%20enfermedad%20a%20la%20QT%20para%20decidir%20en%20cada%20caso%20y%20en%20cada%20momento%20el%20tratamiento%20m%5Cu00e1s%20adecuado.%20El%20manejo%20terap%5Cu00e9utico%20de%20esta%20neoplasia%20debe%20ser%20indivi%5Cu00acdualizado%2C%20adapt%5Cu00e1ndose%20al%20riesgo%20de%20cada%20paciente%20y%20a%20la%20circunstancia%20concreta%20de%20su%20evoluci%5Cu00f3n%2C%20de%20manera%20que%20aquellos%20pacientes%20que%20presentan%20un%20estadio%20limitado%20de%20la%20enfermedad%20y%20no%20tienen%20factores%20de%20riesgo%2C%20pueden%20ser%20tratados%20con%20reg%5Cu00edmenes%20tera%5Cu00acp%5Cu00e9uticos%20menos%20agresivos%20evitando%20la%20quimioterapia%20%28QT%29%20m%5Cu00e1s%20t%5Cu00f3xica%20y%20la%20radioterapia%20%28RT%29%20innecesaria%2C%20especialmente%20cuando%20la%20enfermedad%20ha%20respondido%20adecuadamente%20y%20de%20forma%20precoz%20a%20la%20QT15%2C%2016.%20Por%20lo%20tanto%2C%20es%20de%20gran%20importancia%20hacer%20una%20valoraci%5Cu00f3n%20de%20la%20respuesta%20al%20tratamiento%20lo%20m%5Cu00e1s%20exacta%20posible%20y%20de%20forma%20individualizada%2C%20para%20elegir%20el%20tratamiento%20m%5Cu00e1s%20efectivo%20y%20menos%20t%5Cu00f3xico%2C%20en%20pacientes%20de%20bajo%20riesgo%20y%20buena%20respuesta%2C%20mientras%20que%20en%20los%20pacientes%20de%20alto%20riesgo%20es%20importante%20administrar%20el%20tratamiento%20m%5Cu00e1s%20efectivo%20para%20alcanzar%20la%20respuesta%20completa.%20En%20los%20%5Cu00faltimos%20a%5Cu00f1os%20la%20PET-18FDG%20ha%20reemplazado%20a%20la%20gammagraf%5Cu00eda%20con%2067Ga%2C%20en%20el%20uso%20cl%5Cu00ednico%20del%20diagn%5Cu00f3stico%20de%20extensi%5Cu00f3n%20y%20re-estadificaci%5Cu00f3n%20del%20linfoma%20en%20el%20adulto%2C%20y%20ha%20presentado%20mejores%20resultados%20que%20los%20dem%5Cu00e1s%20medios%20de%20diagn%5Cu00f3stico%2C%20incluso%20con%5Cu00acsiderados%20conjuntamente.%20En%20el%20linfoma%20es%20muy%20importante%20detectar%20la%20existencia%20de%20enfermedad%20viable%20duran%5Cu00acte%20y%20despu%5Cu00e9s%20del%20tratamiento%2C%20ya%20que%20frecuentemente%20las%20masas%20linfomatosas%20no%20dismi%5Cu00acnuyen%20de%20tama%5Cu00f1o%20aunque%20carezcan%20de%20actividad%20tumoral17-19%2C%20limitando%20as%5Cu00ed%20el%20valor%20de%20los%20m%5Cu00e9todos%20de%20diagn%5Cu00f3sticos%20convencionales%20%28MDC%29%20para%20la%20valoraci%5Cu00f3n%20de%20la%20enfermedad%20en%20dichas%20circunstancias.%20Se%20ha%20demostrado%20que%20la%20PET-18FDG%20es%20superior%20a%20los%20MDC%20en%20la%20valoraci%5Cu00f3n%20de%20las%20masas%20residuales%20en%20el%20linfoma%20y%20adem%5Cu00e1s%20tiene%20valor%20pron%5Cu00f3stico%20para%20evaluar%20la%20respuesta%20del%20tratamiento%20en%20estos%20pacientes20-22.%20Los%20datos%20publicados%20relativos%20al%20uso%20de%20la%20PET-18FDG%20en%20la%20valoraci%5Cu00f3n%20del%20tratamiento%20en%20pacientes%20pedi%5Cu00e1tri%5Cu00accos%20son%20muy%20prometedores%20aunque%20todav%5Cu00eda%20muy%20limitados.%22%2C%22thesisType%22%3A%22%22%2C%22university%22%3A%22%22%2C%22date%22%3A%222016-01-29%22%2C%22language%22%3A%22spa%22%2C%22url%22%3A%22http%3A%5C%2F%5C%2Fhdl.handle.net%5C%2F11441%5C%2F34573%22%2C%22collections%22%3A%5B%22VN54CXGB%22%5D%2C%22dateModified%22%3A%222025-11-19T12%3A59%3A50Z%22%7D%7D%2C%7B%22key%22%3A%22G3VXH4T2%22%2C%22library%22%3A%7B%22id%22%3A6316110%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Pupo%20Ledo%22%2C%22parsedDate%22%3A%222015-06-22%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BPupo%20Ledo%2C%20M.%20I.%20%282015%29.%20%26lt%3Bi%26gt%3BPapel%20de%20moxifloxacino%20y%20ampicilina%20frente%20a%20%26%23x201C%3Blisteria%20monocytogenes%26%23x201D%3B%20en%20la%20Infecci%26%23xF3%3Bn%20del%20sistema%20nervioso%20central%26lt%3B%5C%2Fi%26gt%3B.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-ItemURL%26%23039%3B%20href%3D%26%23039%3Bhttp%3A%5C%2F%5C%2Fhdl.handle.net%5C%2F11441%5C%2F26980%26%23039%3B%26gt%3Bhttp%3A%5C%2F%5C%2Fhdl.handle.net%5C%2F11441%5C%2F26980%26lt%3B%5C%2Fa%26gt%3B%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22thesis%22%2C%22title%22%3A%22Papel%20de%20moxifloxacino%20y%20ampicilina%20frente%20a%20%5Cu201clisteria%20monocytogenes%5Cu201d%20en%20la%20Infecci%5Cu00f3n%20del%20sistema%20nervioso%20central%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22M%5Cu00aa%20Inmaculada%22%2C%22lastName%22%3A%22Pupo%20Ledo%22%7D%5D%2C%22abstractNote%22%3A%22%22%2C%22thesisType%22%3A%22%22%2C%22university%22%3A%22%22%2C%22date%22%3A%222015-06-22%22%2C%22language%22%3A%22spa%22%2C%22url%22%3A%22http%3A%5C%2F%5C%2Fhdl.handle.net%5C%2F11441%5C%2F26980%22%2C%22collections%22%3A%5B%22VN54CXGB%22%5D%2C%22dateModified%22%3A%222025-11-24T12%3A58%3A12Z%22%7D%7D%2C%7B%22key%22%3A%22EPRPF9NW%22%2C%22library%22%3A%7B%22id%22%3A6316110%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Merino%20S%5Cu00e1nchez%22%2C%22parsedDate%22%3A%222015-06-19%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BMerino%20S%26%23xE1%3Bnchez%2C%20M.%20%282015%29.%20%26lt%3Bi%26gt%3BEstudio%20de%20los%20derrames%20pleurales%20paraneum%26%23xF3%3Bnicos%20complicados%20y%20de%20los%20empiemas.%20Evoluci%26%23xF3%3Bn%20en%20los%20%26%23xFA%3Bltimos%2020%20a%26%23xF1%3Bos.%26lt%3B%5C%2Fi%26gt%3B%20%26lt%3Ba%20class%3D%26%23039%3Bzp-ItemURL%26%23039%3B%20href%3D%26%23039%3Bhttp%3A%5C%2F%5C%2Fhdl.handle.net%5C%2F11441%5C%2F26944%26%23039%3B%26gt%3Bhttp%3A%5C%2F%5C%2Fhdl.handle.net%5C%2F11441%5C%2F26944%26lt%3B%5C%2Fa%26gt%3B%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22thesis%22%2C%22title%22%3A%22Estudio%20de%20los%20derrames%20pleurales%20paraneum%5Cu00f3nicos%20complicados%20y%20de%20los%20empiemas.%20Evoluci%5Cu00f3n%20en%20los%20%5Cu00faltimos%2020%20a%5Cu00f1os.%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mercedes%22%2C%22lastName%22%3A%22Merino%20S%5Cu00e1nchez%22%7D%5D%2C%22abstractNote%22%3A%221.%20Objetivo%20El%20espectro%20cl%5Cu00ednico%20de%20los%20empiemas%20ha%20ido%20variando%20en%20las%20%5Cu00faltimas%20d%5Cu00e9cadas%2C%20influenciado%20por%20varios%20factores%2C%20como%20son%20el%20aumento%20de%20la%20esperanza%20de%20vida%2C%20el%20n%5Cu00famero%20cada%20vez%20mayor%20de%20pacientes%20inmunodeprimidos%20%28pacientes%20con%20neoplasia%2C%20transplantados%2C%20en%20tratamiento%20inmunosupresor%2C%20etc.%29%20y%20el%20descenso%20de%20pacientes%20con%20manifestaciones%20secundarias%20a%20la%20infecci%5Cu00f3n%20por%20VIH%20o%20a%20la%20tuberculosis%2C%20gracias%20a%20las%20nuevas%20terapias%20antirretrovirales%20en%20el%20primer%20caso%20y%20al%20mejor%20control%20de%20la%20enfermedad%20en%20el%20segundo.%20Asimismo%20la%20microbiolog%5Cu00eda%20asociada%20a%20la%20infecci%5Cu00f3n%20de%20la%20cavidad%20pleural%20ha%20ido%20modific%5Cu00e1ndose%2C%20as%5Cu00ed%20como%20su%20abordaje%2C%20con%20un%20empleo%20m%5Cu00e1s%20generalizado%20y%20m%5Cu00e1s%20precoz%20de%20fibrinol%5Cu00edticos%20intrapleurales%2C%20la%20introducci%5Cu00f3n%20de%20la%20videotoracoscopia%2C%20etc.%20Derivado%20de%20todo%20lo%20anterior%2C%20puede%20haber%20variado%20a%20su%20vez%20la%20morbi-mortalidad%20asociada%20a%20esta%20patolog%5Cu00eda.%20Por%20otra%20parte%2C%20es%20importante%20el%20estudio%20de%20los%20derrames%20pleurales%20paraneum%5Cu00f3nicos%20complicados%20%28DPC%29%20y%20de%20los%20empiemas%20en%20pacientes%20con%20caracter%5Cu00edsticas%20especiales%2C%20como%20pacientes%20con%20cirrosis%20hep%5Cu00e1tica%2C%20donde%20existen%20pocos%20estudios%20y%20con%20series%20peque%5Cu00f1as%20que%20analicen%20esta%20asociaci%5Cu00f3n%2C%20o%20pacientes%20con%20infecci%5Cu00f3n%20VIH.%20Tanto%20la%20cl%5Cu00ednica%20como%20la%20microbiolog%5Cu00eda%20como%20el%20abordaje%20de%20esta%20patolog%5Cu00eda%20en%20estos%20subgrupos%20puede%20ser%20diferente%2C%20as%5Cu00ed%20como%20sus%20resultados.%202.%20Material%20y%20m%5Cu00e9todo%20Estudio%20retrospectivo%2C%20descriptivo%2C%20de%20todos%20los%20casos%20recogidos%20seg%5Cu00fan%20el%20departamento%20de%20Documentaci%5Cu00f3n%20Cl%5Cu00ednica%20de%20nuestro%20hospital%2C%20de%20empiemas%20o%20de%20DPC%2C%20desde%20el%201%20de%20enero%20de%201.985%20hasta%20el%2031%20de%20diciembre%20de%202.008.%20Se%20incluyen%20417%20pacientes%2C%20con%20diagn%5Cu00f3stico%20de%20Empiema%20o%20de%20derrame%20pleural%20paraneum%5Cu00f3nico%20complicado%20%28DPC%29%2C%20por%20los%20Servicios%20de%20Neumolog%5Cu00eda%2C%20Digestivo%2C%20Medicina%20Interna%20e%20Infecciosos%20del%20Hospital%20Universitario%20de%20Valme%2C%20perteneciente%20al%20%5Cu00c1rea%20Sanitaria%20Sur%20de%20Sevilla%2C%20cuya%20cobertura%20es%20de%20380.000%20habitantes%2C%20con%20nivel%20del%20estudio%20intrahospitalario.%20Todos%20los%20sujetos%20eran%20mayores%20de%2018%20a%5Cu00f1os%20y%20ten%5Cu00edan%20diagn%5Cu00f3stico%20de%20derrame%20pleural%20con%20datos%20bioqu%5Cu00edmicos%5C%2Fmicrobiol%5Cu00f3gicos%20de%20empiema%20o%20DPC.%20Para%20el%20diagn%5Cu00f3stico%20de%20empiema%20o%20DPC%20se%20usaron%203%20criterios%3A%20la%20microbiolog%5Cu00eda%20positiva%2C%20el%20aspecto%20macrosc%5Cu00f3pico%20purulento%20del%20LP%20y%5C%2Fo%20criterios%20bioqu%5Cu00edmicos%20%28glucopleura%26lt%3B%2040%20mg%5C%2Fdl%2C%20o%20pH%20%26lt%3B%207%2C10%29.%20Se%20excluyeron%20del%20estudio%20aquellos%20pacientes%20con%20derrame%20pleural%20paraneum%5Cu00f3nico%20no%20complicado%20o%20con%20derrame%20pleural%20de%20otra%20etiolog%5Cu00eda.%20El%20principal%20criterio%20de%20inclusi%5Cu00f3n%20fue%20la%20presencia%20de%20DP%20complicado%20o%20empiema.%20Para%20el%20diagn%5Cu00f3stico%20de%20empiema%20o%20DPC%20se%20utilizaron%203%20criterios%3A%20la%20microbiolog%5Cu00eda%20positiva%2C%20el%20aspecto%20macrosc%5Cu00f3pico%20purulento%20del%20LP%20y%5C%2Fo%20criterios%20bioqu%5Cu00edmicos%20%28glucopleura%26lt%3B%2040%20mg%5C%2Fdl%2C%20LDH%26gt%3B%201.000%20UI%5C%2Fl%20o%20pH%20%26lt%3B%207%2C10%29.%20A%20los%20pacientes%20que%20reunieron%20el%20criterio%20de%20inclusi%5Cu00f3n%2C%20se%20les%20incluy%5Cu00f3%20en%20el%20estudio.%20De%20todos%20ellos%20se%20ten%5Cu00eda%20acceso%20a%20la%20historia%20cl%5Cu00ednica.%20El%20tratamiento%20de%20los%20pacientes%20no%20se%20vio%20modificado%20por%20la%20realizaci%5Cu00f3n%20del%20estudio%2C%20al%20tratarse%20de%20un%20estudio%20retrospectivo.%20Se%20rellen%5Cu00f3%20un%20protocolo%20espec%5Cu00edfico%20de%20recogida%20de%20datos%20en%20todos%20los%20casos%2C%20que%20inclu%5Cu00eda%20los%20datos%20demogr%5Cu00e1ficos%20de%20filiaci%5Cu00f3n%2C%20sexo%2C%20edad%2C%20fecha%20de%20ingreso%20y%20de%20alta%20hospitalaria%2C%20de%20exitus%20%28en%20su%20caso%29%20y%20datos%20cl%5Cu00ednicos%20y%20radiogr%5Cu00e1ficos%20%28radiograf%5Cu00eda%20simple%20de%20t%5Cu00f3rax%20y%20tomograf%5Cu00eda%20computarizada%29%2C%20valorando%20la%20localizaci%5Cu00f3n%20del%20derrame%2C%20la%20disposici%5Cu00f3n%20%28libre%20o%20loculada%29%2C%20la%20extensi%5Cu00f3n%2C%20la%20afectaci%5Cu00f3n%20parenquimatosa%20y%20la%20cavitaci%5Cu00f3n.%20Se%20consider%5Cu00f3%20bacteriemia%20cuando%20se%20aisl%5Cu00f3%20un%20germen%20en%20m%5Cu00e1s%20de%202%20hemocultivos.%20Se%20anotaron%20los%20d%5Cu00edas%20desde%20el%20inicio%20de%20los%20s%5Cu00edntomas%20hasta%20el%20ingreso%20hospitalario%2C%20los%20d%5Cu00edas%20desde%20el%20ingreso%20hasta%20la%20colocaci%5Cu00f3n%20del%20drenaje%20pleural%2C%20los%20d%5Cu00edas%20de%20drenaje%2C%20el%20uso%20de%20fibrinol%5Cu00edticos%20y%20el%20volumen%20de%20drenaje%20total%2C%20as%5Cu00ed%20como%20el%20%5Cu00e9xito%20de%20cada%20procedimiento%20%28mejor%5Cu00eda%20cl%5Cu00ednica%20o%20radiol%5Cu00f3gica%20en%20las%2024-48%20horas%20siguientes%29%20y%20los%20d%5Cu00edas%20de%20hospitalizaci%5Cu00f3n%2C%20las%20complicaciones%20y%20los%20resultados.%20Los%20criterios%20de%20colocaci%5Cu00f3n%2C%20de%20manejo%20de%20los%20drenajes%20pleurales%20y%20de%20retirada%20se%20ajustaron%20a%20las%20gu%5Cu00edas%20existentes%2C%20de%20tal%20manera%20que%20el%20drenaje%20se%20mantuvo%20hasta%20que%20el%20d%5Cu00e9bito%20fue%20inferior%20a%2050%20ml%5C%2Fd%5Cu00eda%20y%20la%20mejor%5Cu00eda%20radiol%5Cu00f3gica%20fue%20significativa.%20Se%20aplic%5Cu00f3%20tratamiento%20fibrinol%5Cu00edtico%20intrapleural%20en%20aquellos%20casos%20con%20colecci%5Cu00f3n%20persistente%20con%20drenaje%20inadecuado%20por%20tubo%20de%20toracostom%5Cu00eda%2C%20con%20SK%20%28250.000%20UI%5C%2Fd%5Cu00eda%29%2C%20hasta%20que%20se%20produjo%20la%20resoluci%5Cu00f3n%20radiol%5Cu00f3gica%20completa.%20Todos%20los%20pacientes%20incluidos%20en%20el%20estudio%20fueron%20estudiados%20hasta%20la%20resoluci%5Cu00f3n%20del%20cuadro%20o%20el%20exitus%2C%20en%20su%20caso.%203.%20Resultados%20Se%20incluyen%20de%20forma%20retrospectiva%2C%20todos%20los%20casos%20que%20ingresaron%20consecutivamente%2C%20desde%20el%201%20de%20enero%20de%201.985%20hasta%20el%2031%20de%20diciembre%20de%202.008%2C%20con%20los%20diagn%5Cu00f3sticos%20de%20derrame%20pleural%20paraneum%5Cu00f3nico%20complicado%20%28DPC%29%20y%20empiema.%20En%20total%2C%20se%20reclutaron%20417%20casos.%20Primero%20se%20analizan%20los%20resultados%20globales%20de%20la%20muestra%20y%20posteriormente%20se%20separa%20a%20los%20pacientes%20en%20dos%20periodos%20de%20tiempo%3A%20el%20primero%20desde%20enero%20de%201.985%20hasta%20diciembre%20de%201.999%20%28258%20pacientes%29%20y%20el%20segundo%20desde%20enero%20de%202.000%20hasta%20diciembre%20de%202.008%20%28159%20pacientes%29%20y%20se%20comparan%20ambos%20grupos%2C%20para%20comprobar%20si%20hay%20diferencias%20en%20las%20diferentes%20variables%20incluidas%20en%20el%20estudio%20a%20lo%20largo%20del%20tiempo.%20Globalmente%2C%20la%20edad%20media%20de%20los%20pacientes%20fue%20de%2054%20a%5Cu00f1os%20%28rango%2014-94%20a%5Cu00f1os%29%2C%20aunque%20se%20observaron%20dos%20picos%20de%20incidencia%2C%20uno%20en%20torno%20a%20los%2030%20y%20otro%20en%20torno%20a%20los%2060%20a%5Cu00f1os.%20El%2082%2C3%25%20%28343%20pacientes%29%20fueron%20hombres%2C%20frente%20al%2017%2C7%25%20%2874%20pacientes%29%20que%20fueron%20mujeres.%20El%2074%25%20%28309%29%20de%20los%20casos%20fueron%20empiemas%2C%20y%20el%20resto%20fueron%20derrames%20paraneum%5Cu00f3nicos%20complicados%20%28DPC%29.%20La%20etiolog%5Cu00eda%20fue%20desconocida%20solo%20en%20el%2013%2C9%25%2C%20mientras%20que%20en%20el%20resto%20de%20los%20casos%20fue%20conocida%2C%20siendo%20la%20m%5Cu00e1s%20frecuente%20la%20infecci%5Cu00f3n%20pulmonar%2C%20en%20el%2064%25.%20La%20adquisici%5Cu00f3n%20del%20empiema%20fue%20extrahospitalaria%20en%20el%2083%2C9%25%20de%20los%20casos%20y%20nosocomial%20en%20el%20resto.%20El%2080%2C5%25%20de%20los%20pacientes%20ten%5Cu00eda%20alg%5Cu00fan%20factor%20predisponente%20o%20enfermedad%20de%20base.%20El%20m%5Cu00e1s%20frecuente%20fue%20el%20etilismo%20%2827%25%29%2C%20seguido%20de%20la%20neoplasia%20activa%20%2823%2C3%25%29%2C%20la%20EPOC%20%2822%2C8%25%29%20y%20la%20diabetes%20%2818%2C9%25%29.%20El%2046%25%20de%20los%20l%5Cu00edquidos%20pleurales%20fueron%20de%20aspecto%20macrosc%5Cu00f3pico%20purulento.%20El%20s%5Cu00edntoma%20m%5Cu00e1s%20frecuente%20fue%20la%20fiebre%20%2876%25%29%2C%20seguido%20de%20dolor%20tor%5Cu00e1cico%20%2875%25%29%2C%20tos%20%2854%25%29%2C%20disnea%20%2843%25%29%20y%20expectoraci%5Cu00f3n%20%2838%25%29.%20El%20tiempo%20medio%20de%20evoluci%5Cu00f3n%20desde%20la%20aparici%5Cu00f3n%20de%20los%20s%5Cu00edntomas%20hasta%20la%20fecha%20de%20consulta%20fue%20de%2013%2C8%20d%5Cu00edas.%20Exist%5Cu00eda%20alteraci%5Cu00f3n%20a%20nivel%20parenquimatoso%20en%20la%20radiolog%5Cu00eda%20de%20t%5Cu00f3rax%20en%20el%2066%2C4%25%20de%20los%20casos.%20El%20l%5Cu00f3bulo%20m%5Cu00e1s%20frecuentemente%20afectado%20fue%20el%20l%5Cu00f3bulo%20inferior%20derecho%20%2852%25%29.%20El%20DP%20fue%20derecho%20en%20el%2056%2C8%25%20y%20bilateral%20solo%20en%20el%202%2C2%25%20de%20casos.%20La%20disposici%5Cu00f3n%20del%20DP%20fue%20at%5Cu00edpica%20en%20el%2083%2C6%25%20y%20la%20cuant%5Cu00eda%20del%20derrame%20fue%20de%20aproximadamente%20un%20tercio%20de%20hemit%5Cu00f3rax%20en%20la%20mitad%20de%20los%20casos%20%2850%2C2%25%29.%20El%2045%25%20de%20los%20derrames%20estaba%20encapsulado.%20Fue%20posible%20establecer%20el%20diagn%5Cu00f3stico%20microbiol%5Cu00f3gico%20en%20el%2071%2C4%25.%20Los%20g%5Cu00e9rmenes%20m%5Cu00e1s%20frecuentemente%20aislados%20fueron%20los%20aerobios%20%2851%2C7%25%29%2C%20seguidos%20de%20los%20cultivos%20de%20flora%20mixta%20%2810%2C1%25%29%20y%20g%5Cu00e9rmenes%20anaerobios%20%2817%2C7%25%29.%20El%20germen%20m%5Cu00e1s%20frecuente%20fue%20el%20Streptococcus%20pneumoniae%2C%20seguido%20del%20Stafilococcus%20aureus.%20En%20el%2039%2C7%25%20de%20los%20pacientes%20con%20aislamiento%20de%20g%5Cu00e9rmenes%20anaerobios%2C%20estuvo%20presente%20la%20aspiraci%5Cu00f3n%20como%20factor%20predisponente%20o%20causal%2C%20con%20un%20intervalo%20de%20confianza%20del%2095%25%20de%202%2C9%20a%209%2C4%20veces%20mayor%20riesgo%20de%20anaerobios%20en%20sujetos%20con%20antecedente%20de%20aspiraci%5Cu00f3n.%20En%20los%20pacientes%20que%20debutaron%20con%20shock%20s%5Cu00e9ptico%20%285%2C9%25%20del%20total%29%2C%20el%20germen%20m%5Cu00e1s%20frecuente%20fue%20tambi%5Cu00e9n%20el%20neumococo.%20El%20drenaje%20pleural%20fue%20parte%20fundamental%20del%20tratamiento%20en%20el%2090%2C9%25%20de%20los%20pacientes%2C%20adem%5Cu00e1s%20del%20tratamiento%20antibi%5Cu00f3tico.%20La%20causa%20m%5Cu00e1s%20frecuente%20de%20no%20drenaje%20fue%20la%20escasa%20c%5Cu00e1mara%20%2831%2C5%25%29.%20El%2037%2C2%25%20recibieron%20fibrinol%5Cu00edticos%20intrapleurales%2C%20con%20un%20porcentaje%20de%20%5Cu00e9xito%20de%20dicha%20terapia%20del%2093%2C5%25%20y%20de%20efectos%20secundarios%20del%2021%2C2%25%2C%20siendo%20el%20m%5Cu00e1s%20frecuente%20la%20fiebre%20%2878%2C7%25%20del%20total%29.%20El%20agente%20instilado%20en%20espacio%20pleural%20fue%20la%20estreptoquinasa.%20El%20tratamiento%20antibi%5Cu00f3tico%20inicial%20fue%20emp%5Cu00edrico%20en%20todos%20los%20casos%2C%20siendo%20la%20pauta%20est%5Cu00e1ndar%20empleada%20en%20nuestro%20centro%20una%20cefalosporina%20de%203%5Cu00aa%20generaci%5Cu00f3n%20asociada%20a%20clindamicina.%20La%20antibioterapia%20emp%5Cu00edrica%20fue%20modificada%20en%20el%2056%2C6%25.%20Dicha%20modificaci%5Cu00f3n%20obedeci%5Cu00f3%20a%20criterios%20microbiol%5Cu00f3gicos%20en%20el%2075%2C8%25%20%28179%29%20y%20a%20criterios%20cl%5Cu00ednicos%20en%20el%20resto.%20Se%20derivaron%20para%20intervenci%5Cu00f3n%20quir%5Cu00fargica%2026%20pacientes%20%2838%2C2%25%20de%20los%20pacientes%20con%20FBP%3B%206%2C2%25%20del%20total%29.%20La%20mitad%20de%20ellos%20%2813%20pacientes%29%20ten%5Cu00edan%20diagn%5Cu00f3stico%20de%20neoplasia%2C%20y%20en%2011%20pacientes%20la%20neoplasia%20fue%20c%5Cu00e1ncer%20de%20pulm%5Cu00f3n.%20Cinco%20de%20los%20pacientes%20que%20se%20remitieron%20a%20cirug%5Cu00eda%20ten%5Cu00edan%20una%20neumectom%5Cu00eda%20reciente.%20De%20los%20casos%20de%20FBP%20por%20tuberculosis%2C%20se%20remitieron%20a%20cirug%5Cu00eda%209%20pacientes%20%2890%25%29.%20Con%20respecto%20a%20los%20d%5Cu00edas%20de%20drenaje%20pleural%2C%20la%20media%20fue%20de%2013%2C5%20d%5Cu00edas.%20La%20estancia%20hospitalaria%20media%20fue%20de%2026%2C9%20d%5Cu00edas.%20La%20mortalidad%20global%20de%20la%20serie%20fue%20del%2011%2C5%25.%20No%20hubo%20diferencia%20de%20mortalidad%20entre%20los%20dos%20sexos.%20De%20los%20pacientes%20que%20presentaron%20shock%20s%5Cu00e9ptico%20fallecieron%20el%2036%25%2C%20sin%20encontrar%20relaci%5Cu00f3n%20con%20ning%5Cu00fan%20germen.%20El%2029%25%20de%20los%20exitus%20ten%5Cu00eda%20FBP.%20En%20el%20an%5Cu00e1lisis%20multivariante%2C%20las%20variables%20que%20se%20asociaron%20de%20forma%20estad%5Cu00edsticamente%20significativa%20a%20la%20mortalidad%20del%20grupo%20global%20fueron%20cinco%3A%20la%20edad%2C%20la%20adquisici%5Cu00f3n%20nosocomial%2C%20la%20malnutrici%5Cu00f3n%20del%20paciente%2C%20el%20antecedente%20de%20neoplasia%20activa%20y%20la%20cirrosis%20hep%5Cu00e1tica.%20Observamos%20que%20el%20n%5Cu00famero%20de%20casos%20de%20malnutrici%5Cu00f3n%20ha%20disminuido%20a%20lo%20largo%20del%20tiempo%2C%20ya%20que%20de%2044%20casos%20recogidos%20en%20la%20muestra%20global%2C%2033%20%28el%2075%25%29%20se%20recogieron%20durante%20el%20primer%20periodo.%20En%20cuanto%20al%20an%5Cu00e1lisis%20comparativo%20en%20los%20dos%20periodos%20de%20tiempo%20en%20que%20dividimos%20a%20la%20muestra%20global%2C%20encontramos%20diferencias%20estad%5Cu00edsticamente%20significativas%20en%20distintas%20variables.%20En%20primer%20lugar%2C%20la%20edad%20media%20del%20primer%20grupo%20fue%20de%2051%2C9%20a%5Cu00f1os%2C%20frente%20a%20los%2056%2C5%20a%5Cu00f1os%20en%20el%20segundo%20periodo.%20La%20adquisici%5Cu00f3n%20fue%20extrahospitalaria%20en%20el%2080%25%20de%20los%20casos%20en%20el%20primer%20grupo%20y%20en%20el%2090%25%20en%20el%20segundo%20%28p%3D%200%2C004%29.%20La%20etiolog%5Cu00eda%20desconocida%20fue%20del%2011%25%20en%20el%20primer%20grupo%20y%20aument%5Cu00f3%20hasta%20el%2019%25%20en%20el%20segundo%20grupo%20%28p%3D0%2C028%29.%20Todos%20los%20casos%20de%20FBP%20por%20tuberculosis%20ocurrieron%20en%20el%20primer%20periodo.%20El%20porcentaje%20de%20mujeres%20fue%20del%2013%25%20en%20el%20primer%20grupo%20y%20en%20el%20segundo%20fue%20del%2025%25%20%28p%3D0%2C002%29.%20Aument%5Cu00f3%20el%20n%5Cu00famero%20de%20DPC%20en%20el%20segundo%20periodo%20%2832%2C1%25%20vs%2022%2C1%25%3B%20p%3D0%2C02%29.%20En%20referencia%20a%20los%20factores%20predisponentes%20el%20porcentaje%20de%20pacientes%20con%20SIDA%20en%20el%20primer%20grupo%20fue%20del%2013%2C6%25%20frente%20al%204%2C4%25%20del%20segundo%20grupo%20%28p%3D%200%2C003%29.La%20ADVP%20fue%20significativamente%20mayor%20en%20el%20primer%20periodo%20%2814%2C7%25%20vs%204%2C4%25%3B%20p%3D0%2C001%29.%20El%20etilismo%20activo%20tambi%5Cu00e9n%20disminuy%5Cu00f3%20de%20forma%20importante%20en%20el%20segundo%20periodo%20%2836%2C4%25%20vs%2063%2C6%25%29.%20La%20aspiraci%5Cu00f3n%20disminuy%5Cu00f3%20desde%20un%2012%2C4%25%20en%20el%20primer%20periodo%20hasta%20un%201%2C9%25%20en%20el%20segundo.%20En%20cambio%2C%20hemos%20observado%20un%20aumento%20significativo%20de%20las%20neoplasias%2C%20que%20en%20el%20primer%20periodo%20supusieron%20el%2019%2C8%25%20de%20los%20casos%2C%20frente%20al%2028%2C9%25%20en%20el%20segundo%20grupo%20%28p%3D0%2C031%29.%20Radiol%5Cu00f3gicamente%2C%20hubo%20m%5Cu00e1s%20casos%20de%20DP%20encapsulado%20en%20el%20segundo%20periodo%2C%20con%20una%20diferencia%20bastante%20significativa%20%2832%2C2%25%20vs%2066%2C7%25%2C%20p%26lt%3B%200%2C0001%29.%20En%20el%20aspecto%20microbiol%5Cu00f3gico%2C%20durante%20el%20segundo%20periodo%20ha%20disminuido%20el%20aislamiento%20tanto%20de%20aerobios%20como%20de%20cultivos%20polimicrobianos%20y%20Gram%20negativos%2C%20aumentando%20el%20n%5Cu00famero%20de%20cultivos%20con%20resultado%20negativo%20y%20manteni%5Cu00e9ndose%20sin%20cambios%20significativos%20el%20porcentaje%20de%20aislamiento%20de%20anaerobios.%20Tambi%5Cu00e9n%20observamos%20diferencias%20en%20el%20calibre%20del%20tubo%20pleural%20empleado%20en%20el%20drenaje%20tor%5Cu00e1cico.%20As%5Cu00ed%2C%20los%20tubos%20con%20calibre%20inferior%20o%20igual%20a%2020%20Fr%20subieron%20del%205%25%20al%2029%2C6%25%20en%20el%20segundo%20periodo%3B%20los%20de%20calibre%2024%20Fr%20subieron%20del%2036%25%20al%2055%2C3%25%20en%20el%20segundo%20periodo%20y%20los%20de%2028%20Fr%20bajaron%20del%2044%2C6%25%20al%209%2C4%25.%20No%20se%20observ%5Cu00f3%20que%20la%20ausencia%20de%20drenaje%20pleural%20fuera%20un%20factor%20determinante%20de%20exitus%2C%20ya%20que%20los%20pacientes%20que%20fallecieron%20recibieron%20drenaje%20pleural%20en%20el%2090%25%20de%20los%20casos%2C%20porcentaje%20similar%20a%20la%20muestra%20global.%20En%20el%20subgrupo%20de%20pacientes%20con%20cirrosis%20hep%5Cu00e1tica%2C%20el%20tiempo%20de%20evoluci%5Cu00f3n%20media%20fue%20m%5Cu00e1s%20corto%20%288%20d%5Cu00edas%20vs%2013%2C8%20d%5Cu00edas%29%20y%20la%20disnea%20fue%20el%20s%5Cu00edntoma%20m%5Cu00e1s%20frecuente%2C%20por%20delante%20de%20la%20fiebre%20%2869%2C2%25%20vs%2061%2C5%25%29.%20Solo%20en%20el%2010%25%20de%20los%20casos%20hab%5Cu00eda%20constancia%20previa%20de%20hidrot%5Cu00f3rax.%20Otro%20aspecto%20destacable%20y%20diferencial%20es%20que%20el%2053%2C8%25%20presentaban%20un%20DP%20izquierdo%20y%20la%20disposici%5Cu00f3n%20del%20DP%20fue%20at%5Cu00edpica%20en%20el%2069%25.%20Este%20dato%20contrasta%20con%20lo%20descrito%20por%20otros%20autores%2C%20en%20los%20que%20la%20totalidad%20de%20los%20casos%20registrados%20fueron%20en%20el%20lado%20derecho%20y%20de%20disposici%5Cu00f3n%20libre.%20El%20LP%20fue%20purulento%20en%20el%2038%25%20de%20los%20casos.%20Se%20obtuvo%20un%20diagn%5Cu00f3stico%20microbiol%5Cu00f3gico%20en%20el%2085%25%2C%20siendo%20los%20aerobios%20los%20m%5Cu00e1s%20frecuentes%20%2871%25%29%2C%20seguidos%20de%20los%20Gram%20negativos%20%2825%25%29%20y%20de%20los%20anaerobios%20%2818%25%29.%20El%20drenaje%20pleural%20form%5Cu00f3%20parte%20del%20tratamiento%20del%20paciente%20en%20el%2095%25%20de%20estos%20pacientes.%20No%20hemos%20observado%20en%20nuestra%20serie%20relaci%5Cu00f3n%20entre%20el%20drenaje%20de%20la%20cavidad%20pleural%20o%20la%20instilaci%5Cu00f3n%20de%20fibrinol%5Cu00edticos%20intrapleurales%20y%20la%20mortalidad%20en%20estos%20pacientes.%20De%20hecho%2C%20de%20los%20cirr%5Cu00f3ticos%20fallecidos%20durante%20todo%20el%20estudio%2C%20el%2087%2C5%25%20recibi%5Cu00f3%20drenaje%20pleural%20como%20parte%20del%20tratamiento%2C%20es%20decir%2C%20un%20porcentaje%20menor%20que%20los%20no%20fallecidos.%20La%20media%20de%20d%5Cu00edas%20con%20drenaje%20pleural%20fue%20de%2015%2C9%20d%5Cu00edas%2C%20y%20la%20estancia%20hospitalaria%20media%20de%2025%2C7%20d%5Cu00edas.%20Solo%20recibieron%20tratamiento%20fibrinol%5Cu00edtico%20el%2018%25%20de%20los%20casos.%20No%20se%20observ%5Cu00f3%20ninguna%20complicaci%5Cu00f3n%20ni%20efecto%20secundario%20asociados%20a%20este%20tratamiento%20en%20este%20subgrupo%20de%20pacientes.%20La%20mortalidad%20global%20en%20este%20subgrupo%20fue%20del%2041%25%2C%20aunque%20la%20tendencia%20ha%20sido%20a%20disminuir%20la%20mortalidad%2C%20ya%20que%20durante%20el%20primer%20periodo%20fue%20del%2052%2C6%25%20y%20del%2030%25%20durante%20el%20segundo.%20En%20los%20pacientes%20con%20VIH%2C%20el%20s%5Cu00edntoma%20predominante%20fue%20el%20dolor%20tor%5Cu00e1cico%2C%20en%20un%2085%2C7%25%20de%20los%20casos%20%28frente%20al%2075%25%20de%20la%20muestra%20global%29%2C%20seguido%20de%20la%20fiebre%20%2880%2C9%25%29%20y%20de%20la%20expectoraci%5Cu00f3n%20%2871%2C4%25%29.%20El%20tiempo%20de%20evoluci%5Cu00f3n%20medio%20de%20los%20s%5Cu00edntomas%20en%20los%20pacientes%20VIH%20fue%20de%208%20d%5Cu00edas.%20El%20LP%20fue%20purulento%20en%20el%2028%2C6%25.%20El%20porcentaje%20de%20diagn%5Cu00f3stico%20microbiol%5Cu00f3gico%20fue%20del%2076%25.%20Se%20aislaron%20por%20orden%20de%20frecuencia%20un%2066%2C7%25%20de%20aerobios%2C%20seguidos%20de%20los%20Gram%20negativos%20en%20el%2023%2C8%25%20y%20de%20los%20anaerobios%20en%20el%2014%2C3%25.%20Se%20drenaron%20el%2076%25%20de%20los%20casos.%20La%20media%20de%20d%5Cu00edas%20de%20drenaje%20pleural%20fue%20de%2013%2C5%20d%5Cu00edas%2C%20y%20la%20estancia%20hospitalaria%20media%20de%2022%2C4%20d%5Cu00edas.%20Recibieron%20tratamiento%20fibrinol%5Cu00edtico%20el%2046%2C8%25%2C%20hecho%20que%20no%20guarda%20relaci%5Cu00f3n%20con%20la%20presentaci%5Cu00f3n%20radiol%5Cu00f3gica%20encapsulada.%20La%20mortalidad%20en%20pacientes%20VIH%20fue%20inferior%20a%20la%20descrita%20en%20la%20totalidad%20de%20la%20serie%2C%20del%207%2C1%25.%204.%20Conclusiones%20A%20pesar%20de%20que%20la%20infecci%5Cu00f3n%20de%20la%20cavidad%20pleural%20es%20conocida%20desde%20la%20antig%5Cu00fcedad%20y%20se%20trata%20de%20una%20situaci%5Cu00f3n%20cl%5Cu00ednica%20frecuente%20para%20los%20neum%5Cu00f3logos%20y%20los%20cirujanos%20tor%5Cu00e1cicos%2C%20hoy%20en%20d%5Cu00eda%20quedan%20a%5Cu00fan%20muchos%20aspectos%20por%20aclarar%20acerca%20de%20su%20mejor%20manejo.%20Prueba%20de%20ello%2C%20es%20que%20a%20pesar%20de%20que%20ha%20mejorado%20el%20estado%20nutricional%20de%20la%20poblaci%5Cu00f3n%20y%20de%20que%20disponemos%20de%20mejor%20arsenal%20antimicrobiano%2C%20su%20morbi-mortalidad%20no%20solo%20no%20ha%20decrecido%20sino%20que%20est%5Cu00e1%20aumentado%2C%20incluso%20en%20pa%5Cu00edses%20desarrollados.%20Esta%20patolog%5Cu00eda%20adem%5Cu00e1s%2C%20genera%20un%20gasto%20sanitario%20importante.%20Es%20cierto%20que%20factores%20asociados%20a%20la%20mortalidad%2C%20como%20son%20la%20edad%20del%20paciente%2C%20cada%20vez%20mayor%2C%20y%20la%20presencia%20de%20neoplasia%20activa%2C%20cada%20vez%20m%5Cu00e1s%20frecuente%20tambi%5Cu00e9n%2C%20pueden%20jugar%20un%20papel%20negativo%20en%20la%20obtenci%5Cu00f3n%20de%20mejores%20resultados%20globales%20en%20estos%20pacientes.%20Sin%20embargo%2C%20se%20observa%20que%20esta%20patolog%5Cu00eda%20est%5Cu00e1%20aumentando%20en%20todos%20los%20grupos%20de%20edad.%20Aunque%20un%20estudio%20retrospectivo%20no%20aporta%20tanta%20informaci%5Cu00f3n%20v%5Cu00e1lida%20como%20un%20ensayo%20cl%5Cu00ednico%2C%20nuestra%20serie%20es%20amplia%20y%20sobre%20todo%20dilatada%20en%20el%20tiempo%2C%20por%20lo%20que%20ofrece%20una%20visi%5Cu00f3n%20de%20los%20cambios%20acontecidos%20en%20los%20%5Cu00faltimos%2020%20a%5Cu00f1os%20tanto%20en%20el%20manejo%20como%20en%20los%20resultados%20finales%20obtenidos.%20Adem%5Cu00e1s%2C%20incluye%20a%20subgrupos%20especiales%20de%20pacientes%20como%20son%20los%20pacientes%20con%20cirrosis%20hep%5Cu00e1tica%20y%20con%20VIH-SIDA%2C%20donde%20como%20hemos%20podido%20comprobar%20en%20las%20diferentes%20publicaciones%2C%20las%20diferencias%20en%20el%20manejo%20de%20esta%20patolog%5Cu00eda%20son%20a%5Cu00fan%20mayores%2C%20y%20los%20resultados%2C%20heterog%5Cu00e9neos%20y%20de%20dif%5Cu00edcil%20comparativa%2C%20incluyendo%20todos%20estos%20estudios%2C%20un%20menor%20n%5Cu00famero%20de%20pacientes%20que%20los%20aportados%20por%20nuestra%20serie.%20Las%20diferencias%20que%20hemos%20observado%20en%20estos%20subgrupos%20de%20pacientes%20tanto%20en%20factores%20predisponentes%2C%20como%20en%20presentaci%5Cu00f3n%20cl%5Cu00ednica%2C%20etc.%2C%20nos%20deben%20hacer%20reflexionar%20y%20estar%20especialmente%20alerta%20en%20pacientes%20con%20patolog%5Cu00eda%20de%20base%20especial%20para%20no%20retrasar%20el%20diagn%5Cu00f3stico%20y%20el%20tratamiento%2C%20ya%20que%20ello%20conlleva%20irremediablemente%20a%20una%20mayor%20estancia%2C%20mayor%20n%5Cu00famero%20de%20complicaciones%20y%20puede%20acarrear%20unos%20peores%20resultados%20y%20una%20mayor%20mortalidad.%20Por%20tanto%2C%20pensamos%20que%20todo%20lo%20que%20pueda%20arrojar%20un%20poco%20de%20luz%20para%20optimizar%20el%20tratamiento%20y%20poder%20as%5Cu00ed%20reducir%20d%5Cu00edas%20de%20estancia%20hospitalaria%2C%20complicaciones%2C%20y%20en%20definitiva%20reducir%20la%20morbi-mortalidad%20que%20conlleva%20la%20infecci%5Cu00f3n%20pleural%20debe%20ser%20bienvenido.%22%2C%22thesisType%22%3A%22%22%2C%22university%22%3A%22%22%2C%22date%22%3A%222015-06-19%22%2C%22language%22%3A%22spa%22%2C%22url%22%3A%22http%3A%5C%2F%5C%2Fhdl.handle.net%5C%2F11441%5C%2F26944%22%2C%22collections%22%3A%5B%22VN54CXGB%22%5D%2C%22dateModified%22%3A%222025-11-24T12%3A56%3A32Z%22%7D%7D%2C%7B%22key%22%3A%229I5CTKLU%22%2C%22library%22%3A%7B%22id%22%3A6316110%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Bernal%20Mart%5Cu00ednez%22%2C%22parsedDate%22%3A%222014-12-22%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BBernal%20Mart%26%23xED%3Bnez%2C%20S.%20%282014%29.%20%26lt%3Bi%26gt%3BDetecci%26%23xF3%3Bn%20y%20genotipado%20del%20virus%20del%20papiloma%20humano%20mediante%20una%20t%26%23xE9%3Bcnica%20de%20PCR%20a%20tiempo%20real%3A%20utilidad%20de%20la%20muestra%20de%20orina%26lt%3B%5C%2Fi%26gt%3B.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-ItemURL%26%23039%3B%20href%3D%26%23039%3Bhttp%3A%5C%2F%5C%2Fhdl.handle.net%5C%2F11441%5C%2F57442%26%23039%3B%26gt%3Bhttp%3A%5C%2F%5C%2Fhdl.handle.net%5C%2F11441%5C%2F57442%26lt%3B%5C%2Fa%26gt%3B%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22thesis%22%2C%22title%22%3A%22Detecci%5Cu00f3n%20y%20genotipado%20del%20virus%20del%20papiloma%20humano%20mediante%20una%20t%5Cu00e9cnica%20de%20PCR%20a%20tiempo%20real%3A%20utilidad%20de%20la%20muestra%20de%20orina%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Samuel%22%2C%22lastName%22%3A%22Bernal%20Mart%5Cu00ednez%22%7D%5D%2C%22abstractNote%22%3A%22La%20infecci%5Cu00f3n%20por%20el%20virus%20del%20papiloma%20humano%20%28VPH%29%20es%20una%20causa%20necesaria%2C%20aunque%2C%20por%20si%20sola%2C%20insuficiente%20para%20el%20desarrollo%20del%20c%5Cu00e1ncer%20de%20c%5Cu00e9rvix.%20Normalmente%20las%20infecciones%20por%20VPH%20se%20resuelven%20espont%5Cu00e1neamente%2C%20pero%20un%20peque%5Cu00f1o%20porcentaje%20de%20ellas%2C%20dan%20lugar%20al%20desarrollo%20de%20lesiones%20pre-neopl%5Cu00e1sicas%20que%20pueden%20derivar%20en%20lesiones%20invasivas%20de%20la%20mucosa%20produciendo%20el%20c%5Cu00e1ncer.%20El%20tiempo%20medio%20entre%20la%20infecci%5Cu00f3n%20por%20el%20VPH%20y%20el%20desarrollo%20de%20las%20lesiones%20pre-neopl%5Cu00e1sicas%20suele%20ser%20de%20unos%2010%20a%5Cu00f1os%20y%20entre%20el%20desarrollo%20de%20estas%20%5Cu00faltimas%20y%20el%20c%5Cu00e1ncer%20est%5Cu00e1%20entorno%20a%20otros%2010%20a%5Cu00f1os.%20Actualmente%20est%5Cu00e1n%20descritos%20m%5Cu00e1s%20de%20100%20tipos%20de%20VPH%2C%20aunque%20solo%20un%20peque%5Cu00f1o%20grupo%20de%20ellos%2C%20denominados%20de%20alto%20riesgo%2C%20son%20responsables%20del%20c%5Cu00e1ncer%20de%20c%5Cu00e9rvix.%20De%20este%20grupo%20de%20alto%20riesgo%2C%20los%20genotipos%20VPH-16%20y%20VPH-18%20son%20responsables%20de%20m%5Cu00e1s%20del%2070%25%20de%20los%20casos%20de%20c%5Cu00e1ncer%20de%20c%5Cu00e9rvix.%20Una%20caracter%5Cu00edstica%20casi%20%5Cu00fanica%20del%20c%5Cu00e1ncer%20de%20c%5Cu00e9rvix%20provocado%20por%20los%20genotipos%20VPH-16%20y%20VPH-18%2C%20es%20que%20actualmente%20puede%20ser%20prevenido%20mediante%20campa%5Cu00f1as%20sistem%5Cu00e1ticas%20de%20vacunaci%5Cu00f3n.%20La%20infecci%5Cu00f3n%20por%20VPH%20es%20una%20infecci%5Cu00f3n%20de%20transmisi%5Cu00f3n%20sexual%20y%20por%20tanto%2C%20la%20primera%20forma%20de%20prevenir%20el%20c%5Cu00e1ncer%20de%20c%5Cu00e9rvix%20consiste%20en%20promover%20campa%5Cu00f1as%20de%20educaci%5Cu00f3n%20sobre%20las%20practicas%20de%20riesgo%20y%20de%20vacunaci%5Cu00f3n%20en%20j%5Cu00f3venes%2C%20antes%20del%20inicio%20de%20las%20relaciones%20sexuales.%20En%20segundo%20lugar%2C%20la%20prevenci%5Cu00f3n%20secundaria%20en%20mujeres%20no%20vacunadas%2C%20consiste%20en%20la%20realizaci%5Cu00f3n%20de%20cribados%20mediante%20realizaci%5Cu00f3n%20peri%5Cu00f3dica%20de%20citolog%5Cu00edas%20y%5C%2Fo%20de%20pruebas%20moleculares%20de%20detecci%5Cu00f3n%20de%20ADN%20del%20VPH%2C%20en%20muestras%20cervicales%20y%20tratamiento%20asociado%20en%20los%20casos%20positivos.%20Actualmente%20est%5Cu00e1%20demostrado%20que%20la%20detecci%5Cu00f3n%20del%20VPH%20es%20m%5Cu00e1s%20sensible%20y%20presenta%20un%20valor%20predictivo%20negativo%20mayor%20que%20la%20realizaci%5Cu00f3n%20de%20citolog%5Cu00edas%20para%20la%20detecci%5Cu00f3n%20de%20lesiones%20pre-neopl%5Cu00e1sicas%2C%20por%20tanto%2C%20los%20diferentes%20programas%20internacionales%20de%20cribado%20de%20cada%20pa%5Cu00eds%20cada%20vez%20tienden%20a%20emplear%20las%20pruebas%20de%20VPH%20como%20prueba%20inicial%20del%20cribado%20de%20c%5Cu00e1ncer%20de%20c%5Cu00e9rvix.%20No%20obstante%2C%20los%20citados%20programas%2C%20que%20se%20basan%20en%20la%20toma%20de%20muestra%20cervical%2C%20requieren%20una%20infraestructura%20sanitaria%20y%20una%20cualificaci%5Cu00f3n%20del%20personal%20sanitario%20que%20no%20siempre%20est%5Cu00e1%20disponible%2C%20sobre%20todo%2C%20en%20pa%5Cu00edses%20en%20v%5Cu00edas%20de%20desarrollo%2C%20en%20donde%20se%20concentra%20la%20mayor%20incidencia%20de%20este%20tipo%20de%20c%5Cu00e1ncer.%20Por%20otro%20lado%2C%20existen%20barreras%20%5Cu00e9tnicas%2C%20culturales%2C%20religiosas%2C%20etc....%20que%20impiden%20que%20muchas%20mujeres%20se%20sometan%20a%20la%20exploraci%5Cu00f3n%20p%5Cu00e9lvica%20necesaria%20para%20la%20toma%20de%20muestra%20de%20c%5Cu00e9rvix.%20Por%20lo%20tanto%2C%20los%20citados%20programas%20de%20cribado%20de%20c%5Cu00e1ncer%20de%20c%5Cu00e9rvix%20no%20llegan%20a%20toda%20la%20poblaci%5Cu00f3n%20susceptible%20de%20someterse%20a%20ellos.%20En%20esta%20tesis%20se%20desarrolla%20un%20m%5Cu00e9todo%20basado%20en%20la%20tecnolog%5Cu00eda%20de%20PCR%20a%20tiempo%20real%20que%20permite%20simult%5Cu00e1neamente%20la%20detecci%5Cu00f3n%20de%20la%20infecci%5Cu00f3n%20por%20el%20VPH%20y%20la%20de%20los%20genotipos%20VPH-%2016%20y%20VPH-18%20que%20son%20los%20tipos%20m%5Cu00e1s%20oncog%5Cu00e9nicos%20como%20se%20ha%20comentado%20anteriormente.%20La%20segunda%20parte%20de%20la%20tesis%20se%20basa%20en%20la%20utilizaci%5Cu00f3n%20de%20la%20misma%20tecnolog%5Cu00eda%20para%20la%20detecci%5Cu00f3n%20y%20genotipado%20del%20VPH%20en%20una%20muestra%20no%20invasiva%20como%20es%20la%20orina%20de%20las%20pacientes.%20De%20este%20modo%2C%20no%20tendr%5Cu00edan%20que%20someterse%20a%20la%20exploraci%5Cu00f3n%20p%5Cu00e9lvica%20favoreciendo%20el%20aumento%20de%20la%20cobertura%20sanitaria%20y%20tambi%5Cu00e9n%20disminuyendo%20los%20costes%20asociados%20al%20cribado%20basado%20en%20la%20toma%20de%20muestras%20cervicales%20La%20conclusi%5Cu00f3n%20principal%20consiste%20en%20que%20la%20muestra%20de%20orina%20puede%20ser%20empleada%20para%20la%20detecci%5Cu00f3n%20de%20infecciones%20por%20el%20VPH%20de%20alto%20riesgo%20y%20para%20la%20detecci%5Cu00f3n%20de%20lesiones%20preneopl%5Cu00e1sicas%20de%20alto%20grado%22%2C%22thesisType%22%3A%22%22%2C%22university%22%3A%22%22%2C%22date%22%3A%222014-12-22%22%2C%22language%22%3A%22spa%22%2C%22url%22%3A%22http%3A%5C%2F%5C%2Fhdl.handle.net%5C%2F11441%5C%2F57442%22%2C%22collections%22%3A%5B%22VN54CXGB%22%5D%2C%22dateModified%22%3A%222025-11-24T12%3A53%3A58Z%22%7D%7D%2C%7B%22key%22%3A%22J7MXPZCY%22%2C%22library%22%3A%7B%22id%22%3A6316110%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Parra%20S%5Cu00e1nchez%22%2C%22parsedDate%22%3A%222014-10-01%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BParra%20S%26%23xE1%3Bnchez%2C%20M.%20%282014%29.%20%26lt%3Bi%26gt%3BEstudio%20de%20la%20respuesta%20cl%26%23xED%3Bnica%20al%20tratamiento%20antirretroviral%20en%20pacientes%20infectados%20por%20subtipos%20NO-B%20de%20VIH-1%20mediante%20la%20secuenciaci%26%23xF3%3Bn%20de%20la%20proteasa%20retrotranscriptasa%20e%20integras%3A%20estudio%20genot%26%23xED%3Bpico%20del%20T.%26lt%3B%5C%2Fi%26gt%3B%20%26lt%3Ba%20class%3D%26%23039%3Bzp-ItemURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fhdl.handle.net%5C%2F11441%5C%2F74916%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fhdl.handle.net%5C%2F11441%5C%2F74916%26lt%3B%5C%2Fa%26gt%3B%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22thesis%22%2C%22title%22%3A%22Estudio%20de%20la%20respuesta%20cl%5Cu00ednica%20al%20tratamiento%20antirretroviral%20en%20pacientes%20infectados%20por%20subtipos%20NO-B%20de%20VIH-1%20mediante%20la%20secuenciaci%5Cu00f3n%20de%20la%20proteasa%20retrotranscriptasa%20e%20integras%3A%20estudio%20genot%5Cu00edpico%20del%20T.%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Manuel%22%2C%22lastName%22%3A%22Parra%20S%5Cu00e1nchez%22%7D%5D%2C%22abstractNote%22%3A%22En%20este%20trabajo%20se%20han%20detallado%20los%20datos%20epidemiol%5Cu00f3gicos%20de%20la%20infecci%5Cu00f3n%20VIH-1%20en%20Andaluc%5Cu00eda%20occidental%2C%20prestando%20especial%20atenci%5Cu00f3n%20a%20las%20infecciones%20por%20subtipos%20no-%20B.%20Para%20ello%2C%20se%20ha%20realizado%20un%20an%5Cu00e1lisis%20de%20polimorfismos%20en%20los%20genes%20de%20la%20proteasa%2C%20retrotranscriptasa%2C%20integrasa%2C%20as%5Cu00ed%20como%20el%20tropismo%20viral%2C%20ya%20que%20estas%20regiones%20pueden%20determinar%20la%20actividad%20de%20los%20f%5Cu00e1rmacos%20inhibidores%20de%20la%20proteasa%2C%20retrotranscriptasa%2C%20integrasa%20e%20inhibidores%20de%20la%20entrada%20viral%20que%20se%20emplean%20hoy%20d%5Cu00eda.%20Por%20otro%20lado%2C%20analizamos%20la%20efectividad%20de%20los%20tratamientos%20antirretrovirales%20usados%20entre%20nuestros%20pacientes%20VIH-1%20con%20subtipo%20no%20B%20incluidos%20en%20nuestra%20cohorte.%20Adem%5Cu00e1s%20se%20realiz%5Cu00f3%20un%20an%5Cu00e1lisis%20para%20definir%20la%20existencia%20de%20clusters%20de%20subtipos%20no%20B%20en%20nuestra%20%5Cu00e1rea%20de%20estudio.%20Para%20completar%20esta%20tesis%2C%20se%20desarroll%5Cu00f3%20la%20aplicaci%5Cu00f3n%20bioinform%5Cu00e1tica%20%5Cu201cMARGIHIV%20Tropism%5Cu201d%20para%20la%20interpretaci%5Cu00f3n%20genot%5Cu00edpica%20del%20tropismo%20viral%20del%20VIH-1.%22%2C%22thesisType%22%3A%22%22%2C%22university%22%3A%22%22%2C%22date%22%3A%222014-10-01%22%2C%22language%22%3A%22spa%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fhdl.handle.net%5C%2F11441%5C%2F74916%22%2C%22collections%22%3A%5B%22VN54CXGB%22%5D%2C%22dateModified%22%3A%222025-11-24T12%3A52%3A46Z%22%7D%7D%2C%7B%22key%22%3A%22XC97FJP3%22%2C%22library%22%3A%7B%22id%22%3A6316110%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Egea%20Miranda%22%2C%22parsedDate%22%3A%222014-09-24%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BEgea%20Miranda%2C%20M.%20del%20P.%20%282014%29.%20%26lt%3Bi%26gt%3BCaracterizaci%26%23xF3%3Bn%20de%20aislados%20de%20Escherichia%20coli%20de%20origen%20cl%26%23xED%3Bnico%20y%20alimentario%20productores%20de%20batalactamasas%20de%20espectro%20extendido%26lt%3B%5C%2Fi%26gt%3B.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-ItemURL%26%23039%3B%20href%3D%26%23039%3Bhttp%3A%5C%2F%5C%2Fhdl.handle.net%5C%2F11441%5C%2F47905%26%23039%3B%26gt%3Bhttp%3A%5C%2F%5C%2Fhdl.handle.net%5C%2F11441%5C%2F47905%26lt%3B%5C%2Fa%26gt%3B%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22thesis%22%2C%22title%22%3A%22Caracterizaci%5Cu00f3n%20de%20aislados%20de%20Escherichia%20coli%20de%20origen%20cl%5Cu00ednico%20y%20alimentario%20productores%20de%20batalactamasas%20de%20espectro%20extendido%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mar%5Cu00eda%20del%20Pilar%22%2C%22lastName%22%3A%22Egea%20Miranda%22%7D%5D%2C%22abstractNote%22%3A%22Escherichia%20coli%2C%20perteneciente%20a%20la%20familia%20Enterobacteriaceae%2C%20es%20el%20comensal%20m%5Cu00e1s%20prevalente%20en%20el%20tracto%20gastrointestinal%20de%20humanos%20y%20uno%20de%20los%20principales%20agentes%20causantes%20de%20un%20amplio%20espectro%20de%20infecciones%20en%20humanos.%20En%20la%20%5Cu00faltima%20d%5Cu00e9cada%20hemos%20asistido%20a%20un%20incremento%20significativo%20de%20la%20resistencia%20de%20estos%20microorganismos%20a%20diferentes%20familias%20de%20antimicrobianos%20de%20uso%20cl%5Cu00ednico%20%28multirresistencia%29.%20Entre%20los%20mecanismos%20que%20originan%20la%20multirresistencia%20en%20E.%20coli%20destacan%20las%20betalactamasas%20de%20espectro%20extendido%20%28BLEE%29%2C%20enzimas%20capaces%20de%20hidrolizar%20las%20penicilinas%2C%20las%20cefalosporinas%20de%20amplio%20espectro%20y%20los%20monobactames%2C%20lo%20que%20complica%20el%20manejo%20de%20estas%20infecciones.%20Desde%20su%20aparici%5Cu00f3n%2C%20la%20prevalencia%20de%20E.%20coli%20productor%20de%20BLEE%20%28ECBLEE%29%20a%20nivel%20mundial%20ha%20ido%20en%20aumento%20y%20en%20los%20%5Cu00faltimos%20a%5Cu00f1os%20la%20epidemiolog%5Cu00eda%20de%20las%20infecciones%20causadas%20por%20ECBLEE%20ha%20experimentado%20cambios%20significativos%2C%20siendo%20en%20la%20actualidad%20frecuentes%20los%20casos%20de%20infecciones%20no%20solo%20nosocomiales%2C%20sino%20tambi%5Cu00e9n%20comunitarias.%20La%20hip%5Cu00f3tesis%20de%20trabajo%20fue%20que%20los%20alimentos%20podr%5Cu00edan%20actuar%20como%20reservorio%20de%20ECBLEE%20y%20que%20estos%20microorganismos%20o%20los%20elementos%20gen%5Cu00e9ticos%20m%5Cu00f3viles%20que%20portan%20las%20BLEE%20podr%5Cu00edan%20diseminarse%20en%20la%20comunidad%20a%20trav%5Cu00e9s%20de%20la%20cadena%20alimentaria%2C%20jugando%20un%20papel%20importante%20en%20la%20epidemiolog%5Cu00eda%20de%20la%20infecci%5Cu00f3n%20por%20ECBLEE.%20Para%20validar%20estas%20hip%5Cu00f3tesis%20se%20analiz%5Cu00f3%20un%20grupo%20de%20muestras%20de%20origen%20alimentario%20mayoritariamente%20de%20origen%20c%5Cu00e1rnico%2C%20con%20el%20fin%20de%20aislar%20los%20posibles%20ECBLEE%20colonizadores%20de%20las%20mismas.%20Estos%20aislados%2C%20las%20BLEE%20que%20expresaban%20y%20un%20conjunto%20de%20pl%5Cu00e1smidos%20de%20inter%5Cu00e9s%20fueron%20caracterizados%20y%20comparados%20posteriormente%20con%20un%20grupo%20de%20aislados%20de%20origen%20cl%5Cu00ednico%20humano%2C%20con%20el%20fin%20de%20determinar%20si%20exist%5Cu00eda%20relaci%5Cu00f3n%20entre%20aislados%20humanos%20y%20de%20origen%20animal.%20Los%20resultados%20obtenidos%20apoyan%20la%20hip%5Cu00f3tesis%20de%20que%20la%20cadena%20alimentaria%20puede%20actuar%20de%20reservorio%20de%20BLEE%2C%20principalmente%20como%20fuente%20de%20pl%5Cu00e1smidos%20portadores%20de%20genes%20blaSHV-12%20y%20con%20menor%20frecuencia%20de%20aislados%20productores%20de%20BLEE.%20No%20obstante%2C%20el%20reservorio%20asociado%20a%20la%20ingesta%20y%20manipulaci%5Cu00f3n%20de%20alimentos%20c%5Cu00e1rnicos%20s%5Cu00f3lo%20explica%20una%20parte%20de%20la%20diseminaci%5Cu00f3n%20de%20BLEE%2C%20existiendo%20otros%20fen%5Cu00f3menos%20como%20la%20introducci%5Cu00f3n%20de%20un%20clon%20virulento%20productor%20de%20CTX-M-15%20entre%20aislados%20cl%5Cu00ednicos%20no%20relacionados%20con%20la%20cadena%20alimentaria.%22%2C%22thesisType%22%3A%22%22%2C%22university%22%3A%22%22%2C%22date%22%3A%222014-09-24%22%2C%22language%22%3A%22spa%22%2C%22url%22%3A%22http%3A%5C%2F%5C%2Fhdl.handle.net%5C%2F11441%5C%2F47905%22%2C%22collections%22%3A%5B%22VN54CXGB%22%5D%2C%22dateModified%22%3A%222025-11-24T12%3A51%3A48Z%22%7D%7D%2C%7B%22key%22%3A%22QES59SDG%22%2C%22library%22%3A%7B%22id%22%3A6316110%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Machuca%20Barcena%22%2C%22parsedDate%22%3A%222014-09-18%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BMachuca%20Barcena%2C%20J.%20%282014%29.%20%26lt%3Bi%26gt%3BInteracci%26%23xF3%3Bn%20de%20mecanismos%20plasm%26%23xED%3Bdicos%20y%20cromos%26%23xF3%3Bmicos%20de%20resistencia%20a%20Quinolonas%20en%20Escherichia%20coli%20y%20su%20efecto%20en%20la%20resistencia%2C%20fitness%20y%20toxicidad%20celular%26lt%3B%5C%2Fi%26gt%3B.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-ItemURL%26%23039%3B%20href%3D%26%23039%3Bhttp%3A%5C%2F%5C%2Fhdl.handle.net%5C%2F11441%5C%2F56333%26%23039%3B%26gt%3Bhttp%3A%5C%2F%5C%2Fhdl.handle.net%5C%2F11441%5C%2F56333%26lt%3B%5C%2Fa%26gt%3B%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22thesis%22%2C%22title%22%3A%22Interacci%5Cu00f3n%20de%20mecanismos%20plasm%5Cu00eddicos%20y%20cromos%5Cu00f3micos%20de%20resistencia%20a%20Quinolonas%20en%20Escherichia%20coli%20y%20su%20efecto%20en%20la%20resistencia%2C%20fitness%20y%20toxicidad%20celular%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jes%5Cu00fas%22%2C%22lastName%22%3A%22Machuca%20Barcena%22%7D%5D%2C%22abstractNote%22%3A%22Las%20fluoroquinolonas%2C%20junto%20a%20los%20beta-lact%5Cu00e1micos%2C%20son%20los%20antimicrobianos%20de%20mayor%20uso%20cl%5Cu00ednico.%20Por%20tanto%20la%20aparici%5Cu00f3n%20de%20resistencia%20bacteriana%20frente%20a%20estos%20agentes%20supone%20un%20problema%20cl%5Cu00ednico%20de%20elevada%20importancia.%20Modificaciones%20en%20la%20estructura%20de%20las%20quinolonas%2C%20fundamentalmente%20fluoraciones%20en%20distintas%20posiciones%20del%20anillo%204-quinolona%2C%20han%20dado%20lugar%20a%20la%20aparici%5Cu00f3n%20de%20un%20gran%20n%5Cu00famero%20de%20nuevas%20mol%5Cu00e9culas%20con%20gran%20actividad.%20Las%20quinolonas%20act%5Cu00faan%20uni%5Cu00e9ndose%20a%20la%20ADN-girasa%20%28o%20bien%20a%20la%20topoisomerasa%20IV%29%20en%20el%20momento%20en%20que%20se%20produce%20la%20reacci%5Cu00f3n%20de%20topoisomerizaci%5Cu00f3n%20del%20ADN%2C%20de%20modo%20que%20se%20forma%2C%20por%20medio%20de%20un%20cambio%20conformacional%2C%20un%20complejo%20quinolona-enzima-ADN%20muy%20estable%20que%20inhibe%20la%20actividad%20enzim%5Cu00e1tica%20e%20impide%20el%20movimiento%20de%20la%20horquilla%20de%20replicaci%5Cu00f3n.%20Las%20quinolonas%20se%20usan%20en%20el%20tratamiento%20de%20gran%20variedad%20de%20infecciones%20intrahospitalarias%20y%20comunitarias.%20La%20aparici%5Cu00f3n%20de%20resistencia%20a%20betalact%5Cu00e1micos%20en%20enterobacterias%20hizo%20que%20las%20quinolonas%20fueran%20una%20buena%20alternativa%20para%20el%20tratamiento%20de%20infecciones%20causadas%20por%20estos%20microorganismos.%20El%20principal%20problema%20del%20uso%20de%20fluoroquinolonas%20ha%20sido%20la%20r%5Cu00e1pida%20aparici%5Cu00f3n%20de%20resistencias%20a%20las%20mismas.%20La%20resistencia%20a%20quinolonas%20en%20bacterias%20Gram-negativas%20tiene%20su%20origen%20en%20la%20aparici%5Cu00f3n%20de%20mutaciones%20cromos%5Cu00f3micas%20que%20afectan%20a%20los%20genes%20gyrA%20y%20parC%2C%20principalmente%2C%20%28codificantes%20de%20las%20subunidad%20A%20de%20la%20ADN-girasa%20y%20la%20topoisomerasa%20IV%2C%20respectivamente%29%20y%20en%20los%20genes%20gyrB%20y%20parE%2C%20secundariamente%20%28codificantes%20de%20las%20subunidades%20B%20de%20la%20ADN-girasa%20y%20la%20topoisomerasa%20IV%2C%20respectivamente%29.%20La%20adquisici%5Cu00f3n%20de%20mutaciones%20en%20estos%20genes%20es%20secuencial%20y%20afecta%20a%20una%20regi%5Cu00f3n%20concreta%20de%20los%20mismos%20denominada%20QRDR%20%28Quinolone%20Resistance%20Determining%20Region%29.%20Secundariamente%2C%20la%20sensibilidad%20a%20quinolonas%20puede%20verse%20reducida%20por%20bombas%20de%20expulsi%5Cu00f3n%20activa%20o%20la%20disminuci%5Cu00f3n%20de%20la%20permeabilidad%20de%20membrana%20%289%29.%20En%201998%20un%20grupo%20de%20investigaci%5Cu00f3n%20de%20la%20Universidad%20de%20Sevilla%20fue%20el%20primero%20en%20describir%20un%20mecanismo%20de%20resistencia%20a%20quinolonas%20mediado%20por%20pl%5Cu00e1smidos%20en%20una%20cepa%20cl%5Cu00ednica%20de%20K.%20pneumoniae%20aislada%20en%20Alabama%2C%20EEUU%2C%20mediado%20por%20el%20gen%20qnr%20%28quinolone%20resistance%29%2C%20y%20actualmente%20denominado%20qnrA%20%2814%29.%20Este%20gen%20presente%20en%20estructuras%20plasm%5Cu00eddicas%20se%20relaciona%20con%20integrones%20de%20clase%201.%20qnrA%20codifica%20una%20prote%5Cu00edna%20pentapept%5Cu00eddica%20%28COG_1357S%29%20de%20218%20amino%5Cu00e1cidos%20que%20protege%20a%20la%20ADN%20girasa%20y%20a%20la%20topoisomerasa%20IV%20de%20la%20uni%5Cu00f3n%20de%20las%20quinolonas.%20Este%20nuevo%20mecanismo%20de%20resistencia%20produce%20un%20efecto%20aditivo%20sobre%20los%20anteriormente%20mencionados%2C%20y%20en%20consecuencia%20un%20aumento%20significativo%20del%20nivel%20de%20resistencia%20a%20estos%20antimicrobianos.%20Cuando%20los%20pl%5Cu00e1smidos%20que%20contienen%20genes%20qnr%20son%20transferidos%20por%20conjugaci%5Cu00f3n%20confieren%20bajo%20nivel%20de%20resistencia%20al%20receptor.%20Su%20localizaci%5Cu00f3n%20plasm%5Cu00eddicas%20asociado%20al%20amplio%20uso%20actual%20de%20las%20quinolonas%20ha%20conducido%20a%20un%20aumento%20de%20este%20tipo%20de%20resistencias.%20En%20este%20sentido%2C%20en%20los%20%5Cu00faltimos%20a%5Cu00f1os%20se%20han%20descrito%20nuevos%20genes%20de%20tipo%20qnr%20relacionados%20con%20qnrA%20en%20elementos%20de%20transmisi%5Cu00f3n%20horizontal%20y%20pertenecientes%20a%20la%20familia%20de%20prote%5Cu00ednas%20con%20repeticiones%20pentapept%5Cu00eddicas%2C%20como%20son%20qnrB%2C%20qnrS%2C%20qnrC%2C%20qnrD%2C%20qnrVC.%20Todos%20ellos%20han%20sido%20descritos%20mayoritariamente%20en%20especies%20de%20enterobacterias%20de%20importancia%20cl%5Cu00ednica%2C%20e%20incluso%20qnrB%20ha%20sido%20descrito%20recientemente%20en%20Pseudomonas%20fluorescens%20de%20origen%20animal.%20Las%20prote%5Cu00ednas%20resultantes%20de%20estos%20genes%20comparten%20entre%20un%2032%25%20y%20un%2064%25%20de%20identidad%20aminoac%5Cu00eddica%20entre%20ellas%2C%20mostrando%20una%20elevada%20variabilidad%20de%20secuencia.%20Tras%20la%20descripci%5Cu00f3n%20de%20qnrA%2C%20se%20observ%5Cu00f3%20que%20no%20todos%20los%20pl%5Cu00e1smidos%20que%20conten%5Cu00edan%20qnrA%20transfer%5Cu00edan%20el%20mismo%20nivel%20de%20resistencia%20a%20quinolonas.%20Aquellos%20pl%5Cu00e1smidos%20que%20confieren%20mayor%20nivel%20de%20resistencia%20portaban%2C%20adem%5Cu00e1s%20de%20qnr%2C%20una%20variante%20al%5Cu00e9lica%20del%20gen%20de%20resistencia%20a%20aminogluc%5Cu00f3sidos%20aac%286%26%23039%3B%29-Ib%20y%20que%20confiere%20resistencia%20a%20ciprofloxacino%20y%20norfloxacina%20mediante%20acetilaci%5Cu00f3n%20en%20el%20substituyente%20de%20piperazynil%20de%20estos%20antimicrobianos.%20Este%20gen%20presenta%20un%20prevalencia%20elevada%2C%20en%20torno%20al%2020%25%2C%20en%20los%20estudios%20realizados.%20Por%20%5Cu00faltimo%2C%20dos%20sistemas%20de%20flujo%20asociados%20a%20pl%5Cu00e1smidos%20han%20sido%20descritos%20recientemente%2C%20QepA%20y%20OqxAB%20pertenecientes%20a%20las%20familias%20RND%20y%20MFS%2C%20respectivamente%2C%20con%20capacidad%20para%20reducir%20la%20sensibilidad%20frente%20a%20quinolonas%20en%20enterobacterias.%20Mientras%20OqxAB%20ha%20sido%20frecuentemente%20descrito%20en%20K.%20pneumoniae%2C%20la%20distribuci%5Cu00f3n%20de%20QepA%20parece%20ser%20menor.%20Estudios%20recientes%20muestran%20un%20aumento%20de%20la%20prevalencia%20de%20estos%20mecanismos%20de%20resistencia%2C%20tanto%20cromos%5Cu00f3micos%20como%20plasm%5Cu00eddicos.%20En%20nuestro%20pa%5Cu00eds%2C%20la%20resistencia%20en%20E.%20coli%20de%20origen%20urinario%20a%20%5Cu00e1cido%20nalid%5Cu00edxico%20y%20fluoroquinolonas%20ha%20aumentado%20hasta%20un%2030%25%20y%2020%25%2C%20respectivamente.%20La%20resistencia%20a%20fluoroquinolonas%20ha%20aumentado%20en%20otras%20enterobacterias%2C%20tales%20como%20el%20genero%20Enterobacter%2C%20importante%20causante%20de%20infecciones%20invasoras%20nosocomiales.%20Los%20pl%5Cu00e1smidos%20que%20contienen%20genes%20qnr%20incluyen%20tambi%5Cu00e9n%20genes%20que%20codifican%20la%20producci%5Cu00f3n%20de%20beta-lactamasas%20plasm%5Cu00eddicas%20de%20tipo%20AmpC%20o%20betalactamasas%20de%20espectro%20extendido%20%28BLEEs%29.%20Esto%20sugiere%20una%20posible%20relaci%5Cu00f3n%20gen%5Cu00e9tica%20entre%20la%20resistencia%20a%20betalact%5Cu00e1micos%20y%20a%20quinolonas%2C%20fen%5Cu00f3meno%20estad%5Cu00edsticamente%20demostrado%20en%20cepas%20productoras%20de%20BLEEs.%20Adem%5Cu00e1s%2C%20la%20dispersi%5Cu00f3n%20y%20emergencia%20de%20la%20resistencia%20por%20transferencia%20plasm%5Cu00eddica%20es%20un%20factor%20a%20tener%20en%20cuenta.%20Datos%20de%20diferentes%20autores%20muestran%20que%20la%20expresi%5Cu00f3n%20de%20los%20genes%20qnr%20%28qnrA%2C%20qnrB%2C%20qnrS%29%20en%20E.%20coli%20aumentan%20el%20valor%20de%20la%20Concentraci%5Cu00f3n%20Preventiva%20de%20Mutantes%20y%20la%20frecuencia%20de%20aparici%5Cu00f3n%20de%20mutantes.%20El%20efecto%20aditivo%20de%20la%20mutaci%5Cu00f3n%20Ser83Leu%20en%20la%20ADN%20girasa%20y%20la%20expresi%5Cu00f3n%20de%20los%20genes%20qnr%20en%20E.%20coli%20permite%20seleccionar%20mutantes%20de%20un%20solo%20paso%20con%20elevados%20niveles%20de%20resistencia%20a%20fluoroquinolonas.%20En%20este%20proyecto%20nos%20proponemos%20analizar%20la%20interacci%5Cu00f3n%20de%20los%20nuevos%20mecanismos%20de%20resistencia%20a%20quinolonas%20mediada%20por%20pl%5Cu00e1smido%20descritos%20con%20mecanismos%20de%20resistencia%20cromos%5Cu00f3micos.%20El%20desarrollo%20de%20estrategias%20efectivas%20que%20conduzcan%20a%20frenar%20el%20aumento%20de%20la%20resistencia%20a%20quinolonas%20requiere%20una%20mayor%20comprensi%5Cu00f3n%20de%20los%20factores%20que%20conducen%20a%20este%20incremento.%20Previamente%20se%20ha%20descrito%20que%20algunas%20mutaciones%20cromos%5Cu00f3micas%20que%20confieren%20resistencia%20a%20quinolonas%20producen%20una%20disminuci%5Cu00f3n%20del%20fitness%20bacteriano%20que%20a%20su%20vez%20produce%20la%20aparici%5Cu00f3n%20de%20mutaciones%20compensatorias.%20Sin%20embargo%2C%20Marcusson%20et%20al.%20han%20publicado%20recientemente%20un%20estudio%20en%20el%20que%20se%20ha%20evaluado%20el%20papel%20de%20varias%20de%20las%20mutaciones%20cromos%5Cu00f3micas%20m%5Cu00e1s%20frecuentemente%20relacionadas%20con%20resistencia%20a%20quinolonas%20en%20una%20colecci%5Cu00f3n%20isog%5Cu00e9nica%20y%20su%20interacci%5Cu00f3n%20con%20el%20fitness%20bacteriano.%20Estos%20autores%20demuestran%20que%20la%20adici%5Cu00f3n%20de%20ciertas%20mutaciones%2C%20por%20ejemplo%20Ser80Ile%20en%20ParC%20sobre%20una%20cepa%20que%20contiene%20las%20mutaciones%20Ser83Leu%20y%20Asp87Asn%20en%20GyrA%20junto%20con%20una%20deleci%5Cu00f3n%20en%20marR%2C%20incrementan%20el%20fitness%20bacteriano%20lo%20cual%20puede%20tener%20implicaciones%20en%20la%20evoluci%5Cu00f3n%20de%20la%20resistencia%20a%20quinolonas%20en%20ausencia%20de%20presi%5Cu00f3n%20antibi%5Cu00f3tica.%20De%20este%20modo%2C%20mutantes%20con%20bajo%20nivel%20de%20resistencia%20a%20quinolonas%20pueden%20producir%20simplemente%20por%20selecci%5Cu00f3n%20natural%20%28mejora%20de%20la%20tasa%20de%20crecimiento%29%20la%20adquisici%5Cu00f3n%20de%20mutaciones%20que%20incrementen%20el%20nivel%20de%20resistencia%20a%20quinolonas.%20El%20efecto%20que%20los%20mecanismos%20de%20resistencia%20a%20quinolonas%20mediada%20por%20pl%5Cu00e1smido%20sobre%20el%20fitness%20bacteriano%20es%20desconocido%20y%20por%20lo%20tanto%20su%20implicaci%5Cu00f3n%20en%20la%20aparici%5Cu00f3n%20de%20resistencia%20de%20alto%20nivel%20frente%20quinolonas.%20Otro%20aspecto%20que%20parece%20relevante%20para%20comprender%20como%20afecta%20a%20la%20c%5Cu00e9lula%20bacteriana%20la%20adquisici%5Cu00f3n%20de%20pl%5Cu00e1smidos%20portadores%20de%20genes%20qnr%2C%20es%20el%20posible%20papel%20citot%5Cu00f3xico%20derivado%20de%20su%20expresi%5Cu00f3n%2C%20ya%20que%20los%20estudios%20bioqu%5Cu00edmicos%20de%20estos%20genes%20indican%20que%20interaccionan%20con%20las%20topoisomerasas%20bacterianas%2C%20las%20cuales%20son%20enzimas%20esenciales%2C%20y%20se%20comportan%20como%20inhibidores%20d%5Cu00e9biles%20que%20impiden%20la%20activaci%5Cu00f3n%20del%20sistema%20SOS.%20En%20este%20contexto%2C%20recientemente%20se%20ha%20publicado%20la%20caracterizaci%5Cu00f3n%20de%20una%20prote%5Cu00edna%20pentapept%5Cu00eddica%20obtenida%20del%20cromosoma%20de%20Enterococcus%20faecalis%2C%20EfsQnr.%20En%20un%20modelo%20heter%5Cu00f3logo%20en%20E.%20coli%20la%20sobre-expresi%5Cu00f3n%20de%20esta%20prote%5Cu00edna%20produjo%20agrupaci%5Cu00f3n%20celular%20y%20perdida%20de%20viabilidad.%20Se%20desconoce%20si%20las%20prote%5Cu00ednas%20derivadas%20de%20la%20expresi%5Cu00f3n%20de%20genes%20qnr%20mediados%20por%20pl%5Cu00e1smido%20pueden%20ejercer%20un%20efecto%20similar%20y%20tener%20un%20coste%20biol%5Cu00f3gico%20para%20las%20bacterias.%20Si%20esto%20fuese%20as%5Cu00ed%20podr%5Cu00eda%20explicar%20la%20frecuente%20perdida%20de%20los%20pl%5Cu00e1smidos%20portadores%20de%20estos%20genes%20en%20ausencia%20de%20presi%5Cu00f3n%20antibi%5Cu00f3tica.%20Adem%5Cu00e1s%20podr%5Cu00eda%20abrir%20la%20puerta%20para%20un%20potencial%20uso%20de%20prote%5Cu00ednas%20Qnr%20o%20similares%20como%20nuevos%20agentes%20antimicrobianos%20de%20naturaleza%20pept%5Cu00eddica.%20Se%20estima%20que%20el%2060%25%20de%20las%20infecciones%20son%20producidas%20por%20bacterias%20constituidas%20en%20biocapas%20y%20no%20necesariamente%20en%20infecciones%20asociadas%20a%20materiales%20prot%5Cu00e9sicos%20o%20biomateriales.%20La%20biocapas%20bacterianas%20son%20habitualmente%20resistentes%20a%20los%20antimicrobianos%2C%20inclu%5Cu00eddas%20las%20fluoroquinolonas%2C%20por%20diferentes%20mecanismos.%20Entre%20ellos%20se%20postula%20la%20posibilidad%20de%20que%20algunos%20genes%20de%20resistencia%20se%20h%5Cu00edper-expresen%20cuando%20las%20bacterias%20se%20encuentran%20formando%20parte%20de%20biocapas.%20La%20expresi%5Cu00f3n%20de%20los%20genes%20qnr%20en%20biocapas%20bacterianas%20es%20desconocida.%20Las%20diferencias%20en%20la%20expresi%5Cu00f3n%20de%20los%20genes%20qnr%20pueden%20determinar%20una%20mayor%20resistencia%20de%20las%20biocapas%20bacterianas%20a%20la%20acci%5Cu00f3n%20de%20las%20fluoroquinolonas.%20Finalmente%2C%20la%20potencial%20alteraci%5Cu00f3n%20del%20fitness%20bacteriano%20mediada%20por%20estos%20genes%20puede%20tener%20consecuencias%20en%20la%20formaci%5Cu00f3n%20de%20biocapas%20bacterianas.%20Las%20hip%5Cu00f3tesis%20de%20este%20estudio%20son%20las%20siguientes%3A%201.%20La%20asociaci%5Cu00f3n%20de%20mecanismos%20plasm%5Cu00eddicos%20y%20cromos%5Cu00f3micos%20de%20resistencia%20a%20quinolonas%20contribuye%20significativamente%20a%20aumentar%20la%20resistencia%20frente%20a%20estos%20antimicrobianos.%202.%20La%20producci%5Cu00f3n%20de%20especies%20reactivas%20de%20oxigeno%20en%20respuesta%20a%20la%20acci%5Cu00f3n%20de%20las%20quinolonas%2C%20y%20que%20se%20vincula%20a%20la%20actividad%20bactericida%20de%20estos%20antimicrobianos%2C%20se%20ve%20reducida%20por%20la%20presencia%20de%20mecanismos%20de%20resistencia%20tanto%20cromos%5Cu00f3micos%20como%20plasm%5Cu00eddicos.%203.%20Los%20mecanismos%20plasm%5Cu00eddicos%20de%20resistencia%20a%20quinolonas%2C%20solos%20o%20en%20asociaci%5Cu00f3n%20con%20mecanismos%20cromos%5Cu00f3micos%2C%20modifican%20el%20fitness%20bacteriano.%204.%20La%20sobreexpresi%5Cu00f3n%20de%20los%20mecanismos%20plasm%5Cu00eddicos%20de%20resistencia%20a%20quinolonas%20puede%20ejercer%20un%20efecto%20citot%5Cu00f3xico%20sobre%20las%20c%5Cu00e9lulas%20bacterianas.%20El%20objetivo%20general%20de%20este%20estudio%20se%20centra%20en%20el%20an%5Cu00e1lisis%20del%20papel%20que%20los%20mecanismos%20plasm%5Cu00eddicos%20de%20resistencia%20a%20quinolonas%2C%20en%20combinaci%5Cu00f3n%20con%20mecanismos%20cromos%5Cu00f3micos%2C%20juegan%20en%20la%20aparici%5Cu00f3n%20y%20desarrollo%20de%20resistencia%20a%20quinolonas%2C%20as%5Cu00ed%20como%20en%20la%20modificaci%5Cu00f3n%20del%20fitness%20bacteriano.%20Para%20desarrollar%20este%20objetivo%20en%20ausencia%20de%20otros%20factores%20que%20pudieran%20interferir%20se%20dise%5Cu00f1ar%5Cu00e1%20y%20contruir%5Cu00e1%20una%20colecci%5Cu00f3n%20de%20cepas%20isog%5Cu00e9nicas%20de%20E.%20coli%20en%20la%20que%20se%20representen%20la%20mayor%5Cu00eda%20de%20los%20mecanismos%20de%20resistencia%20a%20quinolonas%20com%5Cu00fanmente%20encontrado%20en%20aislados%20cl%5Cu00ednicos%2C%20contemplando%20aquellos%20de%20naturaleza%20tanto%20cromos%5Cu00f3mica%20como%20plasm%5Cu00eddica.%20Los%20objetivos%20espec%5Cu00edficos%20que%20se%20propusieron%20en%20este%20trabajo%20fueron%3A%201.%20An%5Cu00e1lisis%20de%20la%20contribuci%5Cu00f3n%20de%20los%20mecanismos%20cromos%5Cu00f3micos%20y%20plasm%5Cu00eddicos%20de%20resistencia%20a%20quinolonas%20sobre%20la%20actividad%20de%20quinolonas%20y%20su%20impacto%20sobre%20el%20desarrollo%20de%20resistencia%20de%20nivel%20cl%5Cu00ednico.%202.%20An%5Cu00e1lisis%20de%20la%20contribuci%5Cu00f3n%20de%20los%20mecanismos%20cromos%5Cu00f3micos%20y%20plasm%5Cu00eddicos%20de%20resistencia%20a%20quinolonas%20sobre%20la%20producci%5Cu00f3n%20de%20especies%20reactivas%20de%20oxigeno.%203.%20Determinar%20el%20efecto%20de%20los%20mecanismos%20cromos%5Cu00f3micos%20y%20plasm%5Cu00eddicos%2C%20tanto%20en%20combinaciones%20de%20bajo%20nivel%20de%20resistencia%20como%20resistentes%20a%20quinolonas%2C%20sobre%20el%20fitness%20bacteriano%20bajo%20diferentes%20condiciones%20de%20crecimiento%204.%20An%5Cu00e1lisis%20del%20posible%20efecto%20citot%5Cu00f3xico%20causado%20por%20sobreexpresi%5Cu00f3n%20de%20mecanismos%20plasm%5Cu00eddicos%20sobre%20las%20c%5Cu00e9lulas%20bacterianas.%20De%20los%20resultados%20obtenidos%20en%20los%20trabajos%20expuestos%20en%20este%20proyecto%20de%20Tesis%20Doctoral%20se%20pueden%20extraer%20las%20siguientes%20conclusiones%3A%201.%20En%20nuestras%20condiciones%20experimentales%20se%20observa%20una%20relaci%5Cu00f3n%20entre%20la%20combinaci%5Cu00f3n%20de%20mecanismos%20de%20resistencia%20a%20quinolonas%2C%20plasm%5Cu00eddicos%20y%20cromos%5Cu00f3micos%2C%20con%20la%20sensibilidad%20a%20las%20mismas%2C%20la%20categor%5Cu00eda%20cl%5Cu00ednica%20derivada%20y%20el%20fitness%20bacteriano%20en%20E.%20coli.%202.%20La%20presencia%20de%20mecanismos%20plasm%5Cu00eddicos%20de%20resistencia%20en%20cepas%20de%20E.%20coli%20con%20al%20menos%20dos%20mutaciones%20cromos%5Cu00f3micas%20determina%20aumentos%20de%20la%20CMI%20de%20quinolonas%20por%20encima%20de%20los%20puntos%20de%20corte%20establecidos%20para%20cepas%20sensibles%20por%20las%20agencias%20internacionales.%203.%20La%20expresi%5Cu00f3n%20de%20algunos%20mecanismos%20cromos%5Cu00f3micos%20%28deleci%5Cu00f3n%20de%20marR%29%20o%20plasm%5Cu00eddicos%20%28qnrD1%20o%20qepA2%29%20puede%20determinar%20en%20E.%20coli%20valores%20de%20CMI%20de%20fluoroquinolonas%20menores%20que%20los%20establecidos%20para%20el%20denominado%20punto%20de%20corte%20epidemiol%5Cu00f3gico%2C%20por%20debajo%20del%20cual%20se%20presupone%20que%20no%20existen%20mecanismos%20de%20resistencia.%204.%20La%20acumulaci%5Cu00f3n%20de%20mecanismos%20de%20resistencia%20a%20quinolonas%2C%20cromos%5Cu00f3micos%20y%20plasm%5Cu00eddicos%2C%20disminuye%20la%20producci%5Cu00f3n%20de%20especies%20reactivas%20de%20ox%5Cu00edgeno%2C%20lo%20que%20se%20correlaciona%20con%20una%20p%5Cu00e9rdida%20de%20la%20actividad%20bactericida%20de%20las%20mismas.%205.%20En%20ausencia%20de%20mecanismos%20plasm%5Cu00eddicos%20de%20resistencia%20a%20quinolonas%2C%20la%20presencia%20de%20mecanismos%20cromos%5Cu00f3micos%20no%20disminuye%20el%20fitness%20bacteriano.%20Sin%20embargo%2C%20algunos%20mecanismos%20cromos%5Cu00f3micos%2C%20solos%20o%20en%20combinaci%5Cu00f3n%20aumentan%20el%20fitness%20bacteriano.%206.%20El%20efecto%20de%20los%20genes%20qnr%20sobre%20el%20fitness%20bacteriano%20es%20variable.%20En%20nuestras%20condiciones%20experimentales%2C%20la%20presencia%20del%20gen%20qnrA1%20reduce%20el%20fitness%20bacteriano%20y%20los%20genes%20qnrD1%20y%20qnrS1%20lo%20incrementan.%207.%20La%20adquisici%5Cu00f3n%20del%20gen%20qepA2%20tiene%20coste%20biol%5Cu00f3gico%20en%20E.%20coli%20en%20presencia%20de%20un%20gen%20marR%20funcional%2C%20mientras%20que%20este%20coste%20biol%5Cu00f3gico%20es%20compensado%20e%20incluso%20se%20convierte%20en%20una%20condici%5Cu00f3n%20favorable%20para%20el%20crecimiento%20bacteriano%20en%20presencia%20de%20una%20deleci%5Cu00f3n%20en%20este%20mismo%20gen.%208.%20La%20sobreexpresi%5Cu00f3n%20de%20los%20genes%20qnr%20en%20E.%20coli%20tiene%20un%20efecto%20citot%5Cu00f3xico.%209.%20La%20sobreexpresi%5Cu00f3n%20del%20gen%20qepA2%20en%20E.%20coli%20no%20tiene%20un%20efecto%20citot%5Cu00f3xico.%22%2C%22thesisType%22%3A%22%22%2C%22university%22%3A%22%22%2C%22date%22%3A%222014-09-18%22%2C%22language%22%3A%22spa%22%2C%22url%22%3A%22http%3A%5C%2F%5C%2Fhdl.handle.net%5C%2F11441%5C%2F56333%22%2C%22collections%22%3A%5B%22VN54CXGB%22%5D%2C%22dateModified%22%3A%222025-11-24T12%3A49%3A46Z%22%7D%7D%2C%7B%22key%22%3A%22ITDPUWV4%22%2C%22library%22%3A%7B%22id%22%3A6316110%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Pic%5Cu00f3n%20Toro%22%2C%22parsedDate%22%3A%222014-04-02%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BPic%26%23xF3%3Bn%20Toro%2C%20E.%20%282014%29.%20%26lt%3Bi%26gt%3BEstudio%20multic%26%23xE9%3Bntrico%20de%20bacteriemias%20por%20escherichia%20coli%20productor%20de%20betalactamasas%20de%20espectro%20extendido%3A%20factores%20de%20riesgo%2C%20caracter%26%23xED%3Bsticas%20microbiol%26%23xF3%3Bgicas%20de%20impacto%20cl%26%23xED%3Bnico%26lt%3B%5C%2Fi%26gt%3B.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-ItemURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fhdl.handle.net%5C%2F11441%5C%2F73497%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fhdl.handle.net%5C%2F11441%5C%2F73497%26lt%3B%5C%2Fa%26gt%3B%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22thesis%22%2C%22title%22%3A%22Estudio%20multic%5Cu00e9ntrico%20de%20bacteriemias%20por%20escherichia%20coli%20productor%20de%20betalactamasas%20de%20espectro%20extendido%3A%20factores%20de%20riesgo%2C%20caracter%5Cu00edsticas%20microbiol%5Cu00f3gicas%20de%20impacto%20cl%5Cu00ednico%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Encarnaci%5Cu00f3n%22%2C%22lastName%22%3A%22Pic%5Cu00f3n%20Toro%22%7D%5D%2C%22abstractNote%22%3A%22Esta%20tesis%20es%20el%20resultado%20de%20un%20estudio%20de%20investigaci%5Cu00f3n%20multic%5Cu00e9ntrico%20en%20el%20que%20participaron%2013%20hospitales%20y%20un%20centro%20asociado%20de%20diferentes%20zonas%20geogr%5Cu00e1ficas%20de%20Espa%5Cu00f1a%2C%20todos%20pertenecientes%20a%20la%20Red%20Espa%5Cu00f1ola%20de%20Investigaci%5Cu00f3n%20en%20Patolog%5Cu00eda%20Infecciosa%20%28REIPI%29.%20Los%20objetivos%20planteados%20fueron%3A%20conocer%20la%20incidencia%20de%20la%20bacteriemia%20por%20Escherichia%20coli%20productor%20de%20BLEE%20de%20adquisici%5Cu00f3n%20comunitaria%20y%20nosocomial%3B%20investigar%20los%20factores%20de%20riesgo%20para%20las%20bacteriemias%20por%20E.%20coli%20productor%20de%20BLEE%20de%20manera%20que%20ayuden%20a%20identificar%2C%20entre%20los%20pacientes%20con%20sepsis%2C%20aquellos%20en%20los%20que%20es%20necesario%20indicar%20un%20tratamiento%20emp%5Cu00edrico%20con%20actividad%20frente%20a%20estos%20microorganismos%3B%20describir%20las%20caracter%5Cu00edsticas%20microbiol%5Cu00f3gicas%2C%20epidemiol%5Cu00f3gicas%20y%20cl%5Cu00ednicas%20de%20estas%20bacteriemias%20y%20evaluar%20el%20pron%5Cu00f3stico%20de%20las%20mismas%2C%20as%5Cu00ed%20como%20de%20los%20factores%20asociados%20al%20mismo%2C%20y%20espec%5Cu00edficamente%2C%20la%20influencia%20del%20tratamiento%20antimicrobiano.%20El%20periodo%20del%20estudio%20fue%20desde%20mediados%20de%20octubre%20de%202004%20a%20mediados%20de%20enero%20de%202006%2C%20quince%20meses.%20Fue%20un%20trabajo%20prospectivo%20y%20observacional%2C%20el%20dise%5Cu00f1o%20consisti%5Cu00f3%20en%20el%20estudio%20de%20una%20cohorte%20de%20casos%20y%20de%20un%20estudio%20de%20casos%20y%20controles.%20Los%20casos%20eran%20los%20pacientes%20diagnosticados%20de%20bacteriemias%20producidas%20por%20E.%20coli%20productor%20de%20betalactamasas%20de%20espectro%20extendido%20%28BLEE%29%20en%20el%20periodo%20de%20estudio.%20Se%20cumplimentaron%20cuestionarios%20de%20los%20hospitales%20y%20de%20los%20pacientes.%20A%20las%20muestras%20cl%5Cu00ednicas%20de%20los%20casos%20se%20les%20realiz%5Cu00f3%20un%20an%5Cu00e1lisis%20microbiol%5Cu00f3gico%20mediante%20diferentes%20t%5Cu00e9cnicas.%20Tanto%20los%20casos%20como%20los%20controles%20se%20diferenciaron%20en%20funci%5Cu00f3n%20de%20la%20adquisici%5Cu00f3n%20de%20la%20infecci%5Cu00f3n%3A%20en%20nosocomiales%2C%20comunitarios%20y%20%5Cu00e9stos%20a%20su%20vez%20se%20subdividieron%20en%20estrictamente%20comunitarios%20y%20comunitarios%20relacionados%20con%20los%20cuidados%20sanitarios.%20La%20incidencia%20global%20poblacional%20en%20funci%5Cu00f3n%20de%20los%20casos%20obtenidos%20fue%202%2C62%20casos%20por%20cada%20100.000%20habitantes%20durante%20el%20periodo%20estudiado.%20El%20n%5Cu00famero%20de%20aislados%20del%20estudio%20fue%20191%2C%20de%20%5Cu00e9stos%20fueron%2096%20nosocomiales%20y%2095%20de%20adquisici%5Cu00f3n%20comunitaria%2C%20de%20las%20cuales%2023%20%2816%2C6%25%29%20eran%20estrictamente%20comunitarias%20y%2072%20%2868%2C4%25%29%20relacionadas%20con%20los%20cuidados%20sanitarios.%20El%20%5Cu00edndice%20de%20relaci%5Cu00f3n%20clonal%20fue%20bajo%2C%2015%25.%20Los%20aislados%20presentaron%20100%25%20de%20sensibilidad%20a%20las%20carbapenemas%20y%20tigeciclina%2C%20le%20siguieron%20muy%20de%20cerca%20fosfomicina%2C%20piperacilina-tazobactam%20y%20los%20aminogluc%5Cu00f3sidos.%20Las%20enzimas%20encontradas%20mayoritariamente%20pertenec%5Cu00edan%20al%20grupo%20CTX-M-9%20%28123%2C%20el%2064%25%29%20seguidas%20del%20grupo%20CTX-M-1%20%2841%20aislados%29%20y%20SHV%20%2833%20aislados%29.%20Los%20pacientes%20sol%5Cu00edan%20presentar%20diversas%20enfermedades%20cr%5Cu00f3nicas%20de%20base%2C%20alg%5Cu00fan%20dispositivo%20o%20relaci%5Cu00f3n%20con%20los%20cuidados%20sanitarios%2C%20hab%5Cu00edan%20tomado%20antibi%5Cu00f3ticos%20recientemente%20y%20el%20origen%20de%20la%20bacteriemia%20m%5Cu00e1s%20frecuente%20fue%20el%20urinario.%20La%20mortalidad%20global%20fue%20el%2024%2C6%25%20%2847%20pacientes%29.%20Los%20factores%20de%20riesgo%20hallados%20para%20una%20bacteriemia%20por%20E.%20coli%20BLEE%20de%20adquisici%5Cu00f3n%20comunitaria%20fueron%3A%20haber%20tenido%20relaci%5Cu00f3n%20con%20el%20sistema%20sanitario%2C%20el%20uso%20de%20cat%5Cu00e9ter%20urinario%20y%20el%20uso%20reciente%20de%20antimicrobianos.%20Y%20para%20una%20de%20adquisici%5Cu00f3n%20nosocomial%3A%20haber%20recibido%20previamente%20antibi%5Cu00f3ticos%20oxi-imino-%5Cu00df-lact%5Cu00e1micos%20y%20la%20estancia%20en%20el%20hospital%20%28en%20d%5Cu00edas%29.%20Las%20variables%20asociadas%20a%20la%20mortalidad%20para%20las%20bacteriemias%20por%20E.%20coli%20de%20adquisici%5Cu00f3n%20comunitaria%20fueron%3A%20%5Cu00edndice%20de%20Pitt%20%26gt%3B%201%2C%20origen%20diferente%20del%20urinario%20y%20el%20tratamiento%20emp%5Cu00edrico%20inapropiado%2C%20sin%20que%20la%20producci%5Cu00f3n%20de%20BLEE%20fuera%20una%20variable%20asociada.%20Mientras%20que%20para%20las%20de%20adquisici%5Cu00f3n%20nosocomial%20fueron%3A%20%5Cu00edndice%20de%20Pitt%20%26gt%3B%201%2C%20origen%20de%20alto%20riesgo%2C%20aislado%20multirresistente%20y%20sepsis%20grave%20o%20shock%20s%5Cu00e9ptico.%22%2C%22thesisType%22%3A%22%22%2C%22university%22%3A%22%22%2C%22date%22%3A%222014-04-02%22%2C%22language%22%3A%22spa%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fhdl.handle.net%5C%2F11441%5C%2F73497%22%2C%22collections%22%3A%5B%22VN54CXGB%22%5D%2C%22dateModified%22%3A%222025-11-24T12%3A46%3A46Z%22%7D%7D%2C%7B%22key%22%3A%225HCPCV3Q%22%2C%22library%22%3A%7B%22id%22%3A6316110%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Iraurgui%20Arcarazo%22%2C%22parsedDate%22%3A%222012-06-13%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BIraurgui%20Arcarazo%2C%20P.%20%282012%29.%20%26lt%3Bi%26gt%3BEstudio%20fenot%26%23xF3%3Bpico%20y%20genot%26%23xED%3Bpico%20de%20los%20aislamientos%20de%20streptococcus%20pneumoniae%20causantes%20de%20enfermedad%20invasiva%20en%20el%20hospital%20Virgen%20del%20Roc%26%23xED%3Bo%26lt%3B%5C%2Fi%26gt%3B.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-ItemURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fhdl.handle.net%5C%2F11441%5C%2F70786%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fhdl.handle.net%5C%2F11441%5C%2F70786%26lt%3B%5C%2Fa%26gt%3B%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22thesis%22%2C%22title%22%3A%22Estudio%20fenot%5Cu00f3pico%20y%20genot%5Cu00edpico%20de%20los%20aislamientos%20de%20streptococcus%20pneumoniae%20causantes%20de%20enfermedad%20invasiva%20en%20el%20hospital%20Virgen%20del%20Roc%5Cu00edo%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Patricia%22%2C%22lastName%22%3A%22Iraurgui%20Arcarazo%22%7D%5D%2C%22abstractNote%22%3A%22Streptococcus%20pneumoniae%2C%20fue%20descubierto%20simult%5Cu00e1neamente%20por%20Pasteur%20y%20Sternberg%20en%201881%2C%20siendo%20uno%20de%20los%20primeros%20pat%5Cu00f3genos%20aislado%2C%20caracterizado%20y%20que%20jug%5Cu00f3%20un%20papel%20muy%20importante%20en%20el%20desarrollo%20de%20la%20bacteriolog%5Cu00eda%20moderna%2C%20la%20gen%5Cu00e9tica%2C%20la%20inmunolog%5Cu00eda%2C%20la%20terapia%20antimicrobiana%20y%20el%20desarrollo%20de%20vacunas%20%281%2C2%29.%20En%20la%20era%20preantibi%5Cu00f3tica%20la%20neumon%5Cu00eda%20fue%20sumamente%20com%5Cu00fan%2C%20siendo%20responsable%20del%207%25%20de%20los%20fallecimientos%20en%20Estados%20Unidos%20y%20Europa.%20La%20tasa%20de%20mortalidad%20m%5Cu00e1s%20alta%20se%20encontraba%20entre%20los%20ni%5Cu00f1os%20menores%20de%202%20a%5Cu00f1os%2C%20especialmente%20en%20aquellos%20con%20bronconeumon%5Cu00eda%20o%20bacteriemia%20%282%29.%20En%201886%20se%20describrieron%20otras%20localizaciones%20en%20las%20infecciones%20neumoc%5Cu00f3cicas%20asociadas%20a%20la%20neumon%5Cu00eda%2C%20aisl%5Cu00e1ndose%20neumococo%20en%20un%20exudado%20de%20la%20piamadre%20de%20un%20paciente%20que%20falleci%5Cu00f3%20de%20meningitis.%20En%20pocos%20a%5Cu00f1os%20se%20registraron%20otras%20complicaciones%20como%20la%20artritis%2C%20la%20endocarditis%2C%20la%20peritonitis%20o%20la%20bacteriemia%20sin%20foco%20que%20indicaban%20infecci%5Cu00f3n%20hemat%5Cu00f3gena.%20Las%20manifestaciones%20de%20la%20infecci%5Cu00f3n%20primaria%20englobaban%20el%20tracto%20respiratorio%2C%20incluyendo%20la%20neumon%5Cu00eda%2C%20la%20traqueobronquitis%2C%20la%20otitis%20y%20la%20sinusitis%20%282%29.%20El%20descubrimiento%20de%20la%20penicilina%20en%201940%20supuso%20un%20avance%20importante%20en%20el%20tratamiento%20de%20la%20neumon%5Cu00eda%2C%20aunque%20en%20poco%20tiempo%20ya%20se%20hab%5Cu00edan%20seleccionado%20neumococos%20mutantes%20resistentes.%20Veinte%20a%5Cu00f1os%20m%5Cu00e1s%20tarde%20emergi%5Cu00f3%20el%20primer%20aislamiento%20cl%5Cu00ednico%20con%20sensibilidad%20reducida.%20En%20poco%20tiempo%2C%20aparecieron%20cepas%20resistentes%20en%20Pap%5Cu00faa%20Nueva%20Guinea%20y%20en%20la%20misma%20d%5Cu00e9cada%2C%20cepas%20con%20resistencia%20intermedia%20en%20Sud%5Cu00e1frica%2C%20Europa%20y%20Norte%20Am%5Cu00e9rica%20%283%29.%22%2C%22thesisType%22%3A%22%22%2C%22university%22%3A%22%22%2C%22date%22%3A%222012-06-13%22%2C%22language%22%3A%22spa%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fhdl.handle.net%5C%2F11441%5C%2F70786%22%2C%22collections%22%3A%5B%22VN54CXGB%22%5D%2C%22dateModified%22%3A%222025-11-24T13%3A12%3A17Z%22%7D%7D%2C%7B%22key%22%3A%226BMCQAB5%22%2C%22library%22%3A%7B%22id%22%3A6316110%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Arroyo%20Pedrero%22%2C%22parsedDate%22%3A%222012%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BArroyo%20Pedrero%2C%20L.%20A.%20%282012%29.%20%26lt%3Bi%26gt%3BBases%20moleculares%20de%20la%20resistencia%20a%20Polimixinas%20en%20Acinetobacter%20Baumannii%3A%20Implicaciones%20cl%26%23xED%3Bnicas%20y%20epidemiol%26%23xF3%3Bgicas%26lt%3B%5C%2Fi%26gt%3B%20%5BHttp%3A%5C%2F%5C%2Fpurl.org%5C%2Fdc%5C%2Fdcmitype%5C%2FText%2C%20Universidad%20de%20Sevilla%5D.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-ItemURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdialnet.unirioja.es%5C%2Fservlet%5C%2Ftesis%3Fcodigo%3D110541%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdialnet.unirioja.es%5C%2Fservlet%5C%2Ftesis%3Fcodigo%3D110541%26lt%3B%5C%2Fa%26gt%3B%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22thesis%22%2C%22title%22%3A%22Bases%20moleculares%20de%20la%20resistencia%20a%20Polimixinas%20en%20Acinetobacter%20Baumannii%3A%20Implicaciones%20cl%5Cu00ednicas%20y%20epidemiol%5Cu00f3gicas%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Luis%20Antonio%22%2C%22lastName%22%3A%22Arroyo%20Pedrero%22%7D%5D%2C%22abstractNote%22%3A%22Acinetobacter%20baumannii%20se%20ha%20convertido%20en%20un%20importante%20pat%5Cu00f3geno%20oportunista%20en%20el%20medio%20hospitalario.%20La%20aparici%5Cu00f3n%20de%20aislamientos%20cl%5Cu00ednicos%20extremadamente%20resistentes%20deja%20a%20la%20tigeciclina%20y%20polimixinas%20como%20potenciales%20alternativas.%20En%20el%20a%5Cu00f1o%202002%2C%20se%20registr%5Cu00f3%20un%20brote%20nosocomial%20en%20el%20Hospital%20Universitario%20Virgen%20del%20Roc%5Cu00edo%20%28Sevilla%29%20de%20A.%20baumannii%20resistente%20a%20todos%20los%20antimicrobianos%20disponibles%20incluyendo%20la%20colistina.%20Este%20hecho%20plante%5Cu00f3%20los%20siguientes%20objetivos%20de%20la%20presente%20tesis%3A%201.%20Caracterizaci%5Cu00f3n%20del%20brote%20nosocomial.%202.%20Evaluaci%5Cu00f3n%20del%20m%5Cu00e9todo%20E-test%20en%20la%20determinaci%5Cu00f3n%20de%20la%20CMI%20a%20colistina%20en%20comparaci%5Cu00f3n%20con%20el%20m%5Cu00e9todo%20de%20referencia%20de%20microdiluci%5Cu00f3n%20en%20caldo.%203.%20Estudio%20de%20la%20actividad%20de%20tigeciclina%2C%20minociclina%20e%20interacci%5Cu00f3n%20tigeciclina-colistina.%204.%20Investigaci%5Cu00f3n%20de%20las%20bases%20moleculares%20as%5Cu00ed%20como%20de%20las%20potenciales%20modificaciones%20del%20l%5Cu00edpido%20A%20relacionadas%20con%20una%20disminuci%5Cu00f3n%20de%20la%20sensibilidad%20a%20las%20polimixinas%20en%20la%20cepa%20salvaje%20A.%20baumannii%20ATCC%2017978%20y%20sus%20mutantes%20resistentes%2C%20as%5Cu00ed%20como%20en%20una%20colecci%5Cu00f3n%20de%20aislamientos%20cl%5Cu00ednicos%20de%20A.%20baumannii%20procedente%20de%205%20pa%5Cu00edses%20con%20diferentes%20CMI%20a%20poliximinas.%20Resultados%3A%20Se%20detectaron%2019%20aislamientos%20panrresistentes%20pertenecientes%20a%20un%20%5Cu00fanico%20clon.%20A%20pesar%20de%20la%20vigilancia%20activa%20y%20ambiental%2C%20no%20se%20pudo%20determinar%20la%20fuente%20del%20brote%20pero%20la%20instauraci%5Cu00f3n%20de%20diferentes%20medidas%20permiti%5Cu00f3%20su%20control.%20El%20m%5Cu00e9todo%20E-test%20fue%20%5Cu00fatil%20en%20la%20categorizaci%5Cu00f3n%20de%20aislamientos%20cl%5Cu00ednicos%20de%20A.%20baumannii%2C%20mostrando%20una%20concordancia%20de%2098.2%25%20con%20la%20t%5Cu00e9cnica%20de%20referencia.%20Sin%20embargo%2C%20el%20m%5Cu00e9todo%20E-test%20present%5Cu00f3%20una%20tendencia%20a%20determinar%20valores%20m%5Cu00e1s%20altos%20de%20CMI.%20Tigeciclina%20se%20mostr%5Cu00f3%20mucho%20m%5Cu00e1s%20activa%20que%20minociclina%2C%20presentando%20una%20actividad%20similar%20tanto%20en%20los%20aislamientos%20sensibles%20como%20en%20los%20resistentes%20a%20colistina.%20El%20estudio%20de%20la%20interacci%5Cu00f3n%20de%20colistina%20y%20tigeciclina%20frente%20a%20aislamientos%20de%20A.%20baumannii%20no%20demostr%5Cu00f3%20sinergia%20sino%20%5Cu00fanicamente%20indiferencia.%20De%20todos%20los%20sistemas%20reguladores%20de%20dos%20componentes%20relacionados%20con%20la%20sensibilidad%20disminuida%20a%20las%20polimixinas%20en%20otras%20especies%20bacterianas%2C%20s%5Cu00f3lo%20el%20PmrA-PmrB%20obtuvo%20homolog%5Cu00eda%20significativa%20en%20el%20genoma%20de%20A.%20baumannii%20ATCC%2017978.%20La%20secuenciaci%5Cu00f3n%20del%20oper%5Cu00f3n%20pmrCAB%20en%20las%20cepas%20mutantes%20y%20aislamientos%20cl%5Cu00ednicos%20resistentes%20demostr%5Cu00f3%20diferentes%20mutaciones%20y%20variantes.%20La%20deleci%5Cu00f3n%20de%20cada%20uno%20de%20los%20genes%20del%20oper%5Cu00f3n%20pmrCAB%20de%20la%20cepa%20salvaje%20no%20gener%5Cu00f3%20cambios%20significativos%20en%20la%20CMI%20a%20polimixina%20B%2C%20sugiriendo%20que%20este%20oper%5Cu00f3n%20no%20contribuye%20de%20modo%20significativo%20a%20la%20resistencia%20intr%5Cu00ednseca.%20La%20deleci%5Cu00f3n%20de%20los%20genes%20pmrB%20o%20pmrC%20en%20cepas%20y%20aislamientos%20resistentes%20result%5Cu00f3%20en%20una%20disminuci%5Cu00f3n%20de%20dos%20o%20m%5Cu00e1s%20diluciones%20de%20la%20CMI%20a%20polimixina%20B%2C%20sin%20cambios%20significativos%20en%20la%20sensibilidad%20al%20resto%20de%20antimicrobianos.%20La%20restauraci%5Cu00f3n%20de%20la%20resistencia%20a%20polimixina%20B%20se%20produjo%20por%20complementaci%5Cu00f3n%20con%20el%20pl%5Cu00e1smido%20portador%20del%20pmrAB%20de%20cepas%20resistentes%20%28con%20una%20mutaci%5Cu00f3n%20en%20el%20pmrA%20o%20el%20pmrB%29%2C%20pero%20no%20con%20el%20pl%5Cu00e1smido%20vac%5Cu00edo%20o%20con%20el%20pmrAB%20salvaje%2C%20demostrando%20as%5Cu00ed%20que%20esas%20mutaciones%20en%20cada%20uno%20de%20los%20genes%20conducen%20a%20la%20resistencia.%20El%20an%5Cu00e1lisis%20de%20expresi%5Cu00f3n%20gen%5Cu00e9tica%20demostr%5Cu00f3%20una%20correlaci%5Cu00f3n%20directa%20entre%20la%20expresi%5Cu00f3n%20aumentada%20del%20gen%20pmrC%20y%20la%20resistencia%20a%20polimixina%20B.%20Los%20cambios%20detectados%20en%20el%20l%5Cu00edpido%20A%20por%20cromatograf%5Cu00eda%20en%20capa%20fina%20se%20correlacionaron%20con%20la%20CMI%20a%20polimixina%20B.%20El%20an%5Cu00e1lisis%20del%20l%5Cu00edpido%20A%20por%20espectrometr%5Cu00eda%20de%20masas%20de%20la%20cepa%20resistente%20a%20polimixina%20B%20%28R2%29%20revel%5Cu00f3%20cambios%20en%20la%20estructura%20comparada%20con%20su%20respectiva%20cepa%20parental%20ATCC%2017978%2C%20consistentes%20en%20residuos%20de%20phosphoethanolamina.%20El%20an%5Cu00e1lisis%20del%20aislamiento%20cl%5Cu00ednico%20C8%20resistente%20a%20polimixinas%20revel%5Cu00f3%20cambios%20similares.%20Conclusi%5Cu00f3n%3A%20Se%20aportan%20evidencias%20de%20un%20mecanismo%20de%20resistencia%20a%20las%20polimixinas%20en%20A.%20baumannii.%20Este%20hecho%20puede%20conducir%20a%20una%20detecci%5Cu00f3n%20genot%5Cu00edpica%20en%20la%20cl%5Cu00ednica%2C%20as%5Cu00ed%20como%20al%20dise%5Cu00f1o%20de%20nuevos%20antimicrobianos%20que%20superen%20este%20mecanismo%20de%20resistencia.%22%2C%22thesisType%22%3A%22http%3A%5C%2F%5C%2Fpurl.org%5C%2Fdc%5C%2Fdcmitype%5C%2FText%22%2C%22university%22%3A%22Universidad%20de%20Sevilla%22%2C%22date%22%3A%222012%22%2C%22language%22%3A%22es%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fdialnet.unirioja.es%5C%2Fservlet%5C%2Ftesis%3Fcodigo%3D110541%22%2C%22collections%22%3A%5B%22VN54CXGB%22%5D%2C%22dateModified%22%3A%222025-11-25T11%3A01%3A42Z%22%7D%7D%2C%7B%22key%22%3A%22N7K6UB8C%22%2C%22library%22%3A%7B%22id%22%3A6316110%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Toro%20Crespo%22%2C%22parsedDate%22%3A%222011-06-20%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BToro%20Crespo%2C%20M.%20de.%20%282011%29.%20%26lt%3Bi%26gt%3BCaracterizaci%26%23xF3%3Bn%20de%20candida%20parapsilosis%20complex%20en%20el%20%26%23xE1%3Brea%20hospitalaria%20del%20H.U.%20Virgen%20del%20Roc%26%23xED%3Bo%20en%20el%20periodo%202003-2009%26lt%3B%5C%2Fi%26gt%3B.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-ItemURL%26%23039%3B%20href%3D%26%23039%3Bhttp%3A%5C%2F%5C%2Fhdl.handle.net%5C%2F11441%5C%2F58770%26%23039%3B%26gt%3Bhttp%3A%5C%2F%5C%2Fhdl.handle.net%5C%2F11441%5C%2F58770%26lt%3B%5C%2Fa%26gt%3B%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22thesis%22%2C%22title%22%3A%22Caracterizaci%5Cu00f3n%20de%20candida%20parapsilosis%20complex%20en%20el%20%5Cu00e1rea%20hospitalaria%20del%20H.U.%20Virgen%20del%20Roc%5Cu00edo%20en%20el%20periodo%202003-2009%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mar%5Cu00eda%20de%22%2C%22lastName%22%3A%22Toro%20Crespo%22%7D%5D%2C%22abstractNote%22%3A%22En%20los%20%5Cu00faltimos%20a%5Cu00f1os%20se%20ha%20observado%20un%20aumento%20en%20la%20incidencia%20de%20las%20infecciones%20invasoras%20por%20Candida%20spp%2C%20adem%5Cu00e1s%20de%20cambios%20temporales%20en%20las%20especies%20aisladas.%20Tambi%5Cu00e9n%20se%20ha%20registrado%20un%20aumento%20en%20la%20incidencia%20de%20enfermedad%20invasora%20por%20C.%20parapsilosis%20complex%2C%20ya%20que%20hay%20estudios%20que%20muestran%20que%20es%20la%20segunda%20especie%20de%20Candida%20m%5Cu00e1s%20aislada%20en%20hemocultivos.%20Adem%5Cu00e1s%20la%20incidencia%20de%20Candidi%20asis%20invasora%20por%20C.%20parapsilosis%20complex%20var%5Cu00eda%20geogr%5Cu00e1ficamente%20y%20en%20funci%5Cu00f3n%20de%20las%20caracter%5Cu00edsticas%20y%20enfermedades%20de%20base%20del%20paciente.El%20primero%20de%20los%20objetivos%20generales%20de%20este%20trabajo%20es%20analizar%20los%20datos%20procedentes%20de%20las%20candidemias%20producidas%20en%20el%20Hospital%20Universitario%20Virgen%20del%20Roc%5Cu00edo%20en%20el%20per%5Cu00edodo%202003-2009.Con%20respecto%20a%20las%20especies%20integrantes%20del%20complejo%20%5Cu201cpsilosis%5Cu201d%2C%20C.%20parapsilosis%2C%20C.%20orthopsilosis%20y%20C.%20metapsilosis%2C%20hasta%20el%20momento%20en%20la%20literatura%20hay%20muy%20pocos%20datos%20acerca%20de%20su%20distribuci%5Cu00f3n%20as%5Cu00ed%20como%20de%20su%20sensibilidad%20a%20los%20agentes%20antif%5Cu00fangicos%2C%20dicho%20esto%2C%20nuestro%20segundo%20objetivo%20es%20conocer%20la%20distribuci%5Cu00f3n%2C%20mediante%20t%5Cu00e9cnicas%20de%20biolog%5Cu00eda%20molecular%2C%20de%20las%20distintas%20especies%20dentro%20del%20complejo%20en%20una%20colecci%5Cu00f3n%20de%20aislamientos%20de%20C.%20parapsilosis%20complex%20procedentes%20de%20diferentes%20localizaciones.%20La%20formaci%5Cu00f3n%20de%20biopel%5Cu00edculas%20es%20el%20factor%20de%20virulencia%20m%5Cu00e1s%20importante%20en%20C.%20parapsilosis%20complex%2C%20ya%20que%20estas%20confieren%20una%20elevada%20resistencia%20a%20las%20defensas%20del%20hospedador%20y%20a%20los%20agentes%20antif%5Cu00fangicos%2C%20por%20ello%20el%20tercer%20objetivo%20de%20este%20trabajo%20es%20la%20determinaci%5Cu00f3n%20mediante%20un%20ensayo%20in%20vitro%20de%20la%20capacidad%20de%20formaci%5Cu00f3n%20de%20biopeliculas%20de%20los%20diferentes%20aislamientos%20de%20C.%20parapsilosis%20complex.%20Por%20%5Cu00faltimo%20y%20como%20consecuencia%20de%20lo%20anteriormente%20expuesto%2C%20el%20cuarto%20objetivo%20es%20estudiar%20la%20sensibilidad%20a%20los%20antif%5Cu00fangicos%20de%20estas%20levaduras%20tanto%20en%20forma%20planct%5Cu00f3nica%20como%20s%5Cu00e9sil.Los%20objetivos%20concretos%20de%20este%20trabajo%20son%3A1.%20An%5Cu00e1lisis%20de%20las%20candidemias%20identificadas%20en%20HU%20virgen%20del%20Roc%5Cu00edo%20en%20el%20per%5Cu00edodo%202003-2009.-%20Recoger%20y%20analizar%20los%20datos%20correspondientes%20a%20las%20candidemias%20registradas%2C%20teniendo%20en%20cuenta%20la%20especie%20de%20Candida%20productora%20as%5Cu00ed%20como%20el%20porcentaje%20atribuido%20a%20cada%20especie.-%20An%5Cu00e1lisis%20de%20los%20datos%20correspondientes%20a%20candidemias%20producidas%20por%20C.%20parapsilosis%20complex%20en%20relaci%5Cu00f3n%20al%20tipo%20de%20paciente.2.%20Identificaci%5Cu00f3n%20de%20levaduras%20en%20el%20laboratorio.-%20Identificaci%5Cu00f3n%20fenot%5Cu00edpica%20de%20C.%20parapsilosis%20complex.-%20Identificaci%5Cu00f3n%20genot%5Cu00edpica.-%20Puesta%20a%20punto%20de%20RAPD-PCR%20%28Amplificaci%5Cu00f3n%20al%20azar%20de%20ADN%20polim%5Cu00f3rfico%29%3A%20Selecci%5Cu00f3n%20de%20cebadores.-%20Identificaci%5Cu00f3n%20a%20nivel%20de%20especie%20dentro%20del%20complejo%20%5Cu201cpsilosis%5Cu201d%20mediante%20dos%20t%5Cu00e9cnicas%20de%20biolog%5Cu00eda%20molecular%2C%20RAPD-%20PCR%20y%20RFLP%2C%20y%20comparaci%5Cu00f3n%20de%20resultados%20entre%20estas.3.%20Determinaci%5Cu00f3n%20de%20la%20capacidad%20de%20formaci%5Cu00f3n%20de%20biopel%5Cu00edculas.-%20An%5Cu00e1lisis%20de%20la%20relaci%5Cu00f3n%20entre%20especie%20y%20capacidad%20de%20formaci%5Cu00f3n%20de%20biopel%5Cu00edculas.-%20An%5Cu00e1lisis%20de%20la%20relaci%5Cu00f3n%20entre%20procedencia%20de%20aislamiento%20y%20capacidad%20de%20formaci%5Cu00f3n%20de%20biopel%5Cu00edculas.4.%20Estudiar%20la%20sensibilidad%20a%20los%20siguientes%20agentes%20antif%5Cu00fangicos%2C%20anfotericina%20B%2C%20anidulafungina%20y%20voriconazol.-%20Sobre%20las%20formas%20planct%5Cu00f3nicas%20de%20las%20tres%20especies.-%20Sobre%20las%20formas%20s%5Cu00e9siles%20%28biopel%5Cu00edculas%29%20de%20las%20tres%20especies.%22%2C%22thesisType%22%3A%22%22%2C%22university%22%3A%22%22%2C%22date%22%3A%222011-06-20%22%2C%22language%22%3A%22spa%22%2C%22url%22%3A%22http%3A%5C%2F%5C%2Fhdl.handle.net%5C%2F11441%5C%2F58770%22%2C%22collections%22%3A%5B%22VN54CXGB%22%5D%2C%22dateModified%22%3A%222025-11-25T11%3A04%3A27Z%22%7D%7D%2C%7B%22key%22%3A%2287QKYYCX%22%2C%22library%22%3A%7B%22id%22%3A6316110%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Puche%20Valdayo%22%2C%22parsedDate%22%3A%222011%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BPuche%20Valdayo%2C%20B.%20R.%20%282011%29.%20%26lt%3Bi%26gt%3BEl%20virus%20de%20la%20hepatitis%20b.%3A%20Factores%20virol%26%23xF3%3Bgicos%20implicados%20en%20la%20evoluci%26%23xF3%3Bn%20del%20da%26%23xF1%3Bo%20hep%26%23xE1%3Btico%20y%20en%20la%20respuesta%20al%20tratamiento%20antiviral%26lt%3B%5C%2Fi%26gt%3B%20%5BHttp%3A%5C%2F%5C%2Fpurl.org%5C%2Fdc%5C%2Fdcmitype%5C%2FText%2C%20Universidad%20de%20Sevilla%5D.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-ItemURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdialnet.unirioja.es%5C%2Fservlet%5C%2Ftesis%3Fcodigo%3D112377%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdialnet.unirioja.es%5C%2Fservlet%5C%2Ftesis%3Fcodigo%3D112377%26lt%3B%5C%2Fa%26gt%3B%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22thesis%22%2C%22title%22%3A%22El%20virus%20de%20la%20hepatitis%20b.%3A%20Factores%20virol%5Cu00f3gicos%20implicados%20en%20la%20evoluci%5Cu00f3n%20del%20da%5Cu00f1o%20hep%5Cu00e1tico%20y%20en%20la%20respuesta%20al%20tratamiento%20antiviral%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Beatriz%20Rocio%22%2C%22lastName%22%3A%22Puche%20Valdayo%22%7D%5D%2C%22abstractNote%22%3A%22EL%20VIRUS%20DE%20LA%20HEPATITIS%20B%3A%20FACTORES%20VIROL%5Cu00d3GICOS%20IMPLICADOS%20EN%20LA%20EVOLUCI%5Cu00d3N%20DEL%20DA%5Cu00d1O%20HEP%5Cu00c1TICO%20Y%20EN%20LA%20RESPUESTA%20AL%20TRATAMIENTO%20ANTIVIRAL.%20%20No%20se%20dispone%20de%20resumen.%22%2C%22thesisType%22%3A%22http%3A%5C%2F%5C%2Fpurl.org%5C%2Fdc%5C%2Fdcmitype%5C%2FText%22%2C%22university%22%3A%22Universidad%20de%20Sevilla%22%2C%22date%22%3A%222011%22%2C%22language%22%3A%22es%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fdialnet.unirioja.es%5C%2Fservlet%5C%2Ftesis%3Fcodigo%3D112377%22%2C%22collections%22%3A%5B%22VN54CXGB%22%5D%2C%22dateModified%22%3A%222025-11-25T11%3A08%3A31Z%22%7D%7D%2C%7B%22key%22%3A%22L4R26J7Y%22%2C%22library%22%3A%7B%22id%22%3A6316110%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Amblar%20Dom%5Cu00ednguez%22%2C%22parsedDate%22%3A%222010%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BAmblar%20Dom%26%23xED%3Bnguez%2C%20M.%20G.%20%282010%29.%20%26lt%3Bi%26gt%3BBases%20moleculares%20de%20la%20relaci%26%23xF3%3Bn%20entre%20resistencia%20a%20B-lact%26%23xE1%3Bmicos%20y%20fluoroquinolonas%20en%20cepas%20de%20escherichia%20coli%20no%20productoras%20de%20B-lactamasas%20de%20espectro%20extendido.%26lt%3B%5C%2Fi%26gt%3B%20%5BHttp%3A%5C%2F%5C%2Fpurl.org%5C%2Fdc%5C%2Fdcmitype%5C%2FText%2C%20Universidad%20de%20Sevilla%5D.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-ItemURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdialnet.unirioja.es%5C%2Fservlet%5C%2Ftesis%3Fcodigo%3D62323%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdialnet.unirioja.es%5C%2Fservlet%5C%2Ftesis%3Fcodigo%3D62323%26lt%3B%5C%2Fa%26gt%3B%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22thesis%22%2C%22title%22%3A%22Bases%20moleculares%20de%20la%20relaci%5Cu00f3n%20entre%20resistencia%20a%20B-lact%5Cu00e1micos%20y%20fluoroquinolonas%20en%20cepas%20de%20escherichia%20coli%20no%20productoras%20de%20B-lactamasas%20de%20espectro%20extendido.%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mar%5Cu00eda%20Gema%22%2C%22lastName%22%3A%22Amblar%20Dom%5Cu00ednguez%22%7D%5D%2C%22abstractNote%22%3A%22BASES%20MOLECULARES%20DE%20LA%20RELACI%5Cu00d3N%20ENTRE%20RESISTENCIA%20A%20B-LACT%5Cu00c1MICOS%20Y%20FLUOROQUINOLONAS%20EN%20CEPAS%20DE%20ESCHERICHIA%20COLI%20NO%20PRODUCTORAS%20DE%20B-LACTAMASAS%20DE%20ESPECTRO%20EXTENDIDO.%20RESUMEN%20NO%20DISPONIBLE.%22%2C%22thesisType%22%3A%22http%3A%5C%2F%5C%2Fpurl.org%5C%2Fdc%5C%2Fdcmitype%5C%2FText%22%2C%22university%22%3A%22Universidad%20de%20Sevilla%22%2C%22date%22%3A%222010%22%2C%22language%22%3A%22es%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fdialnet.unirioja.es%5C%2Fservlet%5C%2Ftesis%3Fcodigo%3D62323%22%2C%22collections%22%3A%5B%22VN54CXGB%22%5D%2C%22dateModified%22%3A%222025-11-25T10%3A57%3A29Z%22%7D%7D%2C%7B%22key%22%3A%2278FYE8Y8%22%2C%22library%22%3A%7B%22id%22%3A6316110%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Hern%5Cu00e1ndez%20Bello%22%2C%22parsedDate%22%3A%222007-02-06%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BHern%26%23xE1%3Bndez%20Bello%2C%20J.%20R.%20%282007%29.%20%26lt%3Bi%26gt%3BBetalactamasas%20de%20espectro%20extendido%20en%20enterobacterias%20aisladas%20de%20muestras%20cl%26%23xED%3Bnicas%20de%20hospitales%20espa%26%23xF1%3Boles%26lt%3B%5C%2Fi%26gt%3B.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-ItemURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fhdl.handle.net%5C%2F11441%5C%2F110908%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fhdl.handle.net%5C%2F11441%5C%2F110908%26lt%3B%5C%2Fa%26gt%3B%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22thesis%22%2C%22title%22%3A%22Betalactamasas%20de%20espectro%20extendido%20en%20enterobacterias%20aisladas%20de%20muestras%20cl%5Cu00ednicas%20de%20hospitales%20espa%5Cu00f1oles%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jos%5Cu00e9%20Ram%5Cu00f3n%22%2C%22lastName%22%3A%22Hern%5Cu00e1ndez%20Bello%22%7D%5D%2C%22abstractNote%22%3A%22En%201985%2C%20se%20describi%5Cu00f3%20la%20primera%20betalactamasa%20de%20espectro%20extendido%20%28BLEE%29.%20En%20Espa%5Cu00f1a%20la%20primera%20BLEE%20fue%20descrita%20en%201988.%20Desde%20entonces%20estas%20betalactamasas%20se%20han%20diseminado%20por%20todo%20el%20mundo%2C%20gracias%20a%20la%20movilidad%20de%20los%20pl%5Cu00e1smidos%20en%20los%20que%20se%20encuentran.%20Hasta%20el%20momento%20de%20realizar%20este%20estudio%20no%20exist%5Cu00eda%20una%20informaci%5Cu00f3n%20adecuada%20sobre%20la%20importancia%20de%20las%20BLEE%20a%20nivel%20nacional%20en%20Espa%5Cu00f1a.%20El%20trabajo%20de%20investigaci%5Cu00f3n%20recogido%20en%20la%20presente%20Tesis%20Doctoral%20ha%20permitido%20obtener%20informaci%5Cu00f3n%20de%20inter%5Cu00e9s%20sobre%20aspectos%20fundamentales%20que%20rodean%20a%20este%20fen%5Cu00f3meno%3A%201%2C-%20La%20prevalencia%20de%20E.coli%20y%20K.pneumoniae%20productoras%20de%20BLEE%20durante%20el%20periodo%20de%20estudio%20ha%20sido%20del%200.5%20y%20el%202.7%25%2C%20respectivamente.%202%2C-%20Se%20ha%20encontrado%20una%20amplia%20distribuci%5Cu00f3n%20de%20las%20BLEE%20en%20los%20distintos%20hospitales%20participantes.%203%2C-%20Ls%20BLEE%20detectadas%20con%20mayor%20frecuencia%20han%20sido%20CTX-M-9%2C%20SHV-12%20y%20CTX-M-14.%22%2C%22thesisType%22%3A%22%22%2C%22university%22%3A%22%22%2C%22date%22%3A%222007-02-06%22%2C%22language%22%3A%22spa%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fhdl.handle.net%5C%2F11441%5C%2F110908%22%2C%22collections%22%3A%5B%22VN54CXGB%22%5D%2C%22dateModified%22%3A%222025-11-25T10%3A32%3A36Z%22%7D%7D%2C%7B%22key%22%3A%2288R9WY8H%22%2C%22library%22%3A%7B%22id%22%3A6316110%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Rodr%5Cu00edguez%20Mart%5Cu00ednez%22%2C%22parsedDate%22%3A%222006%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BRodr%26%23xED%3Bguez%20Mart%26%23xED%3Bnez%2C%20J.%20M.%20%282006%29.%20%26lt%3Bi%26gt%3BResistencia%20a%20quinolonas%20mediada%20por%20pl%26%23xE1%3Bsmido%20en%20enterobacteriaceae%26lt%3B%5C%2Fi%26gt%3B.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-ItemURL%26%23039%3B%20href%3D%26%23039%3Bhttp%3A%5C%2F%5C%2Fhdl.handle.net%5C%2F11441%5C%2F15954%26%23039%3B%26gt%3Bhttp%3A%5C%2F%5C%2Fhdl.handle.net%5C%2F11441%5C%2F15954%26lt%3B%5C%2Fa%26gt%3B%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22thesis%22%2C%22title%22%3A%22Resistencia%20a%20quinolonas%20mediada%20por%20pl%5Cu00e1smido%20en%20enterobacteriaceae%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jos%5Cu00e9%20Manuel%22%2C%22lastName%22%3A%22Rodr%5Cu00edguez%20Mart%5Cu00ednez%22%7D%5D%2C%22abstractNote%22%3A%22En%201998%2C%20se%20describi%5Cu00f3%20por%20primera%20vez%20resistencia%20a%20quinolonas%20transmisible%20horizontalmente%20mediante%20un%20pl%5Cu00e1smido%20conjugativo.%20La%20diseminaci%5Cu00f3n%20horizontal%20de%20mecanismos%20de%20resistencia%20a%20fluoroquinolonas%20abre%20la%20posibilidad%20de%20una%20r%5Cu00e1pida%20expansi%5Cu00f3n%20de%20la%20resistencia%20a%20estos%20antimicrobianos%2C%20tanto%20en%20pat%5Cu00f3genos%20de%20animales%20como%20humanos%2C%20m%5Cu00e1s%20a%5Cu00fan%20con%20el%20extenso%20uso%20que%20se%20hace%20de%20las%20mismas.%20El%20trabajo%20de%20investigaci%5Cu00f3n%20recogido%20en%20la%20presente%20Tesis%20Doctoral%20ha%20permitido%20obtener%20informaci%5Cu00f3n%20de%20inter%5Cu00e9s%20sobre%20dos%20aspectos%20fundamentales%20que%20rodean%20a%20este%20fen%5Cu00f3meno%3A%201%2C-%20La%20diseminaci%5Cu00f3n%20horizontal%20de%20mecanismos%20de%20resistencia%20a%20fluroquinolonas%20es%20una%20v%5Cu00eda%20eficaz%20para%20la%20r%5Cu00e1pida%20expansi%5Cu00f3n%20de%20la%20resistencia%20este%20grupo%20de%20antimicrobianos.%202%2C-%20La%20disminuci%5Cu00f3n%20de%20sensibilidad%20a%20quinolonas%20mediada%20por%20genes%20qnr%20compromete%20la%20detecci%5Cu00f3n%20de%20resistencia%20mediante%20sistemas%20automatizados%20y%20conduce%20a%20fracaso%20terap%5Cu00e9utico.%22%2C%22thesisType%22%3A%22%22%2C%22university%22%3A%22%22%2C%22date%22%3A%222006%22%2C%22language%22%3A%22spa%22%2C%22url%22%3A%22http%3A%5C%2F%5C%2Fhdl.handle.net%5C%2F11441%5C%2F15954%22%2C%22collections%22%3A%5B%22VN54CXGB%22%5D%2C%22dateModified%22%3A%222025-11-25T10%3A03%3A51Z%22%7D%7D%2C%7B%22key%22%3A%22WS5Z32T3%22%2C%22library%22%3A%7B%22id%22%3A6316110%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Rodr%5Cu00edguez%20Rodr%5Cu00edguez%22%2C%22parsedDate%22%3A%222002%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BRodr%26%23xED%3Bguez%20Rodr%26%23xED%3Bguez%2C%20G.%20%282002%29.%20%26lt%3Bi%26gt%3BMecanismos%20de%20resistencia%20a%20betalact%26%23xE1%3Bmicos%20en%20cepas%20cl%26%23xED%3Bnicas%20de%20acinetobacter%20baumanii.%26lt%3B%5C%2Fi%26gt%3B%20%5BHttp%3A%5C%2F%5C%2Fpurl.org%5C%2Fdc%5C%2Fdcmitype%5C%2FText%2C%20Universidad%20de%20Sevilla%5D.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-ItemURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdialnet.unirioja.es%5C%2Fservlet%5C%2Ftesis%3Fcodigo%3D138498%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdialnet.unirioja.es%5C%2Fservlet%5C%2Ftesis%3Fcodigo%3D138498%26lt%3B%5C%2Fa%26gt%3B%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22thesis%22%2C%22title%22%3A%22Mecanismos%20de%20resistencia%20a%20betalact%5Cu00e1micos%20en%20cepas%20cl%5Cu00ednicas%20de%20acinetobacter%20baumanii.%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Guadalupe%22%2C%22lastName%22%3A%22Rodr%5Cu00edguez%20Rodr%5Cu00edguez%22%7D%5D%2C%22abstractNote%22%3A%22En%20este%20estudio%20se%20analizaron%2030%20cepas%20de%20Acinetobacter%20baumanni%2C%20aislados%20de%20nuestras%20cl%5Cu00ednicas%20en%20el%20Hospital%20Universitario%20Virgen%20Macarena%20%281991-1195%29%20con%20el%20objetivo%20de%20describir%20los%20principales%20mecanismos%20de%20resitencia%20a%20Beta-lact%5Cu00e1micos%20en%20dichas%20cepas%2C%20as%5Cu00ed%20como%20establecer%20una%20relaci%5Cu00f3n%20epidemiologica%20entre%20ellas.%20Para%20ello%20se%20utilizaci%5Cu00f3n%20varios%20m%5Cu00e9todos%3A%20electroforesis%20en%20campo%20pulsante%20para%20el%20an%5Cu00e1lisis%20de%20fragmentos%20de%20restricci%5Cu00f3n%20del%20ADN%20cromos%5Cu00f3nico%20que%20permiti%5Cu00f3%20establecer%20una%20relaci%5Cu00f3n%20clonal%20de%20las%20cepas%20en%208%20pulsotipos%20dismitidos%2C%20la%20sensibilidad%20a%20antimicrobianos%20por%20la%20t%5Cu00e9cnica%20de%20microdiluri%5Cu00f3n%20de%20caldo%20que%20permiti%5Cu00f3%20diferenciar%204%20fenotipos%20de%20resistencia%20y%20el%20estudio%20de%20cada%20uno%20de%20ellos%20de%20la%20actividad%20beta-lactamosa%20de%20extractos%20ensim%5Cu00e1ticos%20obtenidos%20a%20partir%20de%20dichas%20cepas%20por%204%20m%5Cu00e9todos%3A%20determinaci%5Cu00f3n%20espectofotom%5Cu00e9trica%20de%20la%20actividad%20hidrolitico%2C%20ensayo%20microliologico%20de%20hidr%5Cu00f3lisis%20de%20deslact%5Cu00e1micos%2C%20ensay%5Cu00f3%20de%20inducci%5Cu00f3n%20y%20caracterizaci%5Cu00f3n%20por%20isalectroenfoque%2C%20adem%5Cu00e1s%20se%20estudi%5Cu00f3%20tambi%5Cu00e9n%20el%20perfil%20de%20prote%5Cu00ednas%20de%20membrana%20exterior%20de%20A.%20Baumannii.%22%2C%22thesisType%22%3A%22http%3A%5C%2F%5C%2Fpurl.org%5C%2Fdc%5C%2Fdcmitype%5C%2FText%22%2C%22university%22%3A%22Universidad%20de%20Sevilla%22%2C%22date%22%3A%222002%22%2C%22language%22%3A%22es%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fdialnet.unirioja.es%5C%2Fservlet%5C%2Ftesis%3Fcodigo%3D138498%22%2C%22collections%22%3A%5B%22VN54CXGB%22%5D%2C%22dateModified%22%3A%222025-11-25T10%3A50%3A25Z%22%7D%7D%2C%7B%22key%22%3A%22JRKPJI3T%22%2C%22library%22%3A%7B%22id%22%3A6316110%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Briales%20Martin%22%2C%22parsedDate%22%3A%222001%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BBriales%20Martin%2C%20A.%20%282001%29.%20%26lt%3Bi%26gt%3BCaracterizaci%26%23xF3%3Bn%20de%20prote%26%23xED%3Bnas%20pentapept%26%23xED%3Bdicas%20tipo%20QNR%3A%20papel%20en%20resistencia%20natural%20y%20adquirida%20y%20su%20impacto%20en%20la%20actividad%20frente%20a%20quinolonas%20de%20uso%20cl%26%23xED%3Bnico.%26lt%3B%5C%2Fi%26gt%3B%20%5BHttp%3A%5C%2F%5C%2Fpurl.org%5C%2Fdc%5C%2Fdcmitype%5C%2FText%2C%20Universidad%20de%20Sevilla%5D.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-ItemURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdialnet.unirioja.es%5C%2Fservlet%5C%2Ftesis%3Fcodigo%3D64770%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdialnet.unirioja.es%5C%2Fservlet%5C%2Ftesis%3Fcodigo%3D64770%26lt%3B%5C%2Fa%26gt%3B%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22thesis%22%2C%22title%22%3A%22Caracterizaci%5Cu00f3n%20de%20prote%5Cu00ednas%20pentapept%5Cu00eddicas%20tipo%20QNR%3A%20papel%20en%20resistencia%20natural%20y%20adquirida%20y%20su%20impacto%20en%20la%20actividad%20frente%20a%20quinolonas%20de%20uso%20cl%5Cu00ednico.%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alejandra%22%2C%22lastName%22%3A%22Briales%20Martin%22%7D%5D%2C%22abstractNote%22%3A%22%22%2C%22thesisType%22%3A%22http%3A%5C%2F%5C%2Fpurl.org%5C%2Fdc%5C%2Fdcmitype%5C%2FText%22%2C%22university%22%3A%22Universidad%20de%20Sevilla%22%2C%22date%22%3A%222001%22%2C%22language%22%3A%22es%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fdialnet.unirioja.es%5C%2Fservlet%5C%2Ftesis%3Fcodigo%3D64770%22%2C%22collections%22%3A%5B%22VN54CXGB%22%5D%2C%22dateModified%22%3A%222025-11-25T10%3A58%3A38Z%22%7D%7D%2C%7B%22key%22%3A%22LJKW3729%22%2C%22library%22%3A%7B%22id%22%3A6316110%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Conejo%20Gonzalo%22%2C%22parsedDate%22%3A%221992-02-11%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BConejo%20Gonzalo%2C%20M.%20C.%20%281992%29.%20%26lt%3Bi%26gt%3BEfecto%20de%20inhibidores%20de%20betalactamasas%20en%20la%20actividad%20de%20los%20leucocitos%20polimorfonucleares%20humanos%26lt%3B%5C%2Fi%26gt%3B.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-ItemURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fhdl.handle.net%5C%2F11441%5C%2F77945%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fhdl.handle.net%5C%2F11441%5C%2F77945%26lt%3B%5C%2Fa%26gt%3B%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22thesis%22%2C%22title%22%3A%22Efecto%20de%20inhibidores%20de%20betalactamasas%20en%20la%20actividad%20de%20los%20leucocitos%20polimorfonucleares%20humanos%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22M%5Cu00aa%20Carmen%22%2C%22lastName%22%3A%22Conejo%20Gonzalo%22%7D%5D%2C%22abstractNote%22%3A%22CONCLUSIONES%201.%20La%20exposici%5Cu00f3n%20de%20S.%20aureus%20no%20productor%20de%20penicilinasa%20a%20concentraciones%20subinhibitorias%20de%20amoxicilina%20y%20ampicilina%20increment%5Cu00f3%20significativamente%20su%20fagocitosis%20por%20los%20PMN%20humanos%2C%20tanto%20en%20presencia%20como%20en%20ausencia%20de%20opsoninas.%20En%20el%20caso%20de%20piperacilina%20s%5Cu00f3lo%20se%20evidenci%5Cu00f3%20en%20bacterias%20sin%20opsonizar.%202.%20La%20exposici%5Cu00f3n%20de%20S.%20aureus%20a%20concentraciones%20subinhibitorias%20de%20%5Cu00e1cido%20clavul%5Cu00e1nico%20increment%5Cu00f3%20significativamente%20la%20ingesti%5Cu00f3n%20bacteriana%20por%20los%20PMN%20humanos%20por%20un%20mecanismo%20independiente%20de%20la%20opsonizaci%5Cu00f3n.%203.%20A%20concentraciones%20subinhibitorias%20sulbactam%20y%20tazobactam%20no%20modificaron%20significativamente%20la%20ingesti%5Cu00f3n%20de%20S.%20aureus%20por%20los%20PMN%20humanos.%204.%20La%20preincubaci%5Cu00f3n%20de%20S.%20aureus%20no%20productor%20de%20penicilinasa%20con%20concentraciones%20subinhibitorias%20de%20amoxicilina%5C%2F%5Cu00e1cido%20clavul%5Cu00e1nico%20increment%5Cu00f3%20significativamente%20la%20ingesti%5Cu00f3n%20bacteriana%2C%20tanto%20m%5Cu00e1s%20cuanto%20mayor%20era%20la%20proporci%5Cu00f3n%20de%20%5Cu00e1cido%20clavul%5Cu00e1nico.%20La%20exposici%5Cu00f3n%20de%20la%20cepa%20de%20S.%20aureus%20productora%20de%20penicilinasa%20a%20concentraciones%20subinhibitorias%20de%20esta%20asociaci%5Cu00f3n%20increment%5Cu00f3%20significativamente%20su%20fagocitosis%20cuando%20se%20utilizaron%20tiempo%20de%20exposici%5Cu00f3n%20muy%20cortos%20%284%20horas%29.%205.%20La%20exposici%5Cu00f3n%20de%20S.%20aureus%20no%20productor%20de%20penicilinasa%20a%20concentraciones%20subinhibitorias%20de%20ampicilina%5C%2Fsulbactam%20increment%5Cu00f3%20significativamente%20la%20ingesti%5Cu00f3n%20bacteriana%20por%20los%20PMN%20humanos%2C%20tanto%20m%5Cu00e1s%20cuanto%20mayor%20era%20la%20proporci%5Cu00f3n%20de%20ampicilina.%20La%20asociaci%5Cu00f3n%20piperacilina%5C%2Ftazobactam%20solo%20mostr%5Cu00f3%20este%20efecto%20sobre%20bacterias%20sin%20opsonizar.%206.%20Ninguna%20de%20las%20combinaciones%20utilizadas%20de%20ampicilina%5C%2Fsulbactam%20o%20piperacilina%5C%2Ftazobactam%2C%20a%20concentraciones%20subinhibitorias%2C%20modific%5Cu00f3%20la%20ingesti%5Cu00f3n%20de%20S.%20aureus%20productor%20de%20penicilinasa.%207.%20La%20preincubaci%5Cu00f3n%20de%20los%20PMN%20humanos%20con%20concentraciones%20terap%5Cu00e9uticas%20de%20los%20tres%20inhibidores%20de%20betalactamasas%2C%20solos%20o%20en%20combinaci%5Cu00f3n%20con%20aminopenicilinas%2C%20no%20afect%5Cu00f3%20a%20su%20capacidad%20fagoc%5Cu00edtica.%208.%20De%20las%20asociaciones%20de%20inhibidores%20de%20betalactamasas%20con%20aminopenicilinas%20utilziadas%2C%20solo%20piperacilina%5C%2Ftazobactam%20%288%5C%2F1%29%20inhibi%5Cu00f3%20la%20producci%5Cu00f3n%20de%20radicales%20super%5Cu00f3xido%20por%20los%20PMN%20humanos%2C%20a%20concentraciones%20terap%5Cu00e9uticas.%209.%20Ninguno%20de%20los%20inhibidores%20de%20betalactamasas%20evaluados%2C%20solo%20o%20asociadoa%20una%20aminopenicilina%2C%20afect%5Cu00f3%20la%20producci%5Cu00f3n%20de%20per%5Cu00f3xido%20de%20hidr%5Cu00f3geno%20por%20los%20PMN%20humanos.%2010.%20De%20los%20antimicrobianos%20evaluados%20en%20este%20estudio%2C%20solo%20%5Cu00e1cido%20clavul%5Cu00e1nico%20y%20amoxicilina%5C%2F%5Cu00e1cido%20clavul%5Cu00e1nico%20%284%5C%2F1%29%2C%20a%20concentraciones%20elevadas%20%28100%20mg%5C%2Fl%29%2C%20mostraron%20actividad%20intracelular%20significativa%20frente%20a%20S.%20aureus.%2011.%20Para%20la%20evaluaci%5Cu00f3n%20%5Cu201cin%20vitro%5Cu201d%20de%20la%20influencia%20de%20un%20antimicrobiano%20sobre%20la%20actividad%20de%20las%20c%5Cu00e9lulas%20fagoc%5Cu00edticas%2C%20resulta%20necesario%20un%20estudio%20completo%2C%20abarcando%20las%20distintas%20fases%20del%20proceso%20fagoc%5Cu00edtico%2C%20siendo%20incorrecta%20la%20evaluaci%5Cu00f3n%20de%20una%20sola%20funci%5Cu00f3n%2C%20pues%20podr%5Cu00eda%20dar%20lugar%20a%20interpretaciones%20err%5Cu00f3neas.%22%2C%22thesisType%22%3A%22%22%2C%22university%22%3A%22%22%2C%22date%22%3A%221992-02-11%22%2C%22language%22%3A%22spa%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fhdl.handle.net%5C%2F11441%5C%2F77945%22%2C%22collections%22%3A%5B%22VN54CXGB%22%5D%2C%22dateModified%22%3A%222025-11-25T11%3A58%3A29Z%22%7D%7D%2C%7B%22key%22%3A%22GLF7DZNA%22%2C%22library%22%3A%7B%22id%22%3A6316110%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Torres%20S%5Cu00e1nchez%22%2C%22parsedDate%22%3A%221990-11-20%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BTorres%20S%26%23xE1%3Bnchez%2C%20M.%20J.%20%281990%29.%20%26lt%3Bi%26gt%3BDesarrollo%20de%20una%20sonda%20de%20ADN%20de%20origen%20plasm%26%23xED%3Bdico%20para%20la%20identificaci%26%23xF3%3Bn%20y%20detecci%26%23xF3%3Bn%20de%20neisseria%20gonorrhoeae%26lt%3B%5C%2Fi%26gt%3B.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-ItemURL%26%23039%3B%20href%3D%26%23039%3Bhttp%3A%5C%2F%5C%2Fhdl.handle.net%5C%2F11441%5C%2F38346%26%23039%3B%26gt%3Bhttp%3A%5C%2F%5C%2Fhdl.handle.net%5C%2F11441%5C%2F38346%26lt%3B%5C%2Fa%26gt%3B%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22thesis%22%2C%22title%22%3A%22Desarrollo%20de%20una%20sonda%20de%20ADN%20de%20origen%20plasm%5Cu00eddico%20para%20la%20identificaci%5Cu00f3n%20y%20detecci%5Cu00f3n%20de%20neisseria%20gonorrhoeae%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mar%5Cu00eda%20Jos%5Cu00e9%22%2C%22lastName%22%3A%22Torres%20S%5Cu00e1nchez%22%7D%5D%2C%22abstractNote%22%3A%22Neisseria%20gonorrhoeae%2C%20es%20el%20agente%20causal%20de%20la%20gonococia%2C%20enfermedad%20de%20transmisi%5Cu00f3n%20sexual%20reconocida%20como%20una%20de%20las%20causas%20principales%20de%20morbilidad%20en%20muchas%20zonas%20del%20mundo%20%28Donegan%2C%201985%29.%20La%20gonococia%20es%20a%20menudo%20recurrente%20y%20ocasionalmente%20produce%20complicaciones%2C%20como%20la%20enfermedad%20inflamatoria%20p%5Cu00e9lvica%20%5Cu2013causa%20de%20embarazos%20ect%5Cu00f3picos%20e%20infertilidad--%2C%20la%20infecci%5Cu00f3n%20gonoc%5Cu00f3cica%20diseminada%20y%20la%20epididimitis%2C%20entre%20otras.%20Ya%20que%20el%20diagn%5Cu00f3stico%20de%20la%20gonococia%20en%20una%20persona%20puede%20tener%20importantes%20consecuencias%20personales%2C%20sociales%20y%20m%5Cu00e9dico-legales%20%28Whittington%20et%20al.%2C%201988%29%2C%20es%20muy%20importante%20la%20correcta%20identificaci%5Cu00f3n%20de%20Neisseria%20gonorrhoeae.%20Para%20este%20motivo%20se%20han%20desarrollado%20diversas%20pruebas%20para%20la%20confirmaci%5Cu00f3n%20de%20un%20diagn%5Cu00f3stico%20cl%5Cu00ednico%20%28Dillon%20et%20al.%2C%201988%29.%20En%20un%20paciente%20con%20alto%20riesgo%20que%20acude%20a%20un%20centro%20de%20diagn%5Cu00f3stico%20de%20enfermedades%20de%20transmisi%5Cu00f3n%20sexual%2C%20es%20posible%20hacer%20un%20diagn%5Cu00f3stico%20presuntivo%20basado%20en%20la%20observaci%5Cu00f3n%20de%20diplococos%20Gram-%2C%20extra%20e%20intracelulares%20%28dentro%20de%20leucocitos%20p%5Cu00f3limorfonucleares%29%2C%20en%20una%20tinci%5Cu00f3n%20de%20Gram.%20Este%20m%5Cu00e9todo%20es%20v%5Cu00e1lido%20en%20varones%20sintom%5Cu00e1ticos%2C%20para%20los%20que%20la%20tinci%5Cu00f3n%20de%20Gram%20presenta%20una%20sensibilidad%20del%2096%20al%2098%25%20%28Morse%20%26amp%3B%20Knapp%201987%29.%20Sin%20embargo%2C%20en%20varones%20asintom%5Cu00e1ticos%20y%20en%20infecciones%20cervicales%20o%20extragenitales%2C%20la%20sensibilidad%20desciende%20al%2040-60%25%20%28Handsfield%20et%20al.%2C%201974%2C%20Oxtoby%20et%20al.%2C%201982%29.%20Otra%20forma%20de%20diagn%5Cu00f3stico%20presuntivo%20es%20la%20observaci%5Cu00f3n%20de%20crecimiento%20de%20diplococos%20Gram-%20Oxidasa%2B%20en%20medio%20selectivo%20para%20gonococo.%20La%20utilidad%20de%20este%20m%5Cu00e9todo%20es%20limitada%2C%20ya%20que%20cuando%20se%20aplica%20a%20una%20muestra%20far%5Cu00edngea%20existe%20el%20riesgo%20de%20confusi%5Cu00f3n%20con%20Neisseria%20meningitidis%2C%20que%20se%20puede%20encontrar%20en%20orofaringe%20de%20forma%20asintom%5Cu00e1tica%20%28Greenfield%20et%20al.%2C%201971%29%20y%20es%20capaz%20de%20crecer%20en%20medio%20selectivo%20para%20gonococo.%20Tambi%5Cu00e9n%20cabe%20la%20confusi%5Cu00f3n%20con%20otras%20neisserias%20no%20pat%5Cu00f3genas%2C%20flora%20habitual%20de%20orofaringe%2C%20que%20ocasionalmente%20crecen%20en%20medio%20selectivo%20para%20gonococo%20%28Knapp%20et%20al.%2C%201984%2C%20Dossett%20et%20al.%2C%201985%2C%20Knapp%201988%29.%20Adem%5Cu00e1s%20del%20diagn%5Cu00f3stico%20presuntivo%2C%20se%20han%20desarrollado%20numerosas%20pruebas%20para%20la%20realizaci%5Cu00f3n%20de%20un%20diagn%5Cu00f3stico%20definitivo%20de%20laboratorio%3A%20desde%20las%20pruebas%20bioqu%5Cu00edmicas%20tradicionales%2C%20que%20necesitan%20una%20incubaci%5Cu00f3n%20de%2024-48%20horas%20antes%20de%20la%20lectura%20del%20resultado%2C%20hasta%20pruebas%20de%20identificaci%5Cu00f3n%20r%5Cu00e1pidas%2C%20que%20proporcionan%20los%20resultados%20en%20menos%20de%204%20horas.%20Las%20pruebas%20tradicionales%20tienen%20la%20ventaja%20de%20que%20caracterizan%20m%5Cu00e1s%20detalladamente%20el%20microorganismo%20aislado%2C%20pero%20su%20uso%20puede%20demorar%20la%20identificaci%5Cu00f3n%2C%20con%20lo%20que%20se%20retrasa%20la%20instauraci%5Cu00f3n%20de%20un%20tratamiento%20antimicrobiano%20y%20aumenta%20el%20riesgo%20de%20complicaciones%20o%20de%20transmisi%5Cu00f3n%20a%20la%20pareja%20sexual.%20En%20contraste%2C%20algunas%20pruebas%20r%5Cu00e1pidas%20no%20siempre%20nos%20aseguran%20la%20identificaci%5Cu00f3n%20porque%20la%20informaci%5Cu00f3n%20sobre%20el%20microorganismo%20es%20muy%20limitada.%20La%20mayor%5Cu00eda%20de%20estas%20pruebas%20se%20han%20dise%5Cu00f1ado%20espec%5Cu00edficamente%20para%20confirmar%20aislamientos%20Gram-%20Oxidasa%2B%2C%20que%20han%20sido%20identificados%20de%20forma%20presuntiva%20sobre%20el%20medio%20selectivo%20como%20Neisseria%20gonorrhoeae.%20Las%20desventajas%20de%20necesitar%20el%20cultivo%20del%20microorganismo%20son%2C%20entre%20otras%3A%20la%20p%5Cu00e9rdida%20de%20viabilidad%20del%20gonococo%20bajo%20condiciones%20sub%5Cu00f3ptimas%20de%20transporte%20y%20crecimiento%2C%20la%20p%5Cu00e9rdida%20de%20sensibilidad%20del%20cultivo%20cuando%20se%20han%20instaurado%20la%20terapia%20antimicrobiana%2C%20y%20la%20existencia%20de%20estirpes%20sensibles%20a%20Vancomicina%2C%20que%20no%20crecen%20en%20los%20medios%20que%20se%20emplean%20habitualmente%2C%20u%20otras%20estirpes%20con%20caracter%5Cu00edsticas%20de%20crecimiento%20dif%5Cu00edciles.%20Es%20indiscutible%20que%20un%20m%5Cu00e9todo%20que%20obviara%20el%20cultivo%20supondr%5Cu00eda%20una%20gran%20ventaja%2C%20sobre%20todo%20para%20el%20diagn%5Cu00f3stico%20en%20consultorios%20que%20no%20disponen%20de%20la%20infraestructura%20necesaria%20para%20el%20aislamiento%20de%20Neisseria%20gonorrhoeae%20y%20que%20actualmente%20env%5Cu00edan%20las%20muestras%20a%20laboratorios%20de%20referencia%20con%20gran%20riesgo%20de%20p%5Cu00e9rdida%20de%20viabilidad%20durante%20el%20transporte.%20Entre%20los%20m%5Cu00e9todos%20de%20confirmaci%5Cu00f3n%20de%20Neisseria%20gonorrhoeae%20a%20partir%20de%20cultivo%2C%20los%20hay%20que%20se%20basan%20en%20la%20producci%5Cu00f3n%20de%20%5Cu00e1cidos%20a%20partir%20de%20az%5Cu00facares%2C%20en%20la%20utilizaci%5Cu00f3n%20de%20un%20sustrato%20cromog%5Cu00e9nico%20por%20una%20determinada%20enzima%2C%20en%20la%20detecci%5Cu00f3n%20de%20ant%5Cu00edgenos%2C%20y%20en%20la%20homolog%5Cu00eda%20del%20ADN.%20Para%20la%20determinaci%5Cu00f3n%20de%20la%20producci%5Cu00f3n%20de%20%5Cu00e1cidos%20a%20partir%20de%20az%5Cu00facares%20se%20utilizan%20los%20carbohidratos%20glucosa%2C%20maltosa%2C%20lactosa%20y%20sacarosa.%20Hay%20numerosos%20productos%20comerciales%20que%20sirven%20para%20realizar%20esta%20determinaci%5Cu00f3n%2C%20entre%20ellos%20Minitek%20%28BBL%20Microbiology%20Systems%29%2C%20Quadferm%2B%20%28Analyticals%20Products%29%2C%20RIM-N%20%28American%20Micro%20Scan%29%2C%20Neisseria-Stat%20%28Richardson%20Scientific%29%20y%20Neisseria-Kwik%20%28Micro-biologics%29.%20Puesto%20que%20todos%20ellos%20se%20realizan%20a%20partir%20de%20un%20cultivo%20puro%2C%20una%20cepa%20no%20puede%20ser%20identificada%20hasta%2024%20horas%20despu%5Cu00e9s%20de%20su%20aislamiento.%20Aunque%20el%20uso%20de%20estas%20pruebas%20est%5Cu00e1%20muy%20extendido%2C%20presentan%20algunos%20problemas%20en%20la%20identificaci%5Cu00f3n%20de%20Neisseria%20gonorrhoeae%3A%201%29%20En%20algunas%20cepas%20la%20producci%5Cu00f3n%20de%20%5Cu00e1cidos%20es%20dif%5Cu00edcil%20de%20interpretar%20cuando%20se%20utilizan%20los%20sistemas%20Minitek%2C%20Neisseria-Stat%20y%20Neisseria-Kwik%20%28Welch%20%26amp%3B%20Cartwright%201988%29.%202%29%20Otras%20cepas%2C%20incluyendo%20las%20que%20pertenecen%20al%20auxotipo%20AHU%2C%20producen%20%5Cu00e1cido%20a%20partir%20de%20glucosa%20de%20una%20forma%20d%5Cu00e9bil%20y%20pueden%20ser%20interpretadas%20como%20glucosa-negativo%20%28Morello%20et%20al.%2C%201976%29.%20Por%20otro%20lado%2C%20algunas%20cepas%20de%20Neisseria%20cinerea%20consideradas%20tradicionalmente%20como%20glucosa-negativo%20%28Vedros%201984%29%20pueden%20dar%20una%20reacci%5Cu00f3n%20positiva%20con%20la%20glucosa%20y%20ello%20conduce%20a%20un%20diagn%5Cu00f3stico%20err%5Cu00f3neo%20de%20gonococia%20%28Knapp%20et%20al.%2C%201984%3B%20Boyce%20et%20al.%2C%201985%3B%20Dossett%20et%20al.%2C%201985%29.%20Las%20pruebas%20enzim%5Cu00e1ticas%20con%20sustrato%20cromog%5Cu00e9nico%20tambi%5Cu00e9n%20se%20realizan%20a%20partir%20de%20microorganismos%20aislados%20en%20medio%20selectivo.%20Diplococos%20Gram-%20Oxidasa%2B%20se%20inoculan%20en%20sustrato%20cromog%5Cu00e9nico%20y%20un%20cambio%20en%20el%20color%20indica%20la%20producci%5Cu00f3n%20de%20Hidroxiprolilaminopeptidasa%20por%20Neisseria%20gonorrhoeae.%20Los%20sistemas%20comercializados%20son%20Gonochek%20II%20%28E%20I%20du%20Pont%20de%20Nemours%20%26amp%3B%20Co.%29%20e%20Identicult-Neisseria%20IDN%20%28Scott%20Laboratories%29%2C%20que%20tambi%5Cu00e9n%20conducen%20a%20veces%20a%20determinaciones%20err%5Cu00f3neas%2C%20pues%20algunas%20cepas%20de%20Neisseria%20sublava%2C%20Neisseria%20cinerea%20y%20Klebsiella%20denitrificans%20pueden%20crecer%20en%20medio%20selectivo%20para%20Neisseria%20gonorrhoeae%20y%20producir%20Hidroxiprolilaminopeptidasa%20%28Dossett%20et%20al.%2C%201985%2C%20Janda%20et%20al.%2C%201985%2C%20Dillon%20et%20al.%2C%201988%29.%20Otra%20serie%20de%20m%5Cu00e9todos%20que%20se%20usan%20con%20frecuencia%20en%20la%20actualidad%20son%20los%20serol%5Cu00f3gicos%2C%20que%20incluyen%20pruebas%20para%20la%20detecci%5Cu00f3n%20de%20ant%5Cu00edgeno%20gonoc%5Cu00f3cico%20directamente%20en%20la%20muestra%20cl%5Cu00ednica%20%28Gonozyme%2C%20Abott%20Laboratories%29%20y%20coaglutinaci%5Cu00f3n%20y%20anticuerpos%20fluorescentes%20%28AF%29%20para%20la%20confirmaci%5Cu00f3n%20del%20cultivo.%20El%20Gonozyme%20se%20desarroll%5Cu00f3%20para%20la%20detecci%5Cu00f3n%20de%20ant%5Cu00edgenos%20gonoc%5Cu00f3cicos%20en%20exudados%20cervicales%20y%20uretrales.%20La%20prueba%20es%20espec%5Cu00edfica%20y%20sensible%20en%20muestras%20uretrales%2C%20pero%20es%20menos%20sensible%20que%20el%20cultivo%20de%20c%5Cu00e9rvix%20en%20mujeres%20%28Schachter%20et.%2C%201984%3B%20Stamm%20et%20al.%2C%201984%29.%20Presenta%20adem%5Cu00e1s%20reacciones%20cruzadas%20con%20Neisseria%20cinerea%20y%20Neisseria%20lactamica%2C%20y%20requiere%2C%20por%20tanto%2C%20una%20prueba%20de%20confirmaci%5Cu00f3n%2C%20no%20dejando%20de%20ser%20un%20diagn%5Cu00f3stico%20presuntivo%20%28Knapp%201988%29.%20La%20coaglutinaci%5Cu00f3n%20y%20los%20test%20de%20AF%20utilizan%20anticuerpos%20monoclonales%20para%20detectar%20Neisseria%20gonorrhoeae.%20Ya%20que%20los%20ensayos%20se%20pueden%20realizar%20con%20colonias%20de%20la%20placa%20de%20aislamiento%20primario%20y%20no%20requieren%20un%20cultivo%20puro%2C%20la%20identificaci%5Cu00f3n%20se%20puede%20conseguir%2024%20horas%20antes%20que%20con%20las%20pruebas%20r%5Cu00e1pidas%20de%20carbohidrato%20o%20de%20enzima%20sustrato.%20GonoGen%20%28New%20Horizons%20Diagnostics%29%2C%20Phadebact%20Monoclonal%20GC%20OMNI%20%28Pharmacia%29%20y%20Meritec%20GC%20%28Meridian%20Laboratories%29%20son%20pruebas%20de%20coaglutinaci%5Cu00f3n%20para%20la%20identificaci%5Cu00f3n%20de%20Neisseria%20gonorrhoeae%2C%20mientras%20que%20SYVA%20Microtak%20Neisseria%20gonorrhoeae%20Culture%20Confirmation%20Test%20%28SYVA%29%20es%20un%20reactivo%20comercial%20de%20anticuerpos%20monoclonales%20fluorescentes.%20En%20general%2C%20el%20diagn%5Cu00f3stico%20con%20anticuerpos%20monoclonales%20en%20Neisseria%20gonorrhoeae%20es%20sensible%20y%20espec%5Cu00edfico%20%28Lawton%20%26amp%3B%20Battaglioli%201983%2C%20Carlson%20et%20al.%2C%201987%29.%20A%20pesar%20de%20ello%2C%20se%20han%20documentado%20problemas%20con%20cada%20uno%20de%20estos%20reactivos%20%28Minshew%20et%20al.%2C%201985%3B%20Laughn%20et%20al.%2C%201987%3B%20Dillon%20et%20al.%2C%201988%3B%20Wech%20%26amp%3B%20Cartwright%201988%3B%20Walton%201989%3B%20Boehmet%20et%20al.%2C%201990%29.%20Con%20el%20desarrollo%20de%20nuevos%20m%5Cu00e9todos%20para%20el%20aislamiento%20y%20purificaci%5Cu00f3n%20de%20los%20%5Cu00e1cidos%20nucle%5Cu00edcos%2C%20se%20ha%20hecho%20posible%20el%20uso%20de%20t%5Cu00e9cnicas%20basadas%20en%20la%20utilizaci%5Cu00f3n%20de%20sondas%2C%20tanto%20de%20ADN%20como%20de%20ARN%2C%20para%20la%20detecci%5Cu00f3n%20e%20identificaci%5Cu00f3n%20de%20microorganismos%20pat%5Cu00f3genos%20en%20muestras%20cl%5Cu00ednicas.%20H.%20zur%20Hausen%20y%20H.%20Schulte-Holthausen%20emplearon%20el%20t%5Cu00e9rmino%20sonda%20por%20primera%20vez%20en%201970%20cuando%20estudiaban%20la%20presencia%20del%20virus%20Epstein-Barr%20en%20c%5Cu00e9lulas%20tumorales.%20Detectaron%20con%20%5Cu00e9xito%20la%20presencia%20de%20ADN%20viral%20en%20c%5Cu00e9lulas%20en%20las%20cuales%20los%20virus%20no%20pod%5Cu00edan%20propagarse%2C%20estableciendo%20la%20sensibilidad%20de%20la%20hibridaci%5Cu00f3n%20de%20%5Cu00e1cidos%20nucle%5Cu00edcos%20como%20herramienta%20diagn%5Cu00f3stica.%20En%20estos%20primeros%20estudios%20se%20usaban%20sondas%20de%20%5Cu00e1cidos%20nucle%5Cu00edcos%20que%20se%20hab%5Cu00edan%20marcado%20mientras%20el%20organismo%20estaba%20creciendo%20o%20replic%5Cu00e1ndose%2C%20es%20decir%2C%20in%20vivo.%20En%20la%20actualidad%2C%20el%20t%5Cu00e9rmino%20de%20sonda%20se%20aplica%20a%20secuencias%20de%20nucle%5Cu00f3tidos%20espec%5Cu00edficas%20que%2C%20o%20bien%20se%20han%20obtenido%20a%20trav%5Cu00e9s%20de%20manipulaciones%20tales%20como%20digesti%5Cu00f3n%20con%20enzimas%20y%20clonaje%2C%20seguida%20por%20marcaje%20in%20vitro%2C%20o%20bien%20mediante%20el%20uso%20de%20sintetizadores%20de%20ADN.%20La%20hibridaci%5Cu00f3n%20con%20sondas%20de%20%5Cu00e1cidos%20nucle%5Cu00edcos%20tiene%20un%20valor%20intr%5Cu00ednseco%20ya%20que%20%5Cu00e9stas%20detectan%20secuencias%20de%20%5Cu00e1cidos%20nucle%5Cu00edcos%20espec%5Cu00edficas%20y%20que%20pueden%20ser%20%5Cu00fanicas%20del%20organismo%20que%20se%20desea%20detectar.%20Los%20otros%20m%5Cu00e9todos%20de%20detecci%5Cu00f3n%20o%20identificaci%5Cu00f3n%20se%20basan%20en%20la%20detecci%5Cu00f3n%20de%20fenotipos%2C%20como%20reacciones%20qu%5Cu00edmicas%20o%20inmunol%5Cu00f3gicas%2C%20que%20representan%20el%20genotipo%20del%20organismo.%20Lo%20m%5Cu00e1s%20destacado%20de%20esta%20t%5Cu00e9cnica%20es%20pues%2C%20que%20detecta%20las%20secuencias%20gen%5Cu00f3micas%20y%20no%20una%20evidencia%20indirecta%20de%20las%20mismas.%20Otras%20ventajas%20de%20la%20hibridaci%5Cu00f3n%20son%3A%20a%29%20Reducci%5Cu00f3n%20de%20los%20falsos%20resultados%20debidos%20a%20cambios%20fenot%5Cu00edpicos%20del%20pat%5Cu00f3geno%2C%20b%29%20Aumento%20del%20rango%20de%20muestras%20y%20de%20pat%5Cu00f3genos%20que%20se%20pueden%20procesar%2C%20y%20c%29%20Debido%20a%20la%20estabilidad%20del%20ADN%2C%20las%20muestras%20se%20pueden%20transportar%20sin%20importar%20que%20el%20pat%5Cu00f3geno%20pierda%20viabilidad%20y%20pueden%20almacenarse%20durante%20mucho%20tiempo.%20La%20homolog%5Cu00eda%20del%20ADN%20ya%20ha%20sido%20aplicada%20en%20la%20identificaci%5Cu00f3n%20de%20bacterias%20%28e.g.%20Salmonella%2C%20Legionella%2C%20Mycobacterium%29%2C%20virus%20%28e.g.%20Rotavirus%2C%20Herpes%20simplex%2C%20Citomegalovirus%29%20y%20par%5Cu00e1sitos%20%28e.g.%20Leishmania%2C%20Plasmodium%20falciparum%2C%20Pneumocystis%29%20%28ver%20revisiones%20de%20Zwadyk%20%26amp%3B%20Cooksey%201987%20y%20Tenover%201988%29.%20Para%20Neisseria%20gonorrhoeae%20se%20han%20comercializado%20dos%20sondas%2C%20una%20para%20la%20identificaci%5Cu00f3n%20a%20partir%20de%20cultivo%20%28Orthoprobe%2C%20Ortho%20Diagnostics%29%20y%20otra%20para%20la%20detecci%5Cu00f3n%20en%20muestras%20cl%5Cu00ednicas%20%28Gen%20Probe%20PACE%2C%20Gen%20Probe%29.%20En%20Neisseria%20gonorrhoeae%20el%20pl%5Cu00e1smido%20cr%5Cu00edptico%20de%204%2C2%20Kilobases%20%28Kb%29%20es%20un%20excelente%20marcador%2C%20dado%20que%20lo%20poseen%20el%2096%25%20de%20las%20cepas%20%28Roberts%20et%20al.%2C%201979%29%2C%20y%20aquellas%20que%20no%20lo%20llevan%20suelen%20tener%20integrado%20una%20parte%20del%20mismo%20en%20el%20cromosoma%20%28Biswas%20et%20al.%2C%201986%29.%20Adem%5Cu00e1s%2C%20es%20un%20pl%5Cu00e1smido%20multicopia%20y%20existen%2030%20copias%20repetidas%20en%20cada%20bacteria%20%28Mayer%20et%20al.%2C%201974%29%2C%20hecho%20que%20facilita%20su%20detecci%5Cu00f3n.%20Este%20pl%5Cu00e1smido%20ha%20sido%20utilizado%20%5Cu00edntegro%20como%20sonda%20marcado%20con%20radiactividad%20%28Totten%20et%20al.%2C%201983%3B%20Perine%20et%20al.%2C%201985%29%20y%20los%20resultados%20fueron%20esperanzadores%2C%20aunque%20no%20del%20todo%20satisfactorios%20por%20la%20aparici%5Cu00f3n%20de%20falsos%20positivos.%20El%20objetivo%20de%20nuestro%20trabajo%20ha%20sido%20obtener%20una%20sonda%20a%20partir%20del%20pl%5Cu00e1smido%20de%204%2C2%20Kb%2C%20de%20tama%5Cu00f1o%20m%5Cu00e1s%20reducido%2C%20marcada%20de%20forma%20no%20isot%5Cu00f3pica%2C%20que%20mejore%20los%20resultados%20obtenidos%20con%20el%20pl%5Cu00e1smido%20entero%20y%20que%20permita%20realizar%20el%20diagn%5Cu00f3stico%20de%20infecci%5Cu00f3n%20gonoc%5Cu00f3cica%20en%20menos%20tiempo%20y%20con%20mayor%20seguridad%20que%20los%20m%5Cu00e9todos%20existentes%20en%20la%20actualidad.%20Para%20ello%2C%20hemos%20desarrollado%20los%20siguientes%20puntos%3A%201.-%20Aislamiento%20del%20pl%5Cu00e1smido%20de%204%2C2%20Kilobases%20de%20la%20cepa%20de%20Neisseria%20gonorrhoeae%2034%5C%2F85%20y%20caracterizaci%5Cu00f3n%20del%20mismo.%202.-%20Obtenci%5Cu00f3n%20de%20una%20genoteca%20a%20partir%20del%20pl%5Cu00e1smido%20de%204%2C2%20Kilobases%2C%20clon%5Cu00e1ndolo%20en%20el%20vector%20apropiado%20y%20transformando%20la%20cepa%20de%20Escherichia%20coli%20JM101.%203.-%20Caracterizaci%5Cu00f3n%20de%20los%20clones%20y%20elecci%5Cu00f3n%20del%20ADN%20que%20se%20iba%20a%20utilizar%20como%20sonda.%204.%20Marcaje%20de%20la%20sonda%20con%20un%20sistema%20no%20radiactivo.%205.%20Utilizaci%5Cu00f3n%20de%20la%20sonda%20para%3A%20a%29%20Hibridaci%5Cu00f3n%20con%20ADN%20y%20cultivos%20puros%20de%20Neisseria%20gonorrhoeae%20a%20distintas%20concentraciones.%20b%29%20Hibridaci%5Cu00f3n%20con%20cultivos%20puros%20de%20otras%20especies%20relacionadas%20filogen%5Cu00e9tica%20o%20ecol%5Cu00f3gicamente%20con%20Neisseria%20gonorrhoeae.%20c%29%20Hibridaci%5Cu00f3n%20con%20muestras%20obtenidas%20de%20pacientes%20que%20acuden%20al%20Centro%20de%20Enfermedades%20de%20Transmisi%5Cu00f3n%20Sexual%20de%20la%20Facultad%20de%20Medicina%20de%20Sevilla%2C%20y%20comparaci%5Cu00f3n%20de%20los%20resultados%20con%20los%20obtenidos%20por%20los%20procedimientos%20actuales%20de%20diagn%5Cu00f3stico%20de%20la%20enfermedad.%22%2C%22thesisType%22%3A%22%22%2C%22university%22%3A%22%22%2C%22date%22%3A%221990-11-20%22%2C%22language%22%3A%22spa%22%2C%22url%22%3A%22http%3A%5C%2F%5C%2Fhdl.handle.net%5C%2F11441%5C%2F38346%22%2C%22collections%22%3A%5B%22VN54CXGB%22%5D%2C%22dateModified%22%3A%222025-11-25T11%3A53%3A49Z%22%7D%7D%2C%7B%22key%22%3A%229EFEPRCI%22%2C%22library%22%3A%7B%22id%22%3A6316110%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Pascual%20Hern%5Cu00e1ndez%22%2C%22parsedDate%22%3A%221985-06-04%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BPascual%20Hern%26%23xE1%3Bndez%2C%20%26%23xC1%3B.%20%281985%29.%20%26lt%3Bi%26gt%3BRequerimientos%20ops%26%23xF3%3Bnicos%20y%20adherencia%20a%20cat%26%23xE9%3Bteres%20pl%26%23xE1%3Bsticos%20de%20estafilococo%20coagulasa%20negativo%26lt%3B%5C%2Fi%26gt%3B.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-ItemURL%26%23039%3B%20href%3D%26%23039%3Bhttp%3A%5C%2F%5C%2Fhdl.handle.net%5C%2F11441%5C%2F42252%26%23039%3B%26gt%3Bhttp%3A%5C%2F%5C%2Fhdl.handle.net%5C%2F11441%5C%2F42252%26lt%3B%5C%2Fa%26gt%3B%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22thesis%22%2C%22title%22%3A%22Requerimientos%20ops%5Cu00f3nicos%20y%20adherencia%20a%20cat%5Cu00e9teres%20pl%5Cu00e1sticos%20de%20estafilococo%20coagulasa%20negativo%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22%5Cu00c1lvaro%22%2C%22lastName%22%3A%22Pascual%20Hern%5Cu00e1ndez%22%7D%5D%2C%22abstractNote%22%3A%22En%20las%20%5Cu00faltimas%20d%5Cu00e9cadas%2C%20las%20mayores%20innovaciones%20en%20el%20campo%20de%20la%20terap%5Cu00e9utica%20se%20han%20centrado%20en%20el%20desarrollo%20de%20elementos%20prot%5Cu00e9sicos%2C%20terapia%20inmunosupresiva%20de%20enfermedades%20malignas%20y%20agentes%20antimicrobianos%20de%20amplio%20espectro%20para%20la%20terapia%20de%20las%20enfermedades%20infecciosas.%20Sin%20embargo%2C%20como%20respuesta%20negativa%20ante%20esta%20serie%20de%20avances%20terap%5Cu00e9uticos%2C%20han%20surgido%20un%20n%5Cu00famero%20de%20pat%5Cu00f3genos%20nosocomiales%2C%20considerados%20previamente%20de%20escasa%20o%20nula%20virulencia%20en%20los%20humanos.%20A%20esta%20l%5Cu00ednea%2C%20que%20incluye%20entre%20otros%20Serratia%20marcescens%2C%20Aspergilus%20fumigatus%2C%20Mycobacterium%20fortuitum%5Cu2026%20tenemos%20que%20a%5Cu00f1adir%20estafilococo%20coagulasa%20negativo%20%28ECN%29.%20Los%20tiempos%20en%20que%20el%20aislamiento%20de%20ECN%20en%20cultivo%20de%20exudados%20de%20heridas%2C%20sangre%20y%20cat%5Cu00e9teres%20era%20considerado%20autom%5Cu00e1ticamente%20como%20contaminaci%5Cu00f3n%2C%20han%20terminado%20definitivamente%20y%20en%20la%20actualidad%20se%20le%20reconoce%20como%20un%20importante%20agente%20etiol%5Cu00f3gico%20de%20infecciones%20en%20pacientes%20con%20cat%5Cu00e9teres%20intravenosos%2C%20bacteriemia%20en%20neutrop%5Cu00e9nicos%2C%20endocarditis%20sobre%20v%5Cu00e1lvulas%20prot%5Cu00e9sicas%20e%20infecciones%20en%20shunts%20de%20derivaci%5Cu00f3n%20en%20hidrocefalias%2C%20entre%20otras.%20La%20taxonom%5Cu00eda%20del%20g%5Cu00e9nero%20Staphylococcus%20ha%20sido%20renovada%20continuamente%20en%20los%20%5Cu00faltimos%20a%5Cu00f1os.%20En%20su%20inicio%2C%20el%20g%5Cu00e9nero%20Staphylococcus%20se%20dividi%5Cu00f3%20en%20funci%5Cu00f3n%20de%20la%20producci%5Cu00f3n%20de%20la%20enzima%20coagulasa%20desde%20el%20momento%20en%20que%20se%20observ%5Cu00f3%20la%20relaci%5Cu00f3n%20entre%20la%20capacidad%20de%20producir%20este%20enzima%20y%20su%20poder%20pat%5Cu00f3geno%20en%20humanos.%20De%20esta%20manera%2C%20se%20diferenci%5Cu00f3%20una%20especie%20productora%20de%20coagulasa%20y%20por%20tanto%20pat%5Cu00f3gena%20en%20humanos%20a%20la%20que%20se%20denomin%5Cu00f3%20S.%20aureus%20y%20el%20resto%20de%20especies%20que%20no%20pose%5Cu00edan%20la%20capacidad%20de%20producirla%20y%20por%20lo%20tanto%2C%20sin%20aparente%20poder%20pat%5Cu00f3geno%2C%20fueron%20agrupadas%20como%20estafilococos%20coagulasa%20negativo%2C%20denominaci%5Cu00f3n%20que%20ha%20continuado%20hasta%20nuestros%20d%5Cu00edas.%20A%20partir%20del%20reconocimiento%20general%20de%20su%20papel%20en%20patolog%5Cu00eda%20humana%2C%20la%20taxonom%5Cu00eda%20de%20ECN%2C%20ha%20sufrido%20importantes%20modificaciones%2C%20de%20tal%20manera%2C%20que%20los%20excelentes%20estudios%20de%20Baird-Parker%2C%20que%20solamente%20reconoc%5Cu00edan%20dos%20especies%2C%20S.%20epidermidis%20y%20S.%20saprophyticus%2C%20han%20quedado%20relegados%20en%20la%20actualidad.%20Posteriormente%2C%20Kloos%20y%20Schleifer%2C%20en%20funci%5Cu00f3n%20de%20estudios%20gen%5Cu00e9ticos%20y%20bioqu%5Cu00edmicos%2C%20distinguen%20nueve%20especies%20diferenciadas.%20En%20la%20actualidad%20se%20admite%20la%20existencia%20de%20hasta%2015%20especies%20de%20ECN%2C%20aunque%20continuamente%20se%20proponen%20nuevas%20especies.%20Cl%5Cu00e1sicamente%2C%20s%5Cu00f3lo%20dos%20de%20ellas%20ten%5Cu00edan%20importancia%20cl%5Cu00ednica%3A%20S.%20epidermidis%20y%20S.%20saprophyticus.%20El%20primero%20de%20ellos%20se%20considera%20el%20agente%20causal%20del%2075%25%20de%20las%20infecciones%20atribuidas%20a%20ECN.%20S.%20saprophyticus%20es%20productor%20de%20infecciones%20del%20tracto%20urinario%2C%20predominantemente%20en%20mujeres%20j%5Cu00f3venes.%20Otras%20especies%20incluyen%3A%20S.%20auricularis%2C%20S.%20capitis%2C%20S.%20cohnii%2C%20S.%20haemolyticus%2C%20S.%20hominis%2C%20S.%20lentus%2C%20S.%20sciuri%2C%20S.%20simulans%2C%20S.%20warneri%2C%20S.%20xylosus%2C%20S.%20intermedius%20y%20S.%20hyicus%2C%20que%20cada%20vez%20se%20van%20conociendo%20mejor.%20En%20las%20%5Cu00faltimas%20d%5Cu00e9cadas%2C%20ECN%20ha%20emergido%20como%20pat%5Cu00f3geno%20significativo%2C%20particularmente%20en%20pacientes%20que%20portan%20material%20prot%5Cu00e9sico%20y%20cat%5Cu00e9teres%20intrasvasculares.%20%5Cu00daltimamente%2C%20las%20septicemias%20por%20ECN%20se%20reconocen%20como%20una%20complicaci%5Cu00f3n%20frecuente%20y%20problem%5Cu00e1tica%20en%20reci%5Cu00e9n%20nacidos%20prematuros%2C%20en%20los%20que%20se%20utilizan%20con%20frecuencia%20pr%5Cu00f3tesis%20intravasculares%20para%20monitorizaci%5Cu00f3n%20y%20nutrici%5Cu00f3n.%20En%20adultos%2C%20las%20tromboflebitis%20y%20septicemias%20producidas%20por%20ECN%2C%20son%20complicaciones%20bien%20conocidas%20del%20uso%20de%20cat%5Cu00e9teres%20intravenosos%2C%20y%20aunque%20las%20consecuencias%20suelen%20ser%20menos%20graves%20que%20en%20neonatos%2C%20a%20veces%20tambi%5Cu00e9n%20suponen%20una%20importante%20complicaci%5Cu00f3n.%20Christensen%20y%20cols.%20encontraron%20a%20S.%20epidermidis%20como%20agente%20causal%20de%20una%20epidemia%20de%20septicemia%20nosocomial%20de%2020%20meses%20de%20duraci%5Cu00f3n%2C%20relacionada%20con%20el%20uso%20de%20cat%5Cu00e9teres%20de%20nutrici%5Cu00f3n%20parenteral%20en%20Estados%20Unidos.%20Otras%20epidemias%20relacionadas%20al%20uso%20de%20cat%5Cu00e9teres%20intravenosos%20han%20sido%20descritas%20en%20Estados%20Unidos%2C%20Canad%5Cu00e1%20y%20pa%5Cu00edses%20europeos.%20ECN%20y%20en%20particular%20S.%20epidermidis%20ha%20sido%20descrito%20como%20el%20agente%20etiol%5Cu00f3gico%20m%5Cu00e1s%20importante%20de%20peritonitis%20en%20pacientes%20que%20utilizan%20di%5Cu00e1lisis%20peritoneal%20cr%5Cu00f3nica%20ambulatoria%20debido%20principalmente%20al%20uso%20de%20cat%5Cu00e9teres%20pl%5Cu00e1sticos%20de%20di%5Cu00e1lisis%2C%20siendo%20el%20causante%20del%2017%20al%2038%25%20de%20los%20episodios.%20El%20incremento%20de%20las%20infecciones%20por%20ECN%20relacionadas%20con%20el%20uso%20d%20cat%5Cu00e9teres%20pl%5Cu00e1sticos%2C%20viene%20determinada%20por%20una%20serie%20de%20circunstancias%20de%20las%20que%20detallaremos%20las%20m%5Cu00e1s%20importantes.%20En%20primer%20lugar%2C%20hay%20una%20tendencia%2C%20cada%20vez%20m%5Cu00e1s%20acentuada%2C%20a%20utilizar%20nutrici%5Cu00f3n%20parenteral%20en%20pacientes%20graves%20y%20por%20largos%20periodos%20de%20tiempo.%20Para%20este%20tipo%20de%20alimentaci%5Cu00f3n%2C%20se%20utilizan%20v%5Cu00edas%20pl%5Cu00e1sticas%20que%20a%20veces%20se%20mantienen%20durante%20semanas.%20Paralelamente%2C%20cada%20vez%20es%20mayor%20el%20n%5Cu00famero%20de%20pacientes%20que%20se%20benefician%20de%20la%20di%5Cu00e1lisis%20peritoneal%20cr%5Cu00f3nica%20ambulatoria%20y%20por%20periodos%20de%20tiempo%20m%5Cu00e1s%20prolongados.%20En%20segundo%20lugar%2C%20al%20ser%20ECN%20flora%20residente%20de%20la%20piel%20y%20puesto%20que%20los%20cat%5Cu00e9teres%20se%20insertan%20a%20trav%5Cu00e9s%20de%20ella%2C%20ser%5Cu00e1n%20los%20principales%20contaminantes%20involucrados%20en%20estos%20procedimientos.%20Una%20vez%20introducido%2C%20se%20forma%20alrededor%20del%20cat%5Cu00e9ter%20un%20manguito%20de%20fibrina%20que%20favorece%20la%20emigraci%5Cu00f3n%20de%20las%20bacterias%20desde%20el%20exterior%20al%20interior.%20En%20tercer%20lugar%2C%20los%20sistemas%20de%20nutrici%5Cu00f3n%20parenteral%20se%20utilizan%20frecuentemente%20en%20pacientes%20graves%20ingresados%20en%20zonas%20de%20fuerte%20presi%5Cu00f3n%20antibi%5Cu00f3tica%2C%20lo%20que%20permite%20la%20colonizaci%5Cu00f3n%20por%20cepas%20multirresistentes%20de%20ECN.%20Finalmente%2C%20es%20importante%20resaltar%20la%20especial%20afinidad%20de%20ECN%20por%20colonizar%20las%20superficies%20de%20cat%5Cu00e9teres.%20Diversos%20autores%2C%20han%20observado%20%5Cu201cin%20vitro%5Cu201d%20alteraciones%20erosivas%20en%20la%20superficie%20del%20cat%5Cu00e9ter%20tras%20la%20interacci%5Cu00f3n%20con%20ECN.%20Por%20otro%20lado%2C%20se%20ha%20descrito%20en%20cepas%20de%20ECN%20la%20producci%5Cu00f3n%20de%20un%20polisac%5Cu00e1rido%20extracelular%20de%20naturaleza%20mucoide%2C%20al%20que%20se%20atribuyen%20propiedades%20de%20adherencia%20y%20protecci%5Cu00f3n%20frente%20a%20la%20fagocitosis%20por%20leucocitos%20polimorfonucleares.%20Estos%20hallazgos%2C%20podr%5Cu00edan%20explicar%20parcialmente%2C%20la%20gran%20afinidad%20de%20ECN%20por%20el%20material%20prot%5Cu00e9sico%20as%5Cu00ed%20como%20la%20gran%20dificultad%20para%20la%20erradicaci%5Cu00f3n%20de%20las%20infecciones%20producidas%20por%20estas%20bacterias%2C%20si%20no%20se%20retira%20previamente%20el%20cuerpo%20extra%5Cu00f1o.%20Respuesta%20del%20hu%5Cu00e9sped%20frente%20a%20estafilococo%20coagulasa%20negativo.%20Con%20respecto%20a%20la%20interacci%5Cu00f3n%20entre%20estafilococo%20y%20los%20factores%20de%20defensa%20del%20hu%5Cu00e9sped%2C%20la%20piel%20y%20las%20membranas%20mucosas%20juegan%20un%20important%5Cu00edsimo%20papel%20de%20protecci%5Cu00f3n.%20Sin%20embargo%2C%20incluso%20en%20individuos%20sanos%2C%20estas%20barreras%20se%20rompen%20frecuentemente%20ofreciendo%20una%20puerta%20de%20entrada%20para%20estafilococos%20y%20otros%20habitantes%20de%20la%20piel%20que%20les%20permite%20alcanzar%20los%20tejidos%20subyacentes.%20En%20este%20momento%2C%20entra%20en%20funcionamiento%20la%20segunda%20l%5Cu00ednea%20de%20defensa%2C%20que%20est%5Cu00e1%20representada%20por%20el%20sistema%20de%20opsoninas%20y%20las%20c%5Cu00e9lulas%20fagoc%5Cu00edticas%20%28leucocitos%20polimorfonucleares%20y%20monocitos%29.%20Una%20adecuada%20opsonizaci%5Cu00f3n%20es%20un%20requisito%20indispensable%20para%20la%20ingesti%5Cu00f3n%20por%20las%20c%5Cu00e9lulas%20fagoc%5Cu00edticas%20de%20estafilococo%2C%20demostrado%20por%20el%20hecho%20de%20que%20pacientes%20con%20defectos%20en%20el%20sistema%20de%20opsoninas%20sufren%20infecciones%20estafiloc%5Cu00f3cicas%20recurrentes.%20El%20sistema%20de%20opsoninas%20est%5Cu00e1%20formado%20por%20unas%20opsoninas%20termoestables%20representadas%20por%20la%20Inmunoglobulina%20G%20%28IgG%29%20principalmente%20y%20unas%20opsoninas%20termol%5Cu00e1biles%20representadas%20por%20la%20fracci%5Cu00f3n%20C3b%20del%20complemento%2C%20que%20se%20unen%20a%20receptores%20espec%5Cu00edficos%20de%20la%20superficie%20bacteriana%20desencadenando%20el%20proceso%20de%20la%20fagocitosis%20una%20vez%20que%20entran%20en%20contacto%20con%20las%20c%5Cu00e9lulas%20fagoc%5Cu00edticas.%20En%20el%20suero%20de%20individuos%20sanos%2C%20existen%20anticuerpos%20tipo%20IgG%20con%20capacidad%20opsonizante%20dirigidas%20frente%20a%20componentes%20de%20peptidoglicano%20y%20%5Cu00e1cidos%20teicoicos%20de%20estafilococo%20que%20se%20pueden%20detectar%20si%20se%20utiliza%20una%20t%5Cu00e9cnica%20suficientemente%20sensible%20%28ELISA%2C%20Radioimunoan%5Cu00e1lisis%29.%20En%20pacientes%20con%20infecci%5Cu00f3n%20estafiloc%5Cu00f3cica%20severa%2C%20tal%20como%20endocarditis%2C%20se%20detectan%20frecuentemente%2C%20niveles%20elevados%20de%20estos%20anticuerpos%2C%20que%20pueden%20ayudar%20en%20el%20diagn%5Cu00f3stico%20de%20estas%20infecciones%20cuando%20los%20cultivos%20permanecen%20negativos.%20Dentro%20de%20%5Cu00e9ste%20sistema%20de%20opsoninas%20termoestables%2C%20los%20anticuerpos%20tipo%20IgG%20dirigidos%20frente%20al%20peptidoglicano%20tienen%20mucha%20mayor%20capacidad%20opsonizante%20que%20aquellos%20dirigidos%20frente%20a%20los%20%5Cu00e1cidos%20teicoicos.%20Sin%20embargo%2C%20actualmente%20existen%20evidencias%20de%20que%20el%20sistema%20de%20opsoninas%20termol%5Cu00e1biles%2C%20representado%20por%20la%20fracci%5Cu00f3n%20C3%20del%20complemento%2C%20juega%20un%20papel%20de%20mucha%20relevancia%20que%20las%20inmunoglobulinas%20en%20la%20fagocitosis%20de%20estafilococo.%20En%20ese%20sentido%2C%20el%20peptidoglicano%20de%20estafilococo%20es%20capaz%20de%20activar%20el%20complemento%20a%20trav%5Cu00e9s%20de%20la%20v%5Cu00eda%20alternativa%2C%20activaci%5Cu00f3n%20por%20lo%20tanto%20no%20dependiente%20de%20anticuerpos%2C%20que%20se%20traduce%20en%20la%20aposici%5Cu00f3n%20de%20mol%5Cu00e9culas%20de%20C3b%20ops%5Cu00f3nicamente%20activas%20en%20la%20envuelta%20celular.%20Una%20vez%20opsonizado%2C%20estafilococo%20es%20f%5Cu00e1cilmente%20reconocido%20e%20ingerido%20por%20las%20c%5Cu00e9lulas%20fagoc%5Cu00edticas%2C%20especialmente%20por%20los%20leucocitos%20polimorgonucleares.%20En%20la%20muerte%20intracelular%20de%20estafilococo%2C%20act%5Cu00faan%20dos%20sistemas%20bactericidas%20de%20los%20leucocitos%20polimorfonucleares%2C%20un%20sistema%20independiente%20del%20ox%5Cu00edgeno%20y%20representado%20por%20el%20contenido%20lisosomal%20%28lisozima%2C%20prote%5Cu00ednas%20cati%5Cu00f3nicas%2C%20lactoferrina...%29%20y%20otro%20dependiente%20de%20ox%5Cu00edgeno%20que%20se%20traduce%20en%20la%20producci%5Cu00f3n%20de%20radicales%20t%5Cu00f3xicos%20del%20mismo%20%28radical%20super%5Cu00f3xido%20%28O-2%29%2C%20hidr%5Cu00f3xilo%20%28OH%29%20etc%5Cu2026%29.%20La%20importancia%20de%20los%20radicales%20t%5Cu00f3xicos%20de%20ox%5Cu00edgeno%20en%20la%20muerte%20intracelular%20de%20estafilococo%20se%20pone%20de%20manifiesto%20en%20los%20pacientes%20con%20Enfermedad%20Cr%5Cu00f3nica%20Granulomatosa.%20Los%20granulocitos%20de%20estos%20pacientes%20son%20incapaces%20de%20generar%20estos%20radicales%20y%20su%20capacidad%20bactericida%20frente%20a%20estafilococo%20est%5Cu00e1%20muy%20reducida.%20Este%20fen%5Cu00f3meno%2C%20demostrable%20f%5Cu00e1cilmente%20%5Cu201cin%20vitro%5Cu201d%2C%20queda%20demostrado%20%5Cu201cin%20vivo%5Cu201d%20por%20el%20hecho%20de%20que%20estos%20pacientes%20sufren%20frecuentemente%20infecciones%20estafiloc%5Cu00f3cicas%20recurrentes%2C%20aunque%20la%20severidad%20y%20la%20tasa%20de%20recurrencia%20var%5Cu00eda%20ampliamente%20entre%20los%20distintos%20pacientes.%20Llegado%20a%20este%20punto%2C%20debemos%20enfatizar%20el%20hecho%20de%20que%20para%20la%20mayor%5Cu00eda%20de%20estos%20estudios%20sobre%20las%20defensas%20del%20hu%5Cu00e9sped%20frente%20a%20estafilococo%2C%20se%20han%20utilizado%20cepas%20de%20S.%20aureus%20y%20s%5Cu00f3lo%20ocasionalmente%20algunas%20cepas%20de%20ECN.%20Anteriormente%20mencion%5Cu00e1bamos%20c%5Cu00f3mo%20numerosos%20investigadores%20han%20demostrado%20la%20importancia%20de%20las%20opsoninas%20para%20una%20adecuada%20fagocitosis%20de%20estafilococo.%20Sin%20embargo%2C%20en%20sus%20trabajos%20empleaban%20normalmente%2C%20bacterias%20suspendidas%20en%20un%20medio%20acuoso.%20Si%20tenemos%20en%20cuenta%20la%20especial%20afinidad%20de%20ECN%20por%20adherirse%20a%20material%20pl%5Cu00e1stico%20como%20el%20utilizado%20en%20la%20fabricaci%5Cu00f3n%20de%20cat%5Cu00e9teres%2C%20ser%5Cu00eda%20interesante%20preguntarnos%20c%5Cu00f3mo%20actuar%5Cu00edan%20los%20mecanismos%20de%20defensa%20del%20hu%5Cu00e9sped%20ante%20estas%20bacterias%20adheridas%20a%20una%20superficie%20y%20qu%5Cu00e9%20papel%20desarrollar%5Cu00eda%20el%20sistema%20de%20las%20opsoninas.%20El%20concepto%20de%20fagocitosis%20de%20%5Cu201csuperficie%5Cu201d%2C%20de%20gran%20inter%5Cu00e9s%20actual%20por%20los%20problemas%20mencionados%20anteriormente%2C%20fue%20descrito%20e%20introducido%20en%201946%20por%20Woos%20y%20cols.%20Estos%20autores%20afirmaban%20que%20la%20fagocitosis%20de%20Streptococcus%20pneumoniae%20en%20los%20alveolos%20pulmonares%20era%20posible%20en%20ausencia%20de%20opsoninas%20cuando%20las%20bacterias%20estaban%20%5Cu201catrapadas%5Cu201d%20en%20una%20superficie%2C%20lo%20que%20facilitaba%20la%20ingesti%5Cu00f3n%20por%20parte%20de%20los%20macr%5Cu00f3fagos%20alveolares%20en%20una%20zona%20pobre%20de%20opsoninas.%20En%20la%20d%5Cu00e9cada%20actual%2C%20resurge%20el%20inter%5Cu00e9s%20por%20la%20fagocitosis%20de%20superficie%2C%20pero%20se%20presta%20muy%20escasa%20atenci%5Cu00f3n%20al%20problema%20en%20relaci%5Cu00f3n%20con%20estafilococo.%20Solamente%20los%20estudios%20de%20Lee%20y%20cols.%20y%20Vandenbroucke%20y%20cols.%20han%20demostrado%20que%20la%20fagocitosis%20de%20S.%20aureus%20adheridos%20a%20superficie%20pl%5Cu00e1stica.%20Sin%20embargo%2C%20no%20han%20sido%20realizados%20hasta%20la%20fecha%20estudios%20similares%20utilizando%20cepas%20de%20ECN%2C%20que%20es%20el%20agente%20etiol%5Cu00f3gico%20m%5Cu00e1s%20importante%20en%20infecciones%20asociadas%20a%20cat%5Cu00e9teres%20y%20material%20prot%5Cu00e9sico.%20Otro%20problema%20al%20que%20se%20ha%20prestado%20escasa%20atenci%5Cu00f3n%20ha%20sido%20a%20la%20adherencia%20ECN%20al%20material%20pl%5Cu00e1stico.%20Diferentes%20autores%20se%20atienen%20exclusivamente%20a%20estudios%20descriptivos%20utilizando%20microscop%5Cu00eda%20electr%5Cu00f3nica.%20Otra%20serie%20de%20autores%20han%20demostrado%20que%20la%20adherencia%20a%20cat%5Cu00e9teres%20pl%5Cu00e1sticos%20est%5Cu00e1%20asociada%20a%20la%20producci%5Cu00f3n%20de%20flebitis%20infecciosa%20en%20modelos%20experimentales.%20Sin%20embargo%2C%20existe%20escasa%20informaci%5Cu00f3n%20sobre%20la%20verdadera%20naturaleza%20de%20la%20uni%5Cu00f3n%20de%20las%20bacterias%20a%20las%20superficies%20pl%5Cu00e1sticas%20y%20los%20mecanismos%20inespec%5Cu00edficos%20que%20en%20ella%20act%5Cu00faan.%20Se%20postula%20la%20importancia%20de%20las%20fuerzas%20hidrof%5Cu00f3bicas%20en%20la%20adherencia%20de%20estafilococo%20a%20superficies%20altamente%20hidr%5Cu00f3fobas%20como%20las%20utilizadas%20en%20la%20fabricaci%5Cu00f3n%20de%20biomateriales%20tales%20como%20el%20tefl%5Cu00f3n%5Cu2026.%20Sin%20embargo%2C%20aunque%20la%20hidrofobicidad%20puede%20promover%20la%20adherencia%2C%20son%20necesarios%20un%20mayor%20n%5Cu00famero%20de%20estudios%20para%20confirmar%20tal%20aseveraci%5Cu00f3n.%20Valorando%20todos%20los%20problemas%20expuestos%20anteriormente%20y%20teniendo%20en%20cuenta%20la%20ausencia%20de%20estudios%20en%20este%20campo%20en%20el%20que%20se%20hayan%20utilizado%20gran%20n%5Cu00famero%20de%20cepas%20aisladas%20de%20muestras%20cl%5Cu00ednicas%2C%20fue%20por%20lo%20que%20decidimos%20la%20realizaci%5Cu00f3n%20de%20este%20trabajo%2C%20con%20la%20intenci%5Cu00f3n%20de%20obtener%20una%20informaci%5Cu00f3n%20concreta%20sobre%20la%20patog%5Cu00e9nesis%20de%20las%20infecciones%20producidas%20por%20ECN%20y%20especialmente%20aquellas%20relacionadas%20con%20el%20uso%20de%20cat%5Cu00e9teres%20pl%5Cu00e1sticos.%20La%20hip%5Cu00f3tesis%20de%20trabajo%20se%20basa%20en%20el%20estudio%20de%20los%20siguientes%20puntos%3A%201.%20Identificaci%5Cu00f3n%20en%20especies%20de%2038%20cepas%20de%20ECN%20aisladas%20en%20procesos%20patol%5Cu00f3gicos%20infecciosos%20en%20los%20que%20ten%5Cu00edan%20un%20papel%20etiol%5Cu00f3gico.%202.%20Estudio%20de%20las%20propiedades%20de%20superficie%20de%20estas%20cepas%20que%20se%20relacionan%20directamente%20con%20la%20colonizaci%5Cu00f3n%20de%20cat%5Cu00e9teres%3A%20producci%5Cu00f3n%20de%20sustancia%20mucoide%20e%20hidrofobicidad%20de%20superficie.%203.%20influencia%20de%20las%20propiedades%20de%20superficie%20de%20ECN%20en%20el%20metabolismo%20del%20leucocito%20polimorfonuclear%20durante%20la%20fagocitosis.%20Alteraciones%20cuantitativas%20en%20la%20emisi%5Cu00f3n%20de%20quimioluminiscencia%20celular.%204.%20Modulaci%5Cu00f3n%20de%20la%20hidrofobicidad%20bacteriana%20por%20diferentes%20fuentes%20ops%5Cu00f3nicas%20y%20diversos%20tratamientos%20de%20las%20mismas.%205.%20Estudio%20de%20los%20requerimientos%20ops%5Cu00f3nicos%20de%20ECN%20suspendido%20en%20medio%20acuoso.%20Fagocitosis%20por%20leucocitos%20polimorfonucleares%20humanos%20utilizando%20bacterias%20marcadas%20por%20is%5Cu00f3topos%20radioactivos.%20Papel%20de%20la%20hidrofobicidad%20y%20de%20la%20sustancia%20mucoide.%206.%20Estudio%20de%20los%20requerimientos%20ops%5Cu00f3nicos%20y%20fagocitosis%20de%20ECN%20utilizando%20bacterias%20adheridas%20a%20superficie%20pl%5Cu00e1stica.%20Comparaci%5Cu00f3n%20con%20cepas%20de%20S.%20aureus.%20Papel%20de%20la%20hidrofobicidad%20y%20producci%5Cu00f3n%20de%20sustancia%20mucoide.%207.%20Estudio%20cuantitativo%20de%20la%20adherencia%20de%20ECN%20a%20cat%5Cu00e9teres%20intravenosos%20de%20tefl%5Cu00f3n%20y%20poliuretano.%20Papel%20que%20juegan%20las%20propiedades%20de%20superficie%20bacterianas.%208.%20Modulaci%5Cu00f3n%20de%20la%20adherencia%20bacteriana%20a%20cat%5Cu00e9teres.%20Papel%20de%20diferentes%20componentes%20del%20suero.%22%2C%22thesisType%22%3A%22%22%2C%22university%22%3A%22%22%2C%22date%22%3A%221985-06-04%22%2C%22language%22%3A%22spa%22%2C%22url%22%3A%22http%3A%5C%2F%5C%2Fhdl.handle.net%5C%2F11441%5C%2F42252%22%2C%22collections%22%3A%5B%22VN54CXGB%22%5D%2C%22dateModified%22%3A%222025-11-25T10%3A54%3A24Z%22%7D%7D%5D%7D